Unnamed: 0,title,date,stock,sentiment
1000270.0,"Shares of several healthcare companies are trading lower in sympathy with the overall market following an increase in coronavirus cases in some US states that have reopened, leading to concerns of a second wave of the virus.",2020-06-11 10:22:00-04:00,PFE,positive
1000271.0,Pfizer Reports FDA Approval Of Co.'s NYVEPRIA,2020-06-11 08:04:00-04:00,PFE,positive
1000272.0,Johnson & Johnson To Start Coronavirus Vaccine Human Trials Ahead Of Schedule In July,2020-06-11 00:16:00-04:00,PFE,neutral
1000273.0,"The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset",2020-06-10 07:30:00-04:00,PFE,positive
1000274.0,"Pfizer Announces Top-Line Results From JADE TEEN Trial Of Abrocitinib In Adolescents With Moderate-To-Severe Atopic Dermatitis; Observed Improvements In Skin Clearance, Disease Extent, And Severity Among Patients 12 To <18",2020-06-10 06:46:00-04:00,PFE,positive
1000275.0,Valneva Announces HSR Clearance For Lyme Vaccine Collaboration With Pfizer,2020-06-08 12:04:00-04:00,PFE,neutral
1000276.0,AstraZeneca Approached Gilead With A Deal That Could Be The Biggest On Record: Report,2020-06-08 03:56:00-04:00,PFE,neutral
1000277.0,Ex-FDA Chief On White House's Coronavirus Vaccine Shortlist: 'They Chose Very Novel Platforms',2020-06-04 11:02:00-04:00,PFE,positive
1000278.0,Revisiting The Coronavirus Vaccine Race: Updates On The 10 Candidates In Clinics,2020-06-03 17:53:00-04:00,PFE,neutral
1000279.0,"UPDATE: Five Companies Chosen For 'Vaccine Finalist' Are Moderna, Johnson & Johnson, Merck, Pfizer And AstraZeneca",2020-06-03 13:09:00-04:00,PFE,neutral
1000280.0,"Fauci Reiterates Moderna Vaccine Data Is 'Cautiously Optimistic,' Expects Pfizer's Results To Be The Same",2020-06-02 08:56:00-04:00,PFE,neutral
1000281.0,"The Daily Biotech Pulse: FDA Nod For Roche's Combo Therapy In Liver Cancer, Allena Rips Higher, Pfizer To Invest Up To $500M In Biotechs",2020-06-02 07:45:00-04:00,PFE,negative
1000282.0,71 Biggest Movers From Yesterday,2020-06-02 04:39:00-04:00,PFE,neutral
1000283.0,"Pfizer Analyst Takes Stock Of Negative Breast Cancer Data, Pharma Giant's 2025 Goals",2020-06-01 14:25:00-04:00,PFE,negative
1000284.0,48 Stocks Moving In Monday's Mid-Day Session,2020-06-01 12:34:00-04:00,PFE,neutral
1000285.0,"JP Morgan Maintains Neutral on Pfizer, Lowers Price Target to $36",2020-06-01 11:31:00-04:00,PFE,positive
1000286.0,Pfizer shares are trading lower after the company's data monitoring committee said its breast cancer treatment trial is unlikely to show statistically significant improvement.,2020-06-01 08:40:00-04:00,PFE,negative
1000287.0,26 Stocks Moving in Monday's Pre-Market Session,2020-06-01 07:02:00-04:00,PFE,neutral
1000288.0,A Peek Into The Markets: US Stock Futures Edge Lower Following Weekend of Violent Protests; Manufacturing Data In Focus,2020-06-01 06:02:00-04:00,PFE,negative
1000289.0,"5 Stocks To Watch For June 1, 2020",2020-06-01 04:31:00-04:00,PFE,neutral
1000290.0,Pfizer Falls On Disappointing Breast Cancer PALLAS Study,2020-05-29 16:55:00-04:00,PFE,negative
1000291.0,"Pfizer Says Data Monitoring Committe Determined Phase 3 Trial Of IBRANCE Plus Endocrine Therapy in HR+, HER2- Early Breast Cancer Is Unlikely To Show Statistically Significant Improvement In Primary Endpoint",2020-05-29 16:16:00-04:00,PFE,positive
1000292.0,Pfizer Reports Final PROSPER Results Show XTANDI Significantly Extends Overall Survival In Men With Non-Metastatic Castration-Resistant Prostate Cancer,2020-05-29 08:18:00-04:00,PFE,negative
1000293.0,"The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant",2020-05-29 07:22:00-04:00,PFE,positive
1000294.0,"Cramer Shares His Thoughts On Teva, Oxford Industries And More",2020-05-29 06:40:00-04:00,PFE,positive
1000295.0,Corning And Pfizer Announce Supply Agreement For Corning Valor Glass Packaging,2020-05-28 08:31:00-04:00,PFE,positive
1000296.0,ContraFect Corporation Announces Private Placement Of Common Stock And Warrants To Pfizer Inc.,2020-05-26 07:32:00-04:00,PFE,neutral
1000297.0,Novavax Begins Phase 1 Clinical Trial Of Its Coronavirus Vaccine,2020-05-26 02:48:00-04:00,PFE,neutral
1000298.0,The Week Ahead In Biotech: ASCO Presentations In The Spotlight,2020-05-24 14:40:00-04:00,PFE,neutral
1000299.0,"In The Midst Of Pandemic, Traders Pin Their Hopes On These Healthcare ETFs",2020-05-19 09:38:00-04:00,PFE,positive
1000300.0,Moncef Slaoui To Divest Moderna Stake As He Joins White House Vaccine Accelerator,2020-05-19 09:00:00-04:00,PFE,neutral
1000301.0,"The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering",2020-05-19 08:24:00-04:00,PFE,positive
1000302.0,"These 6 Coronavirus Vaccine Candidates Are The Likeliest To Succeed, Says Morgan Stanley",2020-05-18 12:07:00-04:00,PFE,positive
1000303.0,"GSK, Pfizer Owned ViiV Healthcare Announces Long-acting Injectable Formulation of Cabotegravir Dosed Every Two Months Shows Higher Efficacy Than Daily Oral PrEP",2020-05-18 06:25:00-04:00,PFE,neutral
1000304.0,Pfizer Highlights Updated Phase 1b Data On PF-06939926 To Treat Duchenne Muscular Dystrophy,2020-05-15 08:03:00-04:00,PFE,positive
1000305.0,"The Daily Biotech Pulse: Co-Diagnostics Earnings, NantKwest Plans Pancreatic Cancer Study, ADC Therapeutics IPO",2020-05-15 07:49:00-04:00,PFE,negative
1000306.0,Pfizer Reports Top-Line Results From Phase 3 Lot Consistency Study Of 20-Valent Pneumococcal Conjugate Vaccine In Pneumococcal Vaccine-Naive Adults 18-49,2020-05-14 10:00:00-04:00,PFE,neutral
1000307.0,"AbbVie's Potential Is 'Underappreciated,' Says Morgan Stanley Analyst",2020-05-13 12:03:00-04:00,PFE,neutral
1000308.0,"Benzinga Pro's Top 5 Stocks To Watch For Wed., May 13, 2020: CSCO, PFE, NCLH, ALLK, SDC",2020-05-13 07:58:00-04:00,PFE,positive
1000309.0,A Peek Into The Markets: US Stock Futures Up Ahead Of Fed's Powell Speech,2020-05-13 05:45:00-04:00,PFE,neutral
1000310.0,Moderna CEO Says Company's Vaccine Alone Can't Meet Global Supply,2020-05-13 05:03:00-04:00,PFE,negative
1000311.0,Pfizer Plans To Test Coronavirus Vaccine On Thousands Of Patients By September,2020-05-13 02:18:00-04:00,PFE,neutral
1000312.0,"Pfizer Highlights New Data From Trials Of 18 Approved, Investigational Medicines Will Be Presented At ASCO 20 Virtual Program May 29-31",2020-05-12 12:04:00-04:00,PFE,positive
1000313.0,Cruise Line Earnings Later This Week Could Provide Insight On Brutal Quarter For Industry,2020-05-11 11:27:00-04:00,PFE,negative
1000314.0,Senator Schumer Called on Veterans Affairs Administration to Come Clean on Whether It's Using Veterans to Test Hydroxychloroquine,2020-05-10 17:11:00-04:00,PFE,positive
1000315.0,"The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight",2020-05-10 15:40:00-04:00,PFE,neutral
1000316.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,PFE,negative
1000317.0,"Pfizer Begins Human Testing Of Coronavirus Vaccine In US, Michigan Among Manufacturing Centers",2020-05-05 14:58:00-04:00,PFE,neutral
1000318.0,'Pfizer begins coronavirus vaccine testing in US; Mich. lab could mass produce it' -Detroit Free Press,2020-05-05 13:16:00-04:00,PFE,positive
1000319.0,"U.S. Immigration And Customs Working With 3M, Amazon, Pfizer & Others To Curtail Imports Of Counterfeit Masks, Coronavirus Tests, Other Gear",2020-05-05 12:34:00-04:00,PFE,positive
1000320.0,What You Should Know About Alexion's $1.4B Proposed Buyout Of Portola Pharma,2020-05-05 09:10:00-04:00,PFE,neutral
1000321.0,Pfizer and BioNTech shares are trading higher after the companies announced they have dosed their first participants in the US as part of the coronavirus mRNA vaccine development program.,2020-05-05 07:12:00-04:00,PFE,positive
1000322.0,Pfizer And BioNTech Dose First Participants In US As Part Of Global COVID-19 (Coronavirus) mRNA Vaccine Development Program,2020-05-05 06:45:00-04:00,PFE,neutral
1000324.0,Pfizer Highlights Results Of New Data For Group B Streptococcus Infection Published In Journal Of Infectious Diseases,2020-05-04 09:01:00-04:00,PFE,neutral
1000325.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,PFE,neutral
1000326.0,From Earlier: Pfizer Aims For 10-20M Virus Vaccine Doses By End Of 2020,2020-04-30 13:07:00-04:00,PFE,neutral
1000327.0,"Valneva and Pfizer Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15",2020-04-30 05:43:00-04:00,PFE,neutral
1000328.0,"Barclays Maintains Equal-Weight on Pfizer, Raises Price Target to $37",2020-04-29 11:59:00-04:00,PFE,neutral
1000329.0,"The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda",2020-04-29 08:40:00-04:00,PFE,positive
1000330.0,"Pfizer Says Coronavirus Vaccine Could Be Available By Fall, US Clinical Trials To Begin Next Week",2020-04-29 00:09:00-04:00,PFE,neutral
1000331.0,A CURE For The Common Earnings Play,2020-04-28 14:48:00-04:00,PFE,positive
1000332.0,Pfizer Says Coronavirus Vaccine Could Be Ready For Emergency Use By Fall If Passes Testing; Could Begin Testing As Soon As Next Week,2020-04-28 13:14:00-04:00,PFE,neutral
1000333.0,From Pfizer Earnings Conference Call: Net Impact Of Coronavirus Pandemic On FY20 Sales Should Be 'Negligible',2020-04-28 10:34:00-04:00,PFE,neutral
1000334.0,Morning Market Stats in 5 Minutes,2020-04-28 10:32:00-04:00,PFE,neutral
1000335.0,Pfizer CEO Says No Change In Commitment To Merger Of Upjohn Unit With Mylan,2020-04-28 10:21:00-04:00,PFE,positive
1000336.0,"Earnings Feast: Bring a Plate With Healthcare and Caterpillar in Morning, GOOGL And AMD Later",2020-04-28 10:06:00-04:00,PFE,neutral
1000337.0,"The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update",2020-04-28 07:36:00-04:00,PFE,neutral
1000338.0,Pfizer shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.,2020-04-28 07:20:00-04:00,PFE,positive
1000339.0,"Pfizer Sees FY20 Adj. EPS $2.82-$2.92 vs $2.86 Est., Sales $48.5B-$50.5B vs $49.33B Est.",2020-04-28 06:46:00-04:00,PFE,neutral
1000340.0,"Pfizer Q1 Adj. EPS $0.800 Beats $0.730 Estimate, Sales $12.028B Beat $11.870B Estimate",2020-04-28 06:45:00-04:00,PFE,neutral
1000341.0,"A Peek Into The Markets: US Stock Futures Up Ahead Of Earnings, Economic Reports",2020-04-28 05:48:00-04:00,PFE,neutral
1000342.0,"Earnings Scheduled For April 28, 2020",2020-04-28 04:55:00-04:00,PFE,neutral
1000343.0,"10 Stocks To Watch For April 28, 2020",2020-04-28 04:04:00-04:00,PFE,neutral
1000344.0,"Apple And Amazon Earnings, Fed Meeting Among Highlights In Busy Week Ahead",2020-04-27 09:44:00-04:00,PFE,positive
1000345.0,"The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight",2020-04-26 16:37:00-04:00,PFE,negative
1000346.0,Inovio CEO Says 'It's Possible' For Coronavirus Vaccine To Be Ready In 12 To 18 Months,2020-04-23 22:19:00-04:00,PFE,positive
1000347.0,Shares of several healthcare companies are trading higher. Movement appears market-related as equities gain amid a rebound in oil prices.,2020-04-23 11:27:00-04:00,PFE,positive
1000348.0,"Mylan Shares Tick Higher, Still Down 0.9% For Session, But Off Intraday Low; Hearing EU Conditional Approval Was Given For Off-Patent Deal With Pfizer",2020-04-22 12:38:00-04:00,PFE,positive
1000349.0,"BioNTech, Immunic Soar On COVID-19 Developmental Updates",2020-04-22 11:02:00-04:00,PFE,neutral
1000350.0,"The Daily Biotech Pulse: Immunic To Develop COVID Treatment, Gilead Strikes IO Partnership",2020-04-22 07:51:00-04:00,PFE,negative
1000351.0,Pfizer shares are trading higher after the company and BioNTech received German regulatory approval to begin the first clinical trial of their coronavirus vaccine candidate.,2020-04-22 06:10:00-04:00,PFE,positive
1000352.0,BioNTech and Pfizer Announce Regulatory Approval from German Authority Paul-Ehrlich-Institut to Commence First Clinical Trial of COVID-19 Vaccine Candidates,2020-04-22 05:34:00-04:00,PFE,positive
1000353.0,How The COVID-19 Pandemic Could End,2020-04-20 16:33:00-04:00,PFE,neutral
1000354.0,S&P 500 Futures Up 3.2% After Hours; Many Other Stocks Moving Higher With Futures; Investors Reacting Favorably To White Phase Guidelines On Reopening Economy,2020-04-16 18:11:00-04:00,PFE,positive
1000355.0,3 Frontrunners In COVID-19 Vaccine Development: What You Need To Know,2020-04-15 15:45:00-04:00,PFE,neutral
1000356.0,Every Member Of Trump's 'Great American Economic Revival' Industry Groups,2020-04-15 13:09:00-04:00,PFE,positive
1000357.0,WHO Spokesperson Says Not Expecting to See the Vaccine for 12 Months or Longer,2020-04-14 05:43:00-04:00,PFE,neutral
1000358.0,"Pfizer, BioNTech, Arcturus Share Timelines For Human Testing As COVID-19 Vaccine Development Intensifies",2020-04-09 13:43:00-04:00,PFE,positive
1000359.0,Why BioNTech's Stock Is Trading Higher Today,2020-04-09 10:25:00-04:00,PFE,neutral
1000360.0,Pfizer Says Anti-Viral Compounds Show Activity Against Sars-cov-2 In Preclinical Screening,2020-04-09 07:54:00-04:00,PFE,neutral
1000361.0,"The Daily Biotech Pulse: FDA Nod For Pfizer, Vanda Forges Partnership For COVID-19 Drug Research, Neuronetics Pre-Announces Revenue Shortfall",2020-04-09 07:52:00-04:00,PFE,neutral
1000362.0,Pfizer And BioNTech Intend To Initiate First Clinical Trials Of Coronavirus Vaccine As Early As Apr. 2020; BioNTech To Receive $185M Upfront And Is Eligible For Up To $563M In Milestones,2020-04-09 07:39:00-04:00,PFE,neutral
1000363.0,"EMD Serono, Pfizer Report Completion Of Submission Of Supplemental Biologics License Application To FDA For BAVENCIO For Treatment Of Urothelial Carcinoma; FDA Grants Breakthrough Therapy Designation",2020-04-09 06:01:00-04:00,PFE,positive
1000364.0,"What's The Difference Between Coronavirus, SARS-CoV-2 and COVID-19?",2020-04-03 16:22:00-04:00,PFE,neutral
1000365.0,Cannabis Opportunity In The Time Of The Coronavirus,2020-04-02 17:59:00-04:00,PFE,positive
1000366.0,Pfizer Reports European Approval For RUXIENCE,2020-04-02 14:05:00-04:00,PFE,positive
1000368.0,"Morgan Stanley Maintains Equal-Weight on Pfizer, Lowers Price Target to $36",2020-04-02 09:25:00-04:00,PFE,negative
1000369.0,Shares of several healthcare companies are trading lower amid market weakness as growing coronavirus concerns in the US weigh on equities.,2020-04-01 09:20:00-04:00,PFE,negative
1000370.0,Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates,2020-03-31 17:15:00-04:00,PFE,neutral
1000371.0,Portfolio Manager Offers Buying Tips: Focus On What You Own,2020-03-30 16:03:00-04:00,PFE,neutral
1000372.0,"Barron's Picks And Pans: Tech Picks, SoftBank, REITs, Tesla And More",2020-03-29 10:29:00-04:00,PFE,neutral
1000373.0,"Cramer Reveals Stock Favorites, Says Intuitive Surgical A 'Winner'",2020-03-27 10:10:00-04:00,PFE,positive
1000374.0,"Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus legislation has boosted economic optimism, demand concerns still exist amid the coronavirus outbreak.",2020-03-27 09:22:00-04:00,PFE,positive
1000375.0,"RBC Capital Maintains Outperform on Pfizer, Lowers Price Target to $44",2020-03-27 07:29:00-04:00,PFE,negative
1000376.0,"Shares of several healthcare companies are trading higher following Senate passage of a $2 trillion economic stimulus package, which has lifted stocks across sectors.",2020-03-26 11:49:00-04:00,PFE,positive
1000377.0,"The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Xencor Licenses Tech To Vir For COVID-19 Treatment, Delay In Pfizer's Upjohn-Mylan Merger",2020-03-26 08:23:00-04:00,PFE,negative
1000378.0,"Mylan, Pfizer Report Delay Of Deal Closing For Mylan, Upjohn Deal, Closing Now Expected H2'20",2020-03-26 07:05:00-04:00,PFE,negative
1000379.0,"Pfizer To Pause Participant Recruitment For New, Ongoing Trials For 3 Weeks",2020-03-25 12:54:00-04:00,PFE,neutral
1000380.0,FDA Says In A Letter To Pfizer And Mylan Detailed How Epipen Devices May Activate Prematurely If Blue Safety Release Is Removed Using A Sideways Force,2020-03-24 13:49:00-04:00,PFE,positive
1000381.0,"Shares of several healthcare companies are trading higher as equities gain amid hopes of a US stimulus agreement. Additionally, the coronavirus outbreak has increased demand for certain medical supplies.",2020-03-24 12:20:00-04:00,PFE,positive
1000382.0,26 Stocks Moving in Tuesday's Pre-Market Session,2020-03-24 07:12:00-04:00,PFE,neutral
1000383.0,Pfizer Announces FDA Approval Of Supplemental New Drug Application For Expanded Indication Of EUCRISA Ointment 2% In Children With Mild-To-Moderate Atopic Dermatitis,2020-03-24 06:46:00-04:00,PFE,positive
1000384.0,Stocks That Hit 52-Week Lows On Monday,2020-03-23 10:34:00-04:00,PFE,negative
1000385.0,Stocks That Hit 52-Week Lows On Friday,2020-03-20 14:26:00-04:00,PFE,negative
1000386.0,"The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection",2020-03-19 07:37:00-04:00,PFE,neutral
1000387.0,Pfizer Announces JADE COMPARE Trial Met All Co-Primary Endpoints,2020-03-18 16:16:00-04:00,PFE,neutral
1000388.0,PreMarket Prep Stock Of The Day: BioNTech,2020-03-18 14:42:00-04:00,PFE,neutral
1000389.0,IDEAYA and Pfizer Enter Clinical Trial Collaboration And Supply Agreement To Evaluate Clinical Combination Of IDE196 And Binimetinib In Solid Tumors Harboring GNAQ Or GNA11 Hotspot Mutations,2020-03-18 06:04:00-04:00,PFE,positive
1000390.0,"Shares of several healthcare companies are trading higher, rebounding from Monday's crash. Stocks may also potentially be getting a boost from expectations of further stimulus proposals.",2020-03-17 09:10:00-04:00,PFE,positive
1000391.0,"The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment",2020-03-17 08:48:00-04:00,PFE,neutral
1000392.0,Phizer & BioNTech shares are trading higher after the companies announced they are working to co-develop a potential coronavirus vaccine.,2020-03-17 08:28:00-04:00,PFE,positive
1000393.0,"Pfizer, BioNTech to Co-develop Potential COVID-19 Vaccine",2020-03-17 05:18:00-04:00,PFE,neutral
1000394.0,8 Biotechs With Coronavirus Vaccines In Development,2020-03-16 10:42:00-04:00,PFE,neutral
1000395.0,Shares of several healthcare companies are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy.,2020-03-16 09:40:00-04:00,PFE,negative
1000396.0,BioNTech Says Coronavirus Vaccine Testing Begins Next Month In 'Project Lightspeed',2020-03-16 09:14:00-04:00,PFE,neutral
1000397.0,Pfizer Issues Press Release Highlighting 5-Point Plan To Battle Coronavirus,2020-03-13 15:25:00-04:00,PFE,negative
1000398.0,Shares of several healthcare companies are trading higher as the market rebounds following Thursday's selloff. NOTE: Since the coronavirus outbreak the healthcare sector has been extremely volatile.,2020-03-13 09:29:00-04:00,PFE,positive
1000399.0,"The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings",2020-03-13 07:52:00-04:00,PFE,negative
1000400.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,PFE,negative
1000401.0,Shares of several healthcare companies are trading lower as equities sell off amid continued global coronavirus concerns. The virus has caused global economic disruption and negatively impacted stocks across sectors.,2020-03-12 09:26:00-04:00,PFE,negative
1000402.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,PFE,negative
1000403.0,Shares of several healthcare companies are trading lower. Movement appears market related amid selloff in equities. The global coronavirus outbreak has caused volatility in global markets and impacted stocks across sectors.,2020-03-11 07:15:00-04:00,PFE,neutral
1000404.0,How Close Are Biotechs To Bringing A COVID-19 Treatment To Market?,2020-03-10 17:24:00-04:00,PFE,neutral
1000405.0,Shares of several healthcare companies are trading higher as markets rebound following Monday's selloff. US President Trump on Monday indicated the US may implement payroll tax cuts and other measures to support the economy amid the coronavirus outbreak.,2020-03-10 07:54:00-04:00,PFE,positive
1000406.0,'CMA welcomes Court of Appeal judgment in Phenytoin case' - GOV.UK,2020-03-10 06:46:00-04:00,PFE,positive
1000407.0,Shares of several healthcare  companies are trading lower. Movement appears market-related as markets continue to dip amid the global coronavirus outbreak and OPEC failing to reach production agreement.,2020-03-09 10:55:00-04:00,PFE,neutral
1000408.0,"GlaxoSmithKline's ViiV Healthcare Reports 5-Year, $20M Renewal Of Partnership With Pfizer, Shionogi, University Of North Carolina For HIV Cure",2020-03-09 10:01:00-04:00,PFE,neutral
1000409.0,52 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-03-09 08:04:00-04:00,PFE,neutral
1000410.0,Shares of several healthcare companies are trading lower. Movement appears market related as markets continue to dip amid the global coronavirus outbreak.,2020-03-06 09:11:00-05:00,PFE,neutral
1000411.0,Lipper Award Winners Pick Healthcare and Technology Stocks Amidst Coronavirus Downturn,2020-03-06 08:33:00-05:00,PFE,positive
1000412.0,Shares of several drugmakers and healthcare companies are trading higher following US Super Tuesday results in which Joe Biden won the highest number of delegates. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.,2020-03-04 07:48:00-05:00,PFE,positive
1000413.0,Pfizer Works On Compounds That May Help Stop Coronaviruses,2020-03-03 06:53:00-05:00,PFE,positive
1000414.0,Pfizer Says Recently Completed A Preliminary Assessment Of Certain Antiviral Compounds That Were Previously In Development And That Inhibited The Replication Of Coronaviruses; Expects To Have Results Regarding Possible Coronavirus Treatment Back By The En,2020-03-02 17:24:00-05:00,PFE,positive
1000415.0,Pfizer's Biologics License Application for Tanezumab Accepted for Review by the FDA,2020-03-02 06:49:00-05:00,PFE,positive
1000416.0,Stocks That Hit 52-Week Lows On Friday,2020-02-28 10:16:00-05:00,PFE,negative
1000417.0,Shares of several healthcare companies are trading lower as the global coronavirus spread continues to cause equities across sectors to sell off amid worsened economic outlook.,2020-02-28 09:06:00-05:00,PFE,negative
1000418.0,"Pfizer Says Continued Spread Of Coronavirus Globally Could Adversely Impact Operations, Including Manufacturing, Supply Chain, Clinical Trial Operations",2020-02-27 14:29:00-05:00,PFE,negative
1000419.0,"Benzinga's Top Upgrades, Downgrades For February 27, 2020",2020-02-27 09:37:00-05:00,PFE,positive
1000420.0,"Barclays Initiates Coverage On Pfizer with Equal-Weight Rating, Announces $36 Price Target",2020-02-27 07:59:00-05:00,PFE,neutral
1000421.0,Basilea Reports Launch of Cresemba in Australia Triggering Milestone Payment from Pfizer,2020-02-27 05:23:00-05:00,PFE,neutral
1000422.0,Shares of several healthcare and biotech companies are trading higher. Not seeing any news to justify the price action.,2020-02-26 14:28:00-05:00,PFE,positive
1000423.0,Shares of several healthcare and biotech companies are trading higher. Movement appears market related as equities have rebounded this session following recent selloffs.,2020-02-26 11:19:00-05:00,PFE,positive
1000424.0,"The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates",2020-02-26 09:36:00-05:00,PFE,negative
1000425.0,Pfizer Announces European Commission Approval Of VYNDAQEL For Transthyretin Amyloid Cardiomyopathy,2020-02-18 06:47:00-05:00,PFE,positive
1000426.0,"Astellas Pharma, Pfizer Reports Results Of Final Overall Survival Analysis From Phase 3 PROSPER Trial Which Evaluated XTANDI",2020-02-11 08:08:00-05:00,PFE,neutral
1000427.0,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology",2020-02-11 07:23:00-05:00,PFE,positive
1000428.0,Here's How Much Investing $100 In Allergan Stock Back In 2010 Would Be Worth Today,2020-02-10 11:48:00-05:00,PFE,positive
1000429.0,3 Leveraged Healthcare ETFs Soaring This Month,2020-02-10 09:39:00-05:00,PFE,neutral
1000430.0,"UPDATE: Mizuho Initiates Coverage On Pfizer with Buy Rating, Announces $42 Price Target As Firm Sees 'products such as Eliquis, Xtandi, and Xeljanz helping ""New Pfizer"" drive 7%+ sales and 9%+ income CAGR from 2020-2025.'",2020-02-06 11:11:00-05:00,PFE,positive
1000431.0,"Mizuho Initiates Coverage On Pfizer with Buy Rating, Announces $42 Price Target",2020-02-06 05:12:00-05:00,PFE,neutral
1000432.0,"Mizuho Initiates Coverage On Pfizer, Evolus, Karuna Therapeutics With Buy Ratings, Neurocrine Biosciences, Sage Therapeutics With Neutrals",2020-02-05 16:48:00-05:00,PFE,neutral
1000433.0,13 Key NASH Drug Candidates To Watch For In A Potential $30-Billion Market,2020-02-05 16:11:00-05:00,PFE,neutral
1000434.0,"The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus",2020-02-02 13:04:00-05:00,PFE,neutral
1000435.0,"Pfizer Receives Positive CHMP Opinion For Oncology Biosimilar, RUXIENCE",2020-01-31 09:01:00-05:00,PFE,positive
1000436.0,EMA's CHMP Adopts Positive Opinion For Pfizer's Staquis For Treatment Of Atropic Dermatitis,2020-01-31 06:15:00-05:00,PFE,positive
1000437.0,Mid-Afternoon Market Update: Dow Surges 250 Points; Delphi Technologies Shares Gain On Acquisition News,2020-01-28 15:00:00-05:00,PFE,positive
1000438.0,Mid-Day Market Update: Crude Oil Rises Over 1%; Acceleron Pharma Shares Spike Higher,2020-01-28 12:08:00-05:00,PFE,negative
1000439.0,PreMarket Prep Recap: Fear Of Missing Out Greater Than Fear Of Coronavirus,2020-01-28 11:40:00-05:00,PFE,negative
1000440.0,"From Pfizer's Earnings Conference Call: 'Exec Says Expects To Bring One New Gene Therapy Into Clinic ""Every Year Or So""'",2020-01-28 11:14:00-05:00,PFE,neutral
1000441.0,From Pfizer's Earnings Conference Call: Executive Says Co Not iNterested In Big M&A,2020-01-28 10:57:00-05:00,PFE,negative
1000442.0,Mid-Morning Market Update: Markets Open Higher; Pfizer Earnings Miss Views,2020-01-28 10:22:00-05:00,PFE,negative
1000443.0,Turnaround Tuesday? Stocks Look To Bounce Back As Apple Earnings Loom Later,2020-01-28 09:39:00-05:00,PFE,negative
1000444.0,Tuesday's Market Minute: Earnings Snapshot,2020-01-28 09:26:00-05:00,PFE,neutral
1000445.0,Pfizer shares are trading lower after the company reported worse-than-expected Q4 EPS results.,2020-01-28 08:10:00-05:00,PFE,neutral
1000446.0,Pfizer Reports Mixed Q4 Earnings,2020-01-28 07:37:00-05:00,PFE,neutral
1000447.0,"Pfizer Sees FY20 Adj. EPS $2.82-$2.92 vs $2.90 Est., Sales $48.5B-$50.5B vs $49.52B Est.",2020-01-28 06:46:00-05:00,PFE,neutral
1000448.0,"Pfizer Q4 Adj. EPS $0.55 Misses $0.57 Estimate, Sales $12.7B Beat $12.61B Estimate",2020-01-28 06:45:00-05:00,PFE,negative
1000449.0,"A Peek Into The Markets: US Stock Futures Up Ahead Of Earnings, Fed Meeting",2020-01-28 06:19:00-05:00,PFE,neutral
1000450.0,"10 Stocks To Watch For January 28, 2020",2020-01-28 04:45:00-05:00,PFE,neutral
1000451.0,"Earnings Scheduled For January 28, 2020",2020-01-28 04:00:00-05:00,PFE,neutral
1000452.0,A Preview Of Pfizer's Q4 Earnings,2020-01-27 13:15:00-05:00,PFE,neutral
1000453.0,"Going Viral: Stocks On Their Back As Virus Spreads Heading Into Key Earnings, Fed Week",2020-01-27 09:58:00-05:00,PFE,neutral
1000454.0,"The Week Ahead In Biotech: Amgen, Eli Lilly, Pfizer In Earnings Mix, IPO Flow Resumes",2020-01-26 10:23:00-05:00,PFE,neutral
1000455.0,"Barron's Picks And Pans: Apple, Boeing, Disney, Tesla And More",2020-01-18 15:42:00-05:00,PFE,neutral
1000456.0,"Cannabis Media Company The Fresh Toast Expands Again, Announces It's Now Cash Positive",2020-01-17 13:48:00-05:00,PFE,positive
1000457.0,"Benzinga Pro's Top 5 Stocks To Watch For Mon., Jan. 13, 2020: WCC, LULU, XLF, TEAM, BIIB",2020-01-13 08:46:00-05:00,PFE,positive
1000458.0,"Biogen To Acquire PF-05251749, A Novel Clinical Stage Asset With Application in Alzheimer's And Parkinson's From Pfizer; Pfizer To Receive $75M Upfront And Up To $635M In Milestones",2020-01-13 07:32:00-05:00,PFE,positive
1000459.0,Zymeworks Announces Agreement with Pfizer; Initiation of New Phase 2 Trial Evaluating ZW25 in Combination with Ibrance,2020-01-12 10:09:00-05:00,PFE,positive
1000460.0,"Barron's Picks And Pans: Apple, Bank of America, Lockheed Martin And More",2020-01-11 11:57:00-05:00,PFE,neutral
1000461.0,"'California Gov. Gavin Newsom wants the state to become the first to create its own generic drug label, an attempt to create more competition and bring down prices.' -Axios, From Earlier",2020-01-10 12:55:00-05:00,PFE,positive
1000462.0,Concerto HealthAI Announces Expanded Collaboration With Pfizer To Accelerate Real-World Evidence And AI Technologies For Additional Disease Areas,2020-01-10 09:33:00-05:00,PFE,neutral
1000463.0,ViiV Healthcare Says EMA's Committee For Medicinal Products For Human Use Has Granted An Accelerated Assessment For Fostemsavir Marketing Authorization Application,2020-01-10 08:20:00-05:00,PFE,positive
1000464.0,"ViiV Healthcare Submits Regulatory Application To The European Medicines Agency For Fostemsavir, An Investigational, First-in-class Attachment Inhibitor For The Treatment Of HIV In Adults With Few Treatment Options Available",2020-01-10 08:18:00-05:00,PFE,positive
1000465.0,"RBC Capital Yesterday Initiated Coverage On Pfizer with Outperform Rating, Announced $46 Price Target",2020-01-07 12:41:00-05:00,PFE,neutral
1000466.0,"Pfizer Shares Quiet After Hours As Hearing RBC Initiates Coverage On Stock With Outperform Rating, $46 Price Target",2020-01-06 16:28:00-05:00,PFE,positive
1000467.0,Pfizer's Phase 3 JAVELIN Bladder 100 Study Met its Primary Endpoint,2020-01-06 07:06:00-05:00,PFE,neutral
1000468.0,Drugmakers Kick Off 2020 With Margin-Expanding Price Hikes,2020-01-02 10:41:00-05:00,PFE,neutral
1000469.0,Pfizer Says To Increase List Prices On Around 27% Of Its U.S. Portfolio By Average Of 5.6% On Jan 1,2019-12-31 15:57:00-05:00,PFE,positive
1000470.0,"Drugmakers Including Pfizer, GlaxoSmithKline, Sanofi, To Hike US Prices On More Than 200 Drugs In January; Median US Drug Price Increase For Jan. 1 2020 Is Around 5%, According To Healthcare Research Firm",2019-12-31 15:56:00-05:00,PFE,positive
1000471.0,"Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck's Lynparza, Pending Clinical Readouts In Focus",2019-12-29 18:38:00-05:00,PFE,neutral
1000472.0,FDA Approves Applications For First Generics Of Eliquis,2019-12-23 15:35:00-05:00,PFE,positive
1000473.0,"Theravance Biopharma And Pfizer Inc. Enter Global License Agreement For Skin-Targeted, Locally-Acting Pan-Janus Kinase Inhibitor Program; Theravance To Receive Upfront Cash Payment Of $10M And Up To $240M In Milestones",2019-12-23 08:18:00-05:00,PFE,positive
1000474.0,Sangamo Announces Early Completion of Transfer to Pfizer of SB-525 Hemophilia A Gene Therapy IND and an Earned $25 Million Milestone Payment,2019-12-23 06:51:00-05:00,PFE,neutral
1000475.0,How The Dow Jones Industrial Average Changed Over The Past Decade,2019-12-22 10:00:00-05:00,PFE,neutral
1000476.0,"FDA Issues Warning On Serious Breathing Problems With Gabapentin, Pregabalin",2019-12-19 15:01:00-05:00,PFE,negative
1000477.0,"Pfizer Reports FDA Accepted, Granted Priority Review Of Supplemental New Drug Application For BRAFTOVI In Combo With ERBITUX For Treatment Of BRAFV600E-Mutant Metastatic Colorectal Cancer After Prior Therapy",2019-12-18 10:33:00-05:00,PFE,negative
1000478.0,19 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-12-17 07:57:00-05:00,PFE,neutral
1000479.0,"The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO",2019-12-17 07:56:00-05:00,PFE,positive
1000480.0,Pfizer Receives FDA Approval For XTANDI For The Treatment Of Metastatic Castration-Sensitive Prostate Cancer,2019-12-16 18:00:00-05:00,PFE,negative
1000481.0,"iRhythm Announces Participation In GUARD-AF Study Focused On Undiagnosed Atrial Fibrillation, Sponsored By Bristol-Myers Squibb-Pfizer Alliance",2019-12-16 16:09:00-05:00,PFE,positive
1000482.0,Pfizer shares are trading higher after the company raised its quarterly dividend from $0.36 to $0.38 per share.,2019-12-16 10:19:00-05:00,PFE,positive
1000483.0,Pfizer Raises Qtr Dividend From $0.36 to $0.38/Share,2019-12-16 08:32:00-05:00,PFE,neutral
1000484.0,"Barron's Picks And Pans: Charles Schwab, Disney, Sprint, Netflix And More",2019-12-14 13:36:00-05:00,PFE,neutral
1000485.0,"The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer",2019-12-13 08:10:00-05:00,PFE,positive
1000486.0,"EMA Reports Pfizer's Amsparity Received Positive Opinion From CHMP For Treatment OF Certain 
Inflammatory, Autoimmune Disorders",2019-12-13 06:17:00-05:00,PFE,positive
1000487.0,"The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares",2019-12-10 07:56:00-05:00,PFE,positive
1000488.0,"Trevena And Pfizer Entered Into Amendment To Development & Supply Agreement, Dated Dec. 15, 2016",2019-12-09 08:29:00-05:00,PFE,positive
1000489.0,"Glaxo, Pfizer's ViiV Healthcare Reports Submission Of New Drug Application To FDA For Fostemsavir For Treatment Of HIV",2019-12-05 07:44:00-05:00,PFE,neutral
1000490.0,"The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial",2019-12-03 07:59:00-05:00,PFE,neutral
1000491.0,Shares of several healthcare stocks are trading lower as US equities dip following escalating US-China tensions over Hong Kong. US Stocks further fell on worse-than-expected manufacturing data.,2019-12-02 11:31:00-05:00,PFE,negative
1000492.0,Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates,2019-11-29 08:13:00-05:00,PFE,neutral
1000493.0,"The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug",2019-11-26 08:06:00-05:00,PFE,positive
1000494.0,"UPDATE: Piper Jaffray Initiates OPKO Health With Overweight, $2.50 Target Notes 'Partner Pfizer recently reported positive Phase III data on once-weekly somatrogon in pediatric Growth Hormone Deficiency'; Pfizer Anticipates Filing 'BLA 2H:20'",2019-11-25 09:09:00-05:00,PFE,positive
1000495.0,3 Health Care ETFs Hitting New Highs,2019-11-25 07:08:00-05:00,PFE,positive
1000496.0,"Barron's Picks And Pans: Pfizer's New Identity, Electric Vehicles, Hong Kong Exodus — And Is The Bull Market About To End?",2019-11-23 15:42:00-05:00,PFE,neutral
1000497.0,"Trump Says he Will Release a Plan to Let States Import Prescription Drugs Which are ""MUCH CHEAPER""",2019-11-22 14:08:00-05:00,PFE,neutral
1000498.0,"Cantor Believes Alnylam Is In 'Breakout Mode,' Sees Recent Strength From 2 Factors: 1. Greater Confidence That RNAi Is A Real New Class Of Commercial Medicines, 2. Less Concern Pfizer's Tafamidis Will Take Meaningful Share From Onpattro Launch",2019-11-21 09:48:00-05:00,PFE,positive
1000499.0,"GSK's ViiV Healthcare Announces Exclusive Licensing Agreement With The National Institutes of Health For Investigational ""bNAb"" With Potential For Long-acting HIV Treatment And Prevention",2019-11-21 09:10:00-05:00,PFE,positive
1000500.0,This Dividend ETF Is Having Its Day,2019-11-21 08:00:00-05:00,PFE,neutral
1000501.0,"The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data",2019-11-20 07:25:00-05:00,PFE,positive
1000502.0,Pfizer's ABRILADA Approved by the FDA as a Biosimilar to Humira for the Treatment of Certain Patients with Rheumatoid Arthritis,2019-11-18 06:48:00-05:00,PFE,positive
1000503.0,"Bristol-Myers, Pfizer Report Randomized, Controlled Trial To Evaluate Effect Of Atrial Fibrillation Screening",2019-11-15 09:03:00-05:00,PFE,neutral
1000504.0,12 Dow Stocks With At Least 2% Dividend Yields,2019-11-13 15:45:00-05:00,PFE,neutral
1000505.0,Abbott CEO Miles White Steps Down,2019-11-13 11:23:00-05:00,PFE,neutral
1000506.0,"Mylan, Pfizer Report New Of Co. To Be Formed By Planned Combo Of Mylan, Upjohn 'Viatris",2019-11-12 12:16:00-05:00,PFE,neutral
1000507.0,Pfizer Announces Phase 3 Study Of XELJANZ In Juvenile Idiopathic Arthritis Met Primary Endpoint,2019-11-12 06:47:00-05:00,PFE,neutral
1000508.0,Seattle Children's Hospital Closes Five Rooms After Detecting Aspergillus,2019-11-11 12:55:00-05:00,PFE,neutral
1000509.0,EMD Serono and Pfizer Announce Topline Results Of the Phase III JAVELIN Gastric 100 Trial,2019-11-08 08:09:00-05:00,PFE,neutral
1000510.0,AstraZeneca Named The Most Innovative Global Pharma Company,2019-11-06 11:20:00-05:00,PFE,positive
1000511.0,Mylan Q3 Non-GAAP EPS Beats Street Estimate; Drugmaker Narrows Guidance Range,2019-11-05 10:59:00-05:00,PFE,neutral
1000512.0,WeTrader Competition: Round Four Wrap-up,2019-11-01 17:15:00-04:00,PFE,neutral
1000513.0,"EMA Safety Committee Review Showed Pfizer's Xeljanz Could Increase Risk Of Blood Clots In Lungs, Deep Veins In Patients Already At High Risk",2019-10-31 10:43:00-04:00,PFE,positive
1000514.0,"Fitbit, Pfizer, And More 'Fast Money' Picks For October 30",2019-10-30 12:15:00-04:00,PFE,neutral
1000515.0,"Decision Day: Fed On Tap Later, Followed by Apple, Facebook After Close",2019-10-30 09:52:00-04:00,PFE,neutral
1000516.0,"Alphabet Misses On Earnings, But Drugmakers, Mastercard Beat Expectations",2019-10-29 10:45:00-04:00,PFE,negative
1000517.0,From Pfizer Earnings Conference Call: Co. Not Looking for Larger M&A At This Time,2019-10-29 10:42:00-04:00,PFE,neutral
1000518.0,From Pfizer Q3 Earnings Conference Call: Sees FY19 Upjohn Sales In China Growing By Mid To High Single Digits,2019-10-29 10:26:00-04:00,PFE,positive
1000519.0,Pfizer Says Efforts To Improve Diagnosis Rates Of Rare Heart Disease Has Helped Drive Sales Of Recently Approved Drug VYNDAQEL,2019-10-29 10:14:00-04:00,PFE,positive
1000520.0,28 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-10-29 08:33:00-04:00,PFE,neutral
1000521.0,"Pharma Earnings: Merck, Pfizer Trade Higher On Q3 Beats",2019-10-29 07:57:00-04:00,PFE,neutral
1000522.0,"The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study",2019-10-29 07:32:00-04:00,PFE,positive
1000523.0,Pfizer shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also raised its FY19 EPS and sales guidance above analyst estimates.,2019-10-29 07:24:00-04:00,PFE,positive
1000524.0,"Pfizer Raises FY19 Adj. EPS Guidance From $2.76-$2.86 To $2.94-$3.00 vs $2.82 Est., Raises Sales Guidance From $50.5B-$52.5B To $51.2B-$52.2B vs $51.32B Est.",2019-10-29 06:48:00-04:00,PFE,neutral
1000525.0,"Pfizer Q3 Adj. EPS $0.75 Beats $0.62 Estimate, Sales $12.68B Beat $12.26B Estimate",2019-10-29 06:47:00-04:00,PFE,neutral
1000526.0,"12 Stocks To Watch For October 29, 2019",2019-10-29 05:23:00-04:00,PFE,neutral
1000527.0,"Earnings Scheduled For October 29, 2019",2019-10-29 04:57:00-04:00,PFE,neutral
1000528.0,Pfizer's Q3 Earnings Preview,2019-10-28 15:06:00-04:00,PFE,neutral
1000529.0,Pfizer Reports EC Has Approved BAVENCIO Plus Axitinib Combo For First-Line Treatment Of Patients With Advanced Renal Cell Carcinoma,2019-10-28 14:01:00-04:00,PFE,positive
1000530.0,More Earnings And A Fed Decision In Week Four Of The WeTrader Competition,2019-10-28 11:56:00-04:00,PFE,neutral
1000531.0,"The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings",2019-10-27 12:56:00-04:00,PFE,neutral
1000532.0,"'Fast Money Halftime Report' Traders Weigh In On Salesforce, Pfizer And More",2019-10-23 17:04:00-04:00,PFE,neutral
1000533.0,Biotech Stock On The Radar: Immunomedics' Long Wait For Redemption,2019-10-23 16:27:00-04:00,PFE,neutral
1000534.0,OPKO and Pfizer's Phase 3 Study of Somatrogon Met its Primary Endpoint,2019-10-21 08:05:00-04:00,PFE,neutral
1000535.0,Bristol-Myers Squibb-Pfizer Alliance Announces They Are Collaborating With Fitbit To Develop Educational Content Around Atrial Fibrillation,2019-10-17 09:06:00-04:00,PFE,neutral
1000536.0,"Bank of America Reinstates Neutral on Pfizer, Announces $37 Price Target",2019-10-17 07:22:00-04:00,PFE,neutral
1000537.0,"ImaginAb Signs Multi-party Collaboration Agreement With Pfizer, AstraZeneca, Takeda to Help Further Develop Company's Cd8 Immunopet Technology",2019-10-14 04:25:00-04:00,PFE,positive
1000538.0,Pfizer Presents Positive Phase 3 Data for Abrocitinib in Moderate to Severe Atopic Dermatitis at EADV 2019,2019-10-12 15:51:00-04:00,PFE,positive
1000539.0,Trader Toolkit: Cash Flow,2019-10-11 09:18:00-04:00,PFE,neutral
1000540.0,BioNTech IPO: What You Need To Know,2019-10-08 07:55:00-04:00,PFE,neutral
1000541.0,Akcea and Ionis Each to Receive a $125M Upfront Payment From Pfizer for the Exclusive Licensing of AKCEA-ANGPTL3-L,2019-10-07 06:54:00-04:00,PFE,positive
1000542.0,"Movers And Shakers At ESMO 2019: Immunomedics, G1 Therapeutics, Seattle Genetics And More",2019-09-30 13:13:00-04:00,PFE,positive
1000543.0,"Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer",2019-09-30 10:53:00-04:00,PFE,negative
1000544.0,Pfizer Reports Chair Ian Read To Retire; CEO Albert Bourla Named Replacement,2019-09-27 08:03:00-04:00,PFE,neutral
1000545.0,"The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave",2019-09-27 07:56:00-04:00,PFE,positive
1000546.0,"Pfizer Reports Top-Line Results From Second Pivotal Phase 3 Study Of Abrocitinib In Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis: Achieved Co-Primary, Key Secondary Endpoints",2019-09-27 06:45:00-04:00,PFE,negative
1000547.0,"Biotech Stock On The Radar: Anavex, A Neurology-Focused Precision Medicine Company",2019-09-25 17:32:00-04:00,PFE,neutral
1000548.0,"Pfizer Presents New Evidence Of Ibrance Effectiveness In HR+, HER2- Metastatic Breast Cancer Patients In Four Real-world Studies At ESMO Congress 2019",2019-09-24 08:01:00-04:00,PFE,negative
1000549.0,The Week Ahead In Biotech: Spotlight On ESMO Conference,2019-09-22 16:22:00-04:00,PFE,neutral
1000550.0,Pfizer Reports CHMP Adopts Positive Opinion For BAVENCIO Plus Axitinib For First-Line Treatment Of Patients With Advanced Renal Cell Carcinoma,2019-09-20 08:10:00-04:00,PFE,positive
1000551.0,Teva Dips Into Medical Marijuana Market With Canndoc Distribution Deal,2019-09-13 08:14:00-04:00,PFE,neutral
1000552.0,Springworks Therapeutics IPO: What You Need To Know,2019-09-12 17:22:00-04:00,PFE,neutral
1000553.0,Shares of several drugmakers are trading lower on news of a drug pricing bill being developed by House Democrats. The proposed bill would set US drug prices based on prices in other wealthy countries.,2019-09-10 10:30:00-04:00,PFE,positive
1000554.0,Pfizer Says Preliminary Results From its Phase 2 Study of 20-Valent Pneumococcal Conjugate Vaccine are Positive,2019-09-09 08:01:00-04:00,PFE,positive
1000555.0,Pfizer Option Alert: Sep 20 $37 Calls Sweep (30) near the Ask: 1254 @ $0.303 vs 4708 OI; Earnings 10/29 Before Open [est] Ref=$36.04,2019-09-03 09:48:00-04:00,PFE,positive
1000556.0,Citi: Solid Biosciences Rally Unsupported By Fundamentals,2019-08-29 11:38:00-04:00,PFE,negative
1000557.0,"Benzinga's Top Upgrades, Downgrades For August 28, 2019",2019-08-28 09:45:00-04:00,PFE,positive
1000558.0,"DZ Bank Upgrades Pfizer to Hold, Announces $36 Price Target",2019-08-28 06:18:00-04:00,PFE,neutral
1000559.0,"Morgan Stanley Maintains Equal-Weight On Pfizer, Maintains $38 Target As Firm Notes 'Prevnar 20-valent (20vPnC) infant Phase 2 readout for prevention of pneumococcal disease is expected soon; we and consensus assume it moves into Phase 3'",2019-08-27 11:30:00-04:00,PFE,neutral
1000560.0,"Morgan Stanley Maintains Equal-Weight on Pfizer, Lowers Price Target to $38",2019-08-27 07:56:00-04:00,PFE,negative
1000561.0,10 Biopharmaceutical Companies Trying To Cure Cancer,2019-08-24 13:46:00-04:00,PFE,negative
1000562.0,"Jim Cramer Weighs In On Pfizer, Teva And More",2019-08-22 11:08:00-04:00,PFE,neutral
1000563.0,"The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Chinese Cheer For FibroGen, Retrophin Flunks Late-Stage Study",2019-08-22 07:18:00-04:00,PFE,positive
1000564.0,"ViiV Healthcare Reports Atlas-2M Study Met Its Primary Endpoint, Showing Similar Efficacy of Cabotegravir and Rilpivirine Administered Every Eight Weeks Compared to Four-week Administration",2019-08-22 04:00:00-04:00,PFE,neutral
1000565.0,Pfizer And Astellas Announce FDA Grants Xtandi (Enzalutamide) Application Priority Review For The Treatment Of Men With Metastatic Hormone-Sensitive Prostate Cancer,2019-08-21 14:02:00-04:00,PFE,negative
1000566.0,Shares of several healthcare companies are trading higher as optimism increased for a resolution to the US-China trade war.,2019-08-19 12:31:00-04:00,PFE,positive
1000567.0,"Shares of healthcare companies are trading higher as US markets rebound from recent weakness following a yield curve inversion, which caused recession fears. Trump also recently announced the US would delay China tariffs, renewing hopes of a trade deal.",2019-08-16 13:27:00-04:00,PFE,negative
1000568.0,Pfizer Option Alert: Dec 20 $38 Calls Sweep (8) near the Ask: 649 @ $0.479 vs 9234 OI; Ref=$34.1212,2019-08-15 12:08:00-04:00,PFE,positive
1000569.0,"The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings",2019-08-15 07:45:00-04:00,PFE,neutral
1000570.0,"The Daily Biotech Pulse: Regeneron's Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics Offering",2019-08-14 07:50:00-04:00,PFE,negative
1000571.0,16 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-08-13 08:36:00-04:00,PFE,neutral
1000572.0,"The Daily Biotech Pulse: Jazz Goes Shopping, Portola Offering, Novelion Delays Quarterly Results",2019-08-13 07:25:00-04:00,PFE,neutral
1000573.0,Pfizer shares are trading lower in sympathy with the overall market as the Treasury yield continues to decline along with ongoing trade tensions with China.,2019-08-12 14:45:00-04:00,PFE,positive
1000574.0,Stocks That Hit 52-Week Lows Of Monday,2019-08-12 11:14:00-04:00,PFE,negative
1000575.0,Stocks That Fell Through 52-Week Lows Wednesday,2019-08-07 14:22:00-04:00,PFE,negative
1000576.0,"The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering",2019-08-06 07:22:00-04:00,PFE,positive
1000577.0,New 52-Week Lows For Monday Morning,2019-08-05 13:16:00-04:00,PFE,negative
1000578.0,Shares of several drug/pharma/medical equipment companies trading lower given weakness in broader stock market following concerns with China trade tensions.,2019-08-05 12:43:00-04:00,PFE,negative
1000579.0,GlycoMimetics Falls 50% After Disappointing Results For Sickle Cell Drug Trial,2019-08-05 08:42:00-04:00,PFE,negative
1000580.0,GlycoMimetics Earlier Announces Pfizer's Phase 3 Clinical Trial Evaluating Rivipansel in Sickle Cell Disease Did Not Meet its Primary or Key Secondary Endpoints,2019-08-05 07:41:00-04:00,PFE,neutral
1000581.0,"Bulls And Bears Of The Week: Boeing, GM, Pfizer, Starbucks And More",2019-08-03 10:25:00-04:00,PFE,neutral
1000582.0,Stocks that Reached Yearly Lows Thursday Morning,2019-08-01 11:09:00-04:00,PFE,negative
1000583.0,"'Fast Money Halftime Report' Traders Share Their Thoughts On Square, Boeing, And More",2019-08-01 07:20:00-04:00,PFE,positive
1000584.0,"The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings",2019-08-01 07:18:00-04:00,PFE,negative
1000585.0,"Biotech Stock On The Radar: Veru, A Catalyst-Rich Biopharma",2019-07-31 13:50:00-04:00,PFE,neutral
1000586.0,REGENXBIO Announces New License Agreement With Pfizer For The Treatment Of Friedreich's Ataxia Using NAV AAV9 Vector,2019-07-31 07:08:00-04:00,PFE,positive
1000587.0,Morgan Stanley Downgrades Pfizer In Wake Of Upjohn-Mylan Merger,2019-07-30 12:14:00-04:00,PFE,neutral
1000588.0,"UPDATE: Bank Of America Downgrades Pfizer To Neutral, Lowers Target From $49 To $41  Based On Firm's 'updated SOTP valuation, including expected dilution from Upjohn spin-merge (Reverse Morris Trust) and valuation outlook for RemainCo'",2019-07-30 10:46:00-04:00,PFE,negative
1000589.0,"Benzinga's Top Upgrades, Downgrades For July 30, 2019",2019-07-30 09:59:00-04:00,PFE,positive
1000590.0,"UPDATE: Morgan Stanley On Pfizer Also Notes 'Although we view the Upjohn exit to MYL as a strategically sound deal, new 2020 management disclosures revealed earnings power that is much weaker than we realized'",2019-07-30 09:27:00-04:00,PFE,negative
1000591.0,"UPDATE: Morgan Stanley Downgrades Pfizer To Equal-Weight, Lowers Target To $40 As Firm Notes 'Our thesis that Pfizer would outperform due to improving prospects was invalidated by a re-set of earnings on both sides of the business'",2019-07-30 09:27:00-04:00,PFE,positive
1000592.0,33 Healthcare Stocks Moving In Today's Pre-Market Session,2019-07-30 09:16:00-04:00,PFE,neutral
1000593.0,Array Shares To No Longer Trade As Pfizer Is Taking Over The Co.,2019-07-30 08:21:00-04:00,PFE,neutral
1000594.0,Pfizer shares are trading lower after Morgan Stanley downgraded the company's stock from Overweight to Equal-Weight. The company on Monday reported worse-than-expected Q2 sales.,2019-07-30 08:16:00-04:00,PFE,negative
1000595.0,Bank of America Downgrades Pfizer to Neutral,2019-07-30 08:00:00-04:00,PFE,neutral
1000596.0,"The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings",2019-07-30 07:00:00-04:00,PFE,positive
1000597.0,Morgan Stanley Downgrades Pfizer to Equal-Weight,2019-07-30 06:40:00-04:00,PFE,neutral
1000598.0,Mid-Afternoon Market Update: Crude Oil Up Over 1%; Lexicon Pharmaceuticals Shares Plunge,2019-07-29 14:22:00-04:00,PFE,negative
1000599.0,Mid-Day Market Update: On Deck Capital Falls On Downbeat Earnings; Medley Management Shares Jump,2019-07-29 12:13:00-04:00,PFE,positive
1000600.0,"Hearing JP Morgan Commented On Mylan Amid Pfizer Upjohn News, Sees New Valuation $25-$32/Share Based On Higher Pro-Forma Multiple Warranted For NewCo., Combined Co. Will Have Less US Generics Exposure, Less Leverage But Improved Corporate Governance",2019-07-29 11:48:00-04:00,PFE,positive
1000601.0,"Mid-Morning Market Update: Markets Mostly Lower; Mylan, Pfizer's Upjohn To Merge",2019-07-29 10:16:00-04:00,PFE,negative
1000602.0,"Host Of Earnings Loom With Beyond Meat, Apple Among Highlights Ahead Of Fed, Payrolls",2019-07-29 09:50:00-04:00,PFE,negative
1000603.0,30 Healthcare Stocks Moving In Today's Pre-Market Session,2019-07-29 09:35:00-04:00,PFE,neutral
1000604.0,Merck's Keytruda Gets A Double Dose Of Positive News,2019-07-29 09:30:00-04:00,PFE,positive
1000605.0,Mylan Says Share Repurchases are Possible in 2021 Following Merger Announcement with Pfizer's Upjohn,2019-07-29 08:39:00-04:00,PFE,positive
1000606.0,Pfizer shares are trading lower after the company reported worse-than-expected Q2 sales results and lowered its FY19 guidance below analyst estimates.,2019-07-29 08:27:00-04:00,PFE,negative
1000607.0,"Mylan, Pfizer's Upjohn To Merge And Create New Company",2019-07-29 08:01:00-04:00,PFE,positive
1000608.0,"Pfizer Reports Mixed Q2 Earnings, Lowers Guidance",2019-07-29 07:56:00-04:00,PFE,negative
1000609.0,A Peek Into The Markets: US Stock Futures Flat; Mylan To Combine With Pfizer's Upjohn Division,2019-07-29 07:32:00-04:00,PFE,neutral
1000610.0,Pfizer Lowers FY2019 EPS Guidance from $2.83-2.93 to $2.76-2.86 vs $2.91 Est; Lowers FY2019 Sales Guidance from $52B-54B to $50.5B-52.5B vs $53.28B Est,2019-07-29 06:48:00-04:00,PFE,negative
1000611.0,"Pfizer Q2 EPS $0.8 Beats $0.75 Estimate, Sales $13.264B Miss $13.4B Estimate",2019-07-29 06:47:00-04:00,PFE,negative
1000612.0,"Mylan and Pfizer's Upjohn to Merge and Create a New Company, Mylan Shareholders to Own 43% of the New Company",2019-07-29 06:46:00-04:00,PFE,positive
1000613.0,"The Week In Cannabis: Tobacco And Retail Stray In The Weeds, Congress Holds SAFE Banking Hearings, New ETFs, And More",2019-07-28 15:51:00-04:00,PFE,positive
1000614.0,Pfizer in Talks to Merge Off-patent Drugs Business with Mylan,2019-07-28 08:15:00-04:00,PFE,neutral
1000615.0,"The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate",2019-07-27 14:32:00-04:00,PFE,negative
1000616.0,"FDA Has Approved Boxed Warning On Increased Risk Of Blood Clots, Death With Higher Dose Of Pfizer's Arthritis, Ulcerative Colitis Medicine Xeljanz",2019-07-26 11:12:00-04:00,PFE,negative
1000617.0,"Jim Cramer Gives His Opinion On eBay, Pfizer And More",2019-07-24 10:25:00-04:00,PFE,neutral
1000618.0,Hearing Unconfirmed Chatter Indicating Pfizer Has Made Takeover Offer For Bristol-Meyers,2019-07-24 09:52:00-04:00,PFE,negative
1000619.0,"Pfizer Announces FDA Has Approved Ruxience (Rituximab-Pvvr) For The Treatment Of Adult Patients With Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, And Granulomatosis With Polyangiiti And Microscopic Polyangiitis",2019-07-23 13:50:00-04:00,PFE,positive
1000620.0,"ICC International Cannabis, Biotii Technologie Sign Advisory Agreement With Dr. Alexandros Makriyannis",2019-07-23 10:55:00-04:00,PFE,positive
1000621.0,"With Earnings On Tap, A Stir In This Leveraged Pharmaceuticals ETF",2019-07-23 09:27:00-04:00,PFE,neutral
1000622.0,"Syapse Reports Strategic Collaboration With Pfizer To Advance Cancer Outcomes Research, No Terms Disclosed",2019-07-23 08:12:00-04:00,PFE,negative
1000623.0,FDA Approves First Generics Of Lyrica,2019-07-22 10:46:00-04:00,PFE,positive
1000624.0,Health Canada Says Pfizer Indicated That It Has Begun Managing Distribution Of Existing Epipen 0.3 Mg Supply To Help Ensure Consistent Access By Patients,2019-07-19 11:47:00-04:00,PFE,positive
1000625.0,Health Canada Says Pfizer Has Confirmed That Epipen 0.3 Mg Supply Is Currently Available And Continues To Be Shipped,2019-07-19 11:44:00-04:00,PFE,neutral
1000626.0,Health Canada Says Aware That Pfizer Canada Is Reporting That A Shortage Of 0.3 Mg Format Epipen Auto-Injector May Lead To Temporary Supply Constraints; Says Epipen Jr (0.15 Mg) Is Not Affected By Shortage,2019-07-19 10:50:00-04:00,PFE,negative
1000627.0,"Shares of several drug manufacturing companies are trading lower, potentially on continued weakness after the Trump Administration on Thursday rolled back a proposal to eliminate rebates from government drug plans.",2019-07-12 09:53:00-04:00,PFE,negative
1000628.0,Study: ViiV Healthcare's 2-Drug HIV Regimen As Effective As 3,2019-07-10 10:15:00-04:00,PFE,positive
1000629.0,"The Daily Biotech Pulse: Jazz Buys Tumor Drug Program, Sanofi's BLA For Multiple Myeloma Drug Accepted, Positive Results For ViiV",2019-07-10 07:17:00-04:00,PFE,positive
1000630.0,ViiV Healthcare Announces Phase III TANGO Study Meets Primary Endpoint,2019-07-10 04:23:00-04:00,PFE,neutral
1000631.0,Pfizer Says Anticipates Further Epipen Supply Shirtages Over The Coming Months,2019-07-09 13:45:00-04:00,PFE,neutral
1000632.0,U.S. Judge Halts Trump Administration Rule Requiring Drug Prices in TV Ads,2019-07-08 18:26:00-04:00,PFE,neutral
1000633.0,"Shares of several healthcare companies are trading lower after Trump on Friday said he was preparing an executive order declaring a 'favored nations clause' for drug prices, lowering the price that consumers will pay prescription drugs.",2019-07-08 12:55:00-04:00,PFE,positive
1000634.0,"Sangamo, Pfizer Announce Updated Phase 1/2 Results for SB-525 Investigational Hemophilia A Gene Therapy Showing Sustained Increased Factor VIII Levels",2019-07-06 07:43:00-04:00,PFE,positive
1000635.0,"The Daily Biotech Pulse: Roche's Flu Drug Aces Late-Stage Trial, Acura Outlicenses Pain Medication, Neuronetics Gets New Finance Chief",2019-07-03 07:31:00-04:00,PFE,negative
1000636.0,"Ex-FDA Chief Scott Gottlieb Defends Return To Private Sector, Warren Calls For Resignation",2019-07-02 15:04:00-04:00,PFE,negative
1000637.0,Calithera Biosciences Initiates Phase 1/2 Trial Of Telaglenastat In Combination With Pfizer's CDK4/6 Inhibitor Palbociclib,2019-07-02 08:00:00-04:00,PFE,negative
1000638.0,"UPDATE: RBC Maintains Sarepta At Outperform, Raises Tgt To $220 As Firm Sees Co. 'as the clear leader in this space and are increasing our out-year DMD share/penetration estimates' 'Based on our analysis of PFE's initial DMD gene therapy results'",2019-07-01 10:32:00-04:00,PFE,positive
1000639.0,"Pfizer Announces 'Positive' Top-Line Results from Phase 4 Study of Crisaborole Ointment, 2%, in Children Aged 3 Months to Less Than 24 Months with Mild to Moderate Atopic Dermatitis",2019-07-01 08:01:00-04:00,PFE,neutral
1000640.0,"5 Stocks To Watch For July 1, 2019",2019-07-01 04:26:00-04:00,PFE,neutral
1000641.0,Pfizer Reports Phase 3 Trial Of Revatio In Newborns With Persistent Pulmonary Hypertension Did Not Meet Primary Efficacy Endpoint,2019-06-28 16:06:00-04:00,PFE,neutral
1000642.0,Meet The 3 Biggest Industries Investing In Cannabis,2019-06-28 15:51:00-04:00,PFE,neutral
1000643.0,"Sarepta Shares Up 14% For Session; Hearing RBC Recently Suggesting Buying Stock, Said Pfizer Data Removed An Overhang",2019-06-28 11:37:00-04:00,PFE,positive
1000644.0,Pfizer Presents Initial Preclinical Data On Phase 1b Gene Therapy Study For Duchenne Muscular Dystrophy At Annual Parent Project Muscular Dystrophy Connect Conference,2019-06-28 10:16:00-04:00,PFE,neutral
1000645.0,Pfizer Reports Received FDA Approval For ZIRABEV,2019-06-28 07:33:00-04:00,PFE,positive
1000646.0,"The Daily Biotech Pulse: Chiasma To Join R3K Index, EU Rejects Amgen's Osteoporosis Drug Application, Karuna IPO",2019-06-28 07:32:00-04:00,PFE,negative
1000647.0,Former FDA Commissioner Scott Gottlieb Elected To Pfizer's Board Of Directors,2019-06-27 16:19:00-04:00,PFE,neutral
1000648.0,Pfizer Says 'Revised Recommendation Reinforces That Prevnar 13 Is Considered Safe And Effective By The Fda And Acip',2019-06-26 16:01:00-04:00,PFE,positive
1000649.0,"UPDATE: Baird Notes 'We remain positively inclined into this dataset as Sarepta has set the bar so high with its results last year, we think Pfizer is likely to fall short on safety, efficacy or both'; Believes Sarepta Will Retain Clear Advantage",2019-06-26 10:17:00-04:00,PFE,positive
1000650.0,"Baird Maintains Outperform, $202 Target On Sarepta Therapeutics As Firm Notes 'When Pfizer presents the first data for its DMD gene therapy Friday morning, we expect the results to have meaningful ramifications to Sarepta'",2019-06-26 10:17:00-04:00,PFE,positive
1000651.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs",2019-06-22 15:07:00-04:00,PFE,neutral
1000652.0,Pfizer Receives European Commission Approval For Breast Cancer Drug TALZENNA,2019-06-21 11:57:00-04:00,PFE,negative
1000653.0,BioMarin Receives $15M In Milestone Payments From Pfizer For TALZENNA For Metastatic Breast Cancer Patients With An Inherited BRCA Mutation,2019-06-21 11:32:00-04:00,PFE,negative
1000654.0,"Pfizer Receives European Approval For TALZENNA, A Once-Daily Parp Inhibitor Approved In Europe For Hereditary Breast Cancer",2019-06-21 10:47:00-04:00,PFE,positive
1000655.0,Sangamo Announces Upcoming Presentation Of Investigational SB-525 Hemophilia A Gene Therapy Data At ISTH 2019,2019-06-21 09:24:00-04:00,PFE,neutral
1000656.0,GlaxoSmithKline Offered Concessions to Address EU Antitrust Concerns Over Planned JV With Pfizer's Consumer Health Business,2019-06-20 04:09:00-04:00,PFE,neutral
1000657.0,"Russian Parliament OKs Cannabis, Psychotropic Cultivation For Pharmaceutical Reasons",2019-06-19 16:05:00-04:00,PFE,neutral
1000658.0,"CEOs From US Firms Including Dow, UPS, Pfizer, Honeywell Meet With Chinese Premier Li In Beijing",2019-06-19 12:08:00-04:00,PFE,neutral
1000659.0,A Beloved Biotech ETF Could Lure Traders Again,2019-06-19 09:27:00-04:00,PFE,positive
1000660.0,"The Daily Biotech Pulse: PhaseBio Pumped Up, Eiger Exults On Breakthrough Therapy Designation, Biohaven Slips On Stock Sale",2019-06-18 07:31:00-04:00,PFE,neutral
1000661.0,60 Biggest Movers From Yesterday,2019-06-18 04:54:00-04:00,PFE,neutral
1000662.0,Mid-Afternoon Market Update: Crude Oil Down 1.5%; C&J Energy Services Shares Spike Higher,2019-06-17 14:52:00-04:00,PFE,negative
1000663.0,44 Stocks Moving In Monday's Mid-Day Session,2019-06-17 12:23:00-04:00,PFE,neutral
1000664.0,Mid-Day Market Update: Sotheby's Jumps On Acquisition News; Flex Pharma Shares Slide,2019-06-17 12:12:00-04:00,PFE,positive
1000665.0,Mid-Morning Market Update: Markets Open Higher; Pfizer To Acquire Array BioPharma For $48/Share,2019-06-17 10:17:00-04:00,PFE,neutral
1000666.0,28 Stocks Moving In Monday's Pre-Market Session,2019-06-17 08:06:00-04:00,PFE,neutral
1000667.0,Pfizer To Buy Array BioPharma For $48/Share,2019-06-17 07:55:00-04:00,PFE,neutral
1000668.0,Pfizer to Acquire Array BioPharma For $48/Share Cash,2019-06-17 06:50:00-04:00,PFE,neutral
1000669.0,"Pfizer Announces Results From XELJANZ XR ORAL Shift Study, The First Phase 3b/4 Study To Evaluate Methotrexate Withdrawal With JAK Inhibitor",2019-06-12 08:12:00-04:00,PFE,negative
1000670.0,"Jim Cramer Weighs In On Tesla, PayPal And More",2019-06-10 07:23:00-04:00,PFE,neutral
1000671.0,"BioXcel Pharmaceuticals CEO On Drug Pipeline, How AI Is Changing Sector",2019-06-09 16:09:00-04:00,PFE,neutral
1000672.0,"Top 10 Most Overbought Stocks Via Benzinga Pro's Radar Tool For Thur., June 06, 2019",2019-06-06 14:57:00-04:00,PFE,positive
1000673.0,"Pfizer Shares Closed Up 0.6%, Seemingly Unaffected Following Negative Washington Post Article From Late Tues. 'Pfizer had clues its blockbuster drug could prevent Alzheimer's. Why didn't it tell the world?'",2019-06-05 16:21:00-04:00,PFE,positive
1000674.0,'I believe it is wrong to charge Americans astronomical prices for life-saving drugs developed with taxpayer dollars. You will not find me encouraging pharmaceutical companies to continue ripping off Americans like my Republican colleagues.' -Sen Sanders,2019-06-04 11:42:00-04:00,PFE,negative
1000675.0,"UPDATE: Morgan Stanley Initiates Pfizer With Overweight, $48 Target As Firm Notes Co's 'organic growth is set to accelerate next year after two decades of challenges, driven by fading patent expiration pressures and contributions from new revenue drivers'",2019-06-04 11:22:00-04:00,PFE,negative
1000676.0,"Morgan Stanley Reinstates Overweight on Pfizer, Announces $48 Price Target",2019-06-04 07:39:00-04:00,PFE,negative
1000677.0,"SIGA Announces TPOXX Promotion Agreement With Meridian Medical Technologies, Inc. (A Pfizer Company) For International Markets",2019-06-03 07:34:00-04:00,PFE,positive
1000678.0,Pfizer Announces Phase 3 Study Of LYRICA Did Not Meet Its Primary Endpoint,2019-05-24 16:03:00-04:00,PFE,neutral
1000679.0,PreMarket Prep Opening NYSE Imbalance Update: GE 215k Shares To Sell; Alibaba 69k To Sell; Pfizer 131k To Sell; Coca-Cola 58k To Sell; J&J 32k To Sell,2019-05-20 08:33:00-04:00,PFE,positive
1000680.0,"Pfizer Has Confirmed Initiation Of EU Review Of Tofacitinib With Interim Recommendations, Will Continue To Work With Regulatory Bodies, Taking Steps To Inform Healthcare Professionals In EU/EEA About Interim Guidance",2019-05-17 08:43:00-04:00,PFE,neutral
1000681.0,FDA Approves First Anticoagulant (Blood Thinner) For Pediatric Patients To Treat Potentially Life-Threatening Blood Clots,2019-05-16 12:28:00-04:00,PFE,positive
1000682.0,PreMarket Prep Opening NYSE Imbalance Update: Disney 57k Shares To Buy; Pfizer 262k To Buy; P&G 22k To Buy; Square 22k To Buy; Macy's 60k To Buy; General Electric 331k To Sell,2019-05-15 08:54:00-04:00,PFE,positive
1000683.0,"The Daily Biotech Pulse: FDA Greenlights Pfizer-Merck KGAa's Kidney Cancer Combo Treatment, Adcom Disappointment For Daiichi",2019-05-15 07:50:00-04:00,PFE,negative
1000684.0,Pfizer Reports Top-Line Results From Abrocitinib In Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis: 'Study achieves all co-primary and secondary endpoints ',2019-05-15 06:46:00-04:00,PFE,negative
1000685.0,"Pfizer, EM Serono Announce FDA Approves BAVENCIO Plus INLYTA Combination for Patients with Advanced Renal Cell Carcinoma",2019-05-14 19:49:00-04:00,PFE,positive
1000686.0,Shares of several drug manufacturers are trading lower after the United States filed a lawsuit against Teva alleging price fixing.,2019-05-13 09:53:00-04:00,PFE,positive
1000687.0,Teva Plummets Amid Massive Price Fixing Accusations; Other Generic Drugmakers Also Fall,2019-05-13 08:40:00-04:00,PFE,negative
1000688.0,Pfizer Buys Rare Disease Biotech Therachon For $340M,2019-05-08 11:17:00-04:00,PFE,neutral
1000689.0,The Cortexyme IPO: What You Need To Know,2019-05-08 09:17:00-04:00,PFE,neutral
1000690.0,Pfizer Acquires Clinical-Stage Biotech Company Therachon For $340M Upfront With Additional $470M In Milestones,2019-05-08 06:46:00-04:00,PFE,neutral
1000691.0,Pfizer's LORVIQUA Approved by the European Commission for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer,2019-05-07 07:35:00-04:00,PFE,positive
1000692.0,"Pfizer Reports FDA Approved VYNDAQEL, VYNDAMAX For Treatment Of Cardiomyopathy Of Wild-Type, Hereditary Transthyretin-Mediated Amyloidosis",2019-05-06 06:46:00-04:00,PFE,positive
1000693.0,IPO Outlook For The Week: Uber (And 11 Others),2019-05-04 17:25:00-04:00,PFE,neutral
1000694.0,"Baird Out Defending Sarepta, Says Pfizer's DMD Program Is 'Too Little Too Late' To Be A Meaningful Competitor To Sarepta's Program",2019-05-01 06:21:00-04:00,PFE,positive
1000695.0,"Pfizer Ceo Albert Bourla Says Significant Growth Coming From China; Says Firm To Grow Based On Volume, Not Price; Says Drug Prices Will Not Be A Growth Driver",2019-04-30 12:36:00-04:00,PFE,positive
1000696.0,From Pfizer Conference Call; Co. Says Will Look At Bolt-On Deals Of 'A Few Billion Dollars' To Complement Pipeline,2019-04-30 10:39:00-04:00,PFE,neutral
1000697.0,Alphabet Revenue Disappoints Ahead Of Apple Earnings After The Bell,2019-04-30 10:05:00-04:00,PFE,negative
1000698.0,Pfizer shares are trading higher after the company reported better-than-expected Q1 earnings and raised guidance.,2019-04-30 08:59:00-04:00,PFE,positive
1000699.0,"The Daily Biotech Pulse: Earnings Deluge, G1 Therapeutics Positive FDA Meeting, Mustang Bio Offering",2019-04-30 08:06:00-04:00,PFE,positive
1000700.0,"Pfizer Raises FY19 Adj. EPS From $2.82-$2.92 To $2.83-$2.93 vs $2.89 Est., Sees Sales $52B-$54B vs $53.25B Est.",2019-04-30 06:48:00-04:00,PFE,neutral
1000701.0,"Pfizer Q1 EPS Adj. $0.85 Beats $0.75 Estimate, Sales $12.12B Miss $13B Estimate",2019-04-30 06:47:00-04:00,PFE,negative
1000702.0,"15 Stocks To Watch For April 30, 2019",2019-04-30 06:37:00-04:00,PFE,neutral
1000703.0,"Earnings Scheduled For April 30, 2019",2019-04-30 06:18:00-04:00,PFE,neutral
1000704.0,Pfizer Reports Received Positive CHMP Opinion For TALZENNA,2019-04-26 11:00:00-04:00,PFE,positive
1000705.0,"Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'",2019-04-23 11:52:00-04:00,PFE,positive
1000706.0,"Eli Lilly-Pfizer's Non-Opioid Painkiller Faces Safety, Efficacy Concerns",2019-04-22 10:24:00-04:00,PFE,positive
1000707.0,"Pfizer, Eli Lilly Late Thurs. Announced Top-Line Results From Long-Term Phase 3 Study Of Tanezumab In Patients With Osteoarthritis",2019-04-22 08:23:00-04:00,PFE,neutral
1000708.0,Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy.,2019-04-18 10:51:00-04:00,PFE,negative
1000709.0,Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy.,2019-04-17 10:31:00-04:00,PFE,negative
1000710.0,Shares of several drug companies are trading lower. Weakness may be tied to uncertainty over healthcare policy going into the 2020 primaries and Washington's recent efforts to curb prescription drug prices.,2019-04-16 15:34:00-04:00,PFE,negative
1000711.0,Pfizer Announces Presentation of Data from a Phase 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older,2019-04-14 09:49:00-04:00,PFE,neutral
1000712.0,PreMarket Prep Opening NYSE Imbalance Update: GE 652k Shares To Sell; ExxonMobil 66k Shares To Sell; BofA 123 To Sell; Citi 52k To Sell; P&G 40k sell; J&J 41k To sell; Pfizer 96k To Sell,2019-04-09 08:34:00-04:00,PFE,positive
1000713.0,"The Daily Biotech Pulse: PhaseBio Gets Breakthrough Therapy Designation, FDA Shoots Down Zogenix Epilepsy Regulatory Filing",2019-04-09 08:10:00-04:00,PFE,neutral
1000714.0,"Pfizer, GlaxoSmithKline Reports Its ViiV Healthcare Co. Received FDA Approval For Dovato Drug Regimen For Treatment-Naive HIV-1 Adults",2019-04-08 16:52:00-04:00,PFE,positive
1000715.0,FDA Says Granted Approval Of Dovato To Viiv Healthcare,2019-04-08 15:39:00-04:00,PFE,positive
1000716.0,FDA Approves First Two-Drug Complete Regimen For HIV-Infected Patients Who Have Never Received Antiretroviral Treatment,2019-04-08 15:33:00-04:00,PFE,positive
1000717.0,"Bulls & Bears Of The Week: Dow, Lyft, Pfizer, Schlumberger, Tesla And More",2019-04-07 16:32:00-04:00,PFE,neutral
1000718.0,FDA Says Extending The Indication Of Ibrance (Palbociclib) Capsules,2019-04-04 14:15:00-04:00,PFE,neutral
1000719.0,A Healthy Rating On A Big Health Care ETF,2019-04-04 11:49:00-04:00,PFE,positive
1000720.0,Pfizer Reports VIZIMPRO Received Marketing Authorization In EU For Treatment of Adult Patients with EGFR-Mutated Non-Small Cell Lung Cancer,2019-04-03 09:49:00-04:00,PFE,negative
1000721.0,Sangamo Soars Amid Multiple Development Pipeline Updates,2019-04-02 12:47:00-04:00,PFE,neutral
1000722.0,UPDATE: Safety Monitoring Committee Recommended Cohort Expansion At The 3E13 Vg/Kg Dose Of SB-525,2019-04-02 07:07:00-04:00,PFE,positive
1000723.0,Sangamo And Pfizer Announce Phase 1/2 Interim Data For Investigational Hemophilia A Gene Therapy; SB-525 Was Well Tolerated And Demonstrated A Dose-Dependent Increase In Factor VIII (FVIII) Levels,2019-04-02 07:07:00-04:00,PFE,positive
1000724.0,"Bank Of America Hikes Pfizer Price Target, Estimates Citing Orphan Drug Catalysts",2019-04-01 13:03:00-04:00,PFE,neutral
1000725.0,"BofA Offers Top 10 US Ideas For Q2: Bullish Burlington Stores, Dover, Masco, Norfolk Southern, Pfizer, Synovus, Thermo Fisher, United Rentals, Bearish Hawaiian Air, ServiceMaster",2019-04-01 11:05:00-04:00,PFE,positive
1000726.0,6 Gene Therapy M&A Targets On The Radar,2019-03-27 12:45:00-04:00,PFE,neutral
1000727.0,Cyclacel Drops After Study Supporting Cancer Drug's Mechanism Of Action,2019-03-26 12:46:00-04:00,PFE,negative
1000728.0,"The Daily Biotech Pulse: FDA Nod For Sage's Postpartum Depression Drug, Pfizer Invests In Gene Therapy Company",2019-03-20 07:46:00-04:00,PFE,negative
1000729.0,Pfizer Secures Exclusive Option To Acquire 15% Equity Interest In Gene Therapy Company Vivet Therapeutics' Pfizer Paid ~$51M Upon Signing And MAy Pay Up To $635.8M,2019-03-20 06:46:00-04:00,PFE,positive
1000730.0,"Merck KGaA, Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer",2019-03-19 20:16:00-04:00,PFE,negative
1000731.0,A New Look For The Barron's 400 ETF,2019-03-19 08:51:00-04:00,PFE,neutral
1000732.0,"Morgan Stanley Drops Bearish Exelixis Stance, Sees 'Limited Downside Risk'",2019-03-18 14:26:00-04:00,PFE,negative
1000733.0,Pfizer's Drug TRAZIMERA Wins FDA Approval,2019-03-11 16:29:00-04:00,PFE,positive
1000734.0,"Shares of several biotech companies are trading lower after FDA commissioner Scott Gottlieb announced he will resign; he pushed to spur the development of new drugs and with his absence, there is concern on future FDA approvals.",2019-03-06 11:59:00-05:00,PFE,negative
1000735.0,"The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings",2019-03-05 07:24:00-05:00,PFE,positive
1000736.0,Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates,2019-03-04 11:50:00-05:00,PFE,neutral
1000737.0,"BioXcel Therapeutics Announces Addition Of Merck KGaA, Darmstadt, Germany, And Pfizer To Clinical Collaboration With Nektar For Development Of Triple-combination Therapy In Pancreatic Cancer",2019-03-04 08:13:00-05:00,PFE,negative
1000738.0,BioXcel Therapeutics Announces Merck and Pfizer Join its Clinical Collaboration with Nektar Therapeutics to Evaluate a Triple Therapy for Pancreatic Cancer,2019-03-04 08:07:00-05:00,PFE,negative
1000739.0,Barron's On: Pharma's Big Hope,2019-03-03 10:47:00-05:00,PFE,positive
1000740.0,"Mylan's Disappointing Outlook Rattles Analysts, Investors",2019-02-27 16:04:00-05:00,PFE,negative
1000741.0,It Could Be Time For This Pharma ETF,2019-02-26 09:42:00-05:00,PFE,neutral
1000742.0,"The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote",2019-02-26 07:56:00-05:00,PFE,positive
1000743.0,FDA Is Working With Pfizer To Evaluate Other Currently Available Safety Info For Tofacitinib,2019-02-25 15:56:00-05:00,PFE,positive
1000744.0,"Supreme Court Rejects Maryland's Bid To Revive A Law Aimed At Preventing Price Gouging By Pharmaceutical Companies, Reuters Reports",2019-02-19 10:04:00-05:00,PFE,positive
1000745.0,"Pfizer Reports Received European Approval For ZIRABEV, A Biosimilar To Avastin",2019-02-19 09:32:00-05:00,PFE,positive
1000746.0,Pfizer And Lilly Announce Top-line Results From Phase 3 Study Of Tanezumab In Chronic Low Back Pain; Tanezumab Met Primary Endpoint,2019-02-19 06:48:00-05:00,PFE,negative
1000747.0,Pfizer Announces Pivotal Phase III Data for BAVENCIO Plus INLYTA in Advanced RCC Published in the New England Journal of Medicine,2019-02-17 08:42:00-05:00,PFE,positive
1000748.0,"PreMarket Prep Opening NYSE Imbalance Update: Bank Of America 335k Shares To Buy, JP Morgan 143k To Buy; Coca-Cola 274k To Buy,  Pfizer 251k To Buy, AT&T 224K To Buy, Verizon 130k To Buy",2019-02-15 09:03:00-05:00,PFE,positive
1000749.0,"The Daily Biotech Pulse: Vanda Q4 Results, Inovio Debt Offering, Caladrius Diabetes Drug Flunks Mid-Stage Trial",2019-02-14 07:50:00-05:00,PFE,negative
1000750.0,"Hearing Alliance Bernstein Reduces Stakes In Apple, Facebook, Amazon, Citigroup, Crown Castle; Raises Stakes In Vertex Pharmaceuticals, Procter & Gamble, Regency Centers, Microsoft, Pfizer",2019-02-13 13:14:00-05:00,PFE,positive
1000751.0,PreMarket Prep Opening NYSE Imbalance Update: Pfizer 112k Shares To Sell; Bank of America 90k To Sell; Square 40k To Buy,2019-02-12 08:32:00-05:00,PFE,positive
1000752.0,"The Daily Biotech Pulse: NASH Disappointment For Gilead, Xeris To Offer Shares",2019-02-12 08:04:00-05:00,PFE,negative
1000753.0,FDA Accepts Pfeizer's sBLA And Grants Priority Review For BAVENCIO Plus INLYTA For The Treatment Of Advanced Renal Cell Carcinoma,2019-02-11 17:51:00-05:00,PFE,positive
1000754.0,Pfizer Reports Results From Phase 3 ARCHES Trial In Men With mHSPC: Showed XTANDI Plus ADT Met Primary Endpoint 'by significantly reducing the risk of radiographic progression or death by 61% versus ADT alone',2019-02-11 17:01:00-05:00,PFE,negative
1000755.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials",2019-02-10 17:37:00-05:00,PFE,neutral
1000756.0,"Barron's Picks And Pans: BB&T, Best Buy, Boeing And More",2019-02-10 16:38:00-05:00,PFE,positive
1000757.0,Solid Biosciences Shares Crash After Data Release On Muscular Dystrophy Candidate,2019-02-07 12:57:00-05:00,PFE,neutral
1000758.0,Trump At State Of The Union Will Ask For Drug Pricing Cuts,2019-02-01 15:36:00-05:00,PFE,negative
1000759.0,Pharma Catches Another Case Of M&A Fever,2019-02-01 10:15:00-05:00,PFE,neutral
1000760.0,Pfizer Receives Positive CHMP Opinion For Vizimpro For The First-line Treatment Of Adult Patients With Locally Advanced Or Metastatic Non-small Cell Lung Cancer With Egfr-activating Mutations,2019-02-01 09:18:00-05:00,PFE,positive
1000761.0,UPDATE: Credit Suisse Upgrades Pfizer As Firm Notes Co 'has been working through a dark period with extensive patent expirations that have hampered its ability to grow' And Firm Believes 'That period is now nearing an end',2019-01-31 10:47:00-05:00,PFE,positive
1000762.0,"Benzinga's Top Upgrades, Downgrades For January 31, 2019",2019-01-31 09:11:00-05:00,PFE,positive
1000763.0,"Argus Upgrades Pfizer to Outperform, Announces $55 Price Target",2019-01-31 07:19:00-05:00,PFE,neutral
1000764.0,Credit Suisse Upgrades Pfizer to Outperform,2019-01-31 07:18:00-05:00,PFE,positive
1000765.0,"Apple, Boeing And The Fed: A Full Day Ahead As Earnings Help Recharge Wall Street",2019-01-30 10:03:00-05:00,PFE,positive
1000766.0,How To Approach Q4 Earnings: The Technical Perspective,2019-01-29 13:11:00-05:00,PFE,neutral
1000767.0,"Apple Today, Powell Tomorrow: Busy Earnings And Fed Week Continues",2019-01-29 12:22:00-05:00,PFE,neutral
1000768.0,From Pfizer Q4 Earnings Conference Call: Sees Pricing In US Flat Over 2019,2019-01-29 11:05:00-05:00,PFE,neutral
1000769.0,Pfizer shares are trading lower after the company said it expects 2019 EPS of $2.82 to $2.92 versus the $3.04 analyst estimate.,2019-01-29 08:35:00-05:00,PFE,neutral
1000770.0,24 Stocks Moving In Tuesday's Pre-Market Session,2019-01-29 08:09:00-05:00,PFE,neutral
1000771.0,"The Daily Biotech Pulse: Big Pharma Earnings, Kiniksa Offering, FDA Decision Day For Aquestive",2019-01-29 07:25:00-05:00,PFE,neutral
1000772.0,"Pfizer Sees FY19 Adj. EPS $2.82-$2.92 vs $3.04 Est., Sales $52B-$54B vs $54.36B Est.",2019-01-29 06:53:00-05:00,PFE,neutral
1000773.0,"Pfizer Q4 Adj. EPS $0.64, Inline, Sales $13.98B Beat $13.95B Estimate",2019-01-29 06:51:00-05:00,PFE,neutral
1000774.0,Pfizer And Lilly Announce Second Phase 3 Study Of Tanezumab In Osteoarthritis Pain Met All Three Co-Primary Endpoints At 24 Weeks,2019-01-29 06:39:00-05:00,PFE,negative
1000775.0,A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of Earnings,2019-01-29 06:35:00-05:00,PFE,negative
1000776.0,"12 Stocks To Watch For January 29, 2019",2019-01-29 04:35:00-05:00,PFE,neutral
1000777.0,"Earnings Scheduled For January 29, 2019",2019-01-29 04:13:00-05:00,PFE,neutral
1000778.0,Q4 Earnings Outlook For Pfizer,2019-01-28 13:20:00-05:00,PFE,neutral
1000779.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings",2019-01-27 16:07:00-05:00,PFE,neutral
1000780.0,UBS Downgrades Pfizer to Neutral,2019-01-23 06:56:00-05:00,PFE,neutral
1000781.0,Aileron Therapeutics Commences Enrollment In Phase 2a Expansion Cohort For ALRN-6924 In Combination With Pfizer's IBRANCE In Patients With MDM2-Amplified Cancers,2019-01-16 12:48:00-05:00,PFE,neutral
1000782.0,How To Approach Q4 Earnings: The Global Perspective,2019-01-14 11:29:00-05:00,PFE,neutral
1000783.0,Pfizer Reports FDA Accepted Regulatory Submissions For Review Of Tafamidis To Treat Transthyretin Amyloid Cardiomyopathy,2019-01-14 08:05:00-05:00,PFE,positive
1000784.0,How 7 New Laws Affected Stocks In The Last Week,2019-01-09 16:59:00-05:00,PFE,negative
1000785.0,"UPDATE: Pfizer Says Closing 2 India Plants Amid 'Very Significant' Long-Term Loss Of Product Demand, Says Manufacturing At IKKT, Aurangabad Sites Not Viable",2019-01-09 09:45:00-05:00,PFE,negative
1000786.0,"Pfizer Conducted Thorough Evaluation Of IKKT, Aurangabad Sites In India, Sites Will Immediately Cease Manufacturing With Intent To Exit Both Sites ASAP In 2019",2019-01-09 09:44:00-05:00,PFE,neutral
1000787.0,"TD Ameritrade IMX Continued Its Dip In December, Falling To A More Than Two-Year Low",2019-01-08 13:39:00-05:00,PFE,negative
1000788.0,Investor Movement Index December Summary,2019-01-07 16:52:00-05:00,PFE,neutral
1000789.0,5 Top-Selling Drugs With Growth Potential In 2019,2019-01-07 15:04:00-05:00,PFE,positive
1000790.0,CytoReason Signs Collaboration Agreement With Pfizer Inc. To Utilize CytoReason's Machine Learning Model Of Immune System For Drug Discovery,2019-01-07 08:28:00-05:00,PFE,positive
1000791.0,Pfizer Reports Initiation Of Phase 2b/3 Trial For PF-06651600 For Treatment of Patients with Moderate to Severe Alopecia Areata,2019-01-03 08:34:00-05:00,PFE,negative
1000792.0,"Adamis Has 'Favorable' Pipeline Setup, Says Bullish Raymond James",2019-01-02 10:21:00-05:00,PFE,neutral
1000793.0,The Week Ahead In Biotech: Focus Shifts To Year-End Clinical Trial Results,2018-12-23 10:37:00-05:00,PFE,neutral
1000794.0,"UPDATE: Merck KGaA Germany, Pfizer Say Interim Analysis Of Phase III Javelin Study Did Not Support Study's Initial Hypothesis",2018-12-21 14:01:00-05:00,PFE,negative
1000795.0,"Merck KGaA Germany, Pfizer Offer Update On Javelin Ovarian 100 Trial OF Avelumab",2018-12-21 14:00:00-05:00,PFE,neutral
1000796.0,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",2018-12-21 07:58:00-05:00,PFE,neutral
1000797.0,Pfizer Reports Independent Data Monitoring Committee Has Recommended Discontinuation Of Phase 2b STRIVE Trial Of Staphylococcus Aureus Vaccine Following Planned Interim Analysis,2018-12-20 16:31:00-05:00,PFE,positive
1000798.0,"Competition Bureau Has Closed Abuse-Of-Dominance Investigation Into Celgene, Pfizer, Sanofi Practices",2018-12-20 16:00:00-05:00,PFE,neutral
1000799.0,"Astellas Pharma, Pfizer Reports Topline Phase 3 ARCHES Trial Results For XTANDI in Men with Metastatic Hormone-Sensitive Prostate Cancer",2018-12-20 09:01:00-05:00,PFE,negative
1000800.0,"GlaxoSmithKline, Pfizer To Merge Consumer Health Care Businesses",2018-12-19 12:01:00-05:00,PFE,positive
1000801.0,"The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas",2018-12-19 07:46:00-05:00,PFE,positive
1000802.0,Dan Nathan Sees Unusual Options Activity In Pfizer,2018-12-19 07:28:00-05:00,PFE,neutral
1000803.0,UPDATE: Pfizer to Hold 32% Stake in JV; GlaxoSmithKline 68%,2018-12-19 04:21:00-05:00,PFE,neutral
1000804.0,"Pfizer, GlaxoSmithKline Announce JV to Create Premier Global Consumer Healthcare Company",2018-12-19 04:19:00-05:00,PFE,positive
1000805.0,Biotechs Were Innovators In 2018: Here Are The Top New Molecules That Were Approved,2018-12-18 08:55:00-05:00,PFE,positive
1000806.0,"The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan",2018-12-18 08:00:00-05:00,PFE,positive
1000807.0,"Pfizer Announces a Research Collaboration and License Agreement with Kineta for Cancer Immunotherapies, Will Make a $15M Upfront Payment",2018-12-17 08:07:00-05:00,PFE,negative
1000808.0,Pfizer Raises Qtr. Dividend From $0.34 To $0.36/Share,2018-12-14 12:11:00-05:00,PFE,neutral
1000809.0,Pfizer Reports $10B Buyback,2018-12-14 12:10:00-05:00,PFE,neutral
1000810.0,Pfizer Reports Received Positive CHMP Opinion For ZIRABEV,2018-12-14 10:29:00-05:00,PFE,positive
1000811.0,Pfizer Reports Initiation Of Phase 3 Program For 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older,2018-12-14 08:03:00-05:00,PFE,neutral
1000812.0,"Benzinga's Top Upgrades, Downgrades For December 11, 2018",2018-12-11 09:18:00-05:00,PFE,positive
1000813.0,A Peek Into The Markets: US Stock Futures Surge Ahead Of Producer Price Index,2018-12-11 07:18:00-05:00,PFE,neutral
1000814.0,"JP Morgan Downgrades Pfizer to Neutral, Announces $46 Price Target",2018-12-11 06:38:00-05:00,PFE,positive
1000815.0,PreMarket Prep Opening NYSE Imbalance Update: Square 95k Shares To Sell; Pfizer 107K To Sell; Visa 56k To Sell; Citigroup 131k To Sell,2018-12-10 08:57:00-05:00,PFE,positive
1000816.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-12-07 16:09:00-05:00,PFE,positive
1000817.0,"The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering",2018-12-06 07:56:00-05:00,PFE,negative
1000818.0,"Stocks Which Set New 52-Week High Yesterday, Mon., Dec. 3, 2018",2018-12-04 09:20:00-05:00,PFE,neutral
1000819.0,"The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO",2018-12-04 07:59:00-05:00,PFE,neutral
1000820.0,Pfizer Presents Positive 26-Week Data For PF-05280586 Potential Biosimilar To Rituximab at ASH 2018,2018-12-02 18:29:00-05:00,PFE,positive
1000821.0,"The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs",2018-12-02 17:51:00-05:00,PFE,neutral
1000822.0,AbbVie shares are trading up 3.4% after the company announced a global patent license with Pfizer for HUMIRA; Pfizer shares up 1.3%.,2018-11-30 13:58:00-05:00,PFE,positive
1000823.0,"Stocks Which Set New 52-Week High Yesterday, Thurs., Nov. 29, 2018",2018-11-30 10:25:00-05:00,PFE,neutral
1000824.0,Pfizer Reaches a Global Agreement With AbbVie For Biosimilar To HUMIRA,2018-11-30 10:01:00-05:00,PFE,positive
1000825.0,PreMarket Prep Opening NYSE Imbalance Update: AT&T 135k Shares To Sell; Pfizer 172k To Sell; GE 263k To Sell,2018-11-30 08:40:00-05:00,PFE,positive
1000826.0,"The Daily Biotech Pulse: EC Nod For Shire, Mirati Gets FDA Clearance For Cancer Drug Trials, PhaseBio's First Earnings",2018-11-30 08:25:00-05:00,PFE,negative
1000827.0,"The Daily Biotech Pulse: IntelliPharmaCeutics Generic Antidepressant Gets FDA Nod, GW Pharma Earnings",2018-11-28 07:46:00-05:00,PFE,neutral
1000828.0,"Pfizer Reports Received 6-Month Pediatric Exclusivity For LYRICA, To Jun. 30, 2019",2018-11-27 15:05:00-05:00,PFE,neutral
1000829.0,GlaxoSmithKline and J&J's HIV Drug Juluca Received Approval In Japan,2018-11-27 14:43:00-05:00,PFE,positive
1000830.0,Aileron Enters Clinical Trial Collaboration With Pfizer To Evaluate ALRN-6924 In Combination With IBRANCE In MDM2-Amplified Cancers,2018-11-27 08:07:00-05:00,PFE,neutral
1000831.0,"Data Dive, Trade Talks And Powell: Busy Post-Holiday Week On The Way",2018-11-26 09:41:00-05:00,PFE,neutral
1000832.0,9 Policy Catalysts For Health Care Investors To Watch Before Year's End,2018-11-25 09:35:00-05:00,PFE,positive
1000833.0,Pfizer Shares Tick Slightly Higher Following FDA Approval Of Daurismo,2018-11-21 12:55:00-05:00,PFE,positive
1000834.0,"Hearing Jana Is Pressuring Exact Sciences To Sell Itself, Pfizer Could Be Interested",2018-11-21 11:04:00-05:00,PFE,positive
1000835.0,October's Biggest Losers And Most Surprising Winners,2018-11-21 10:48:00-05:00,PFE,positive
1000836.0,Merck and Pfizer's Avelumab in Platinum-Resistant/Refractory Ovarian Cancer Did Not Meet Primary Endpoints,2018-11-19 07:15:00-05:00,PFE,negative
1000837.0,Pfizer To Raise Prices On 41 Drugs,2018-11-16 14:57:00-05:00,PFE,neutral
1000838.0,October's biggest Losers And Most Surprising Winners,2018-11-12 13:19:00-05:00,PFE,positive
1000839.0,"Stocks Trading Ex Dividend For Thurs., Nov. 8, 2018",2018-11-08 10:55:00-05:00,PFE,neutral
1000840.0,"Tariffs, Drug Prices, Legislative Gridlock: What Economists Are Watching Following The Midterm Election",2018-11-07 11:30:00-05:00,PFE,neutral
1000841.0,Here's What's At Stake For Your Investments In The 2018 Midterms,2018-11-06 08:54:00-05:00,PFE,neutral
1000842.0,"Bulls & Bears Of The Week: Amazon, Apple, Ford, GE And More",2018-11-05 16:03:00-05:00,PFE,positive
1000843.0,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-11-04 13:35:00-05:00,PFE,neutral
1000844.0,U.S. FDA Approves Pfeizer's LORBRENA For Previously-Treated ALK-Positive Metastatic NSCLC,2018-11-02 16:42:00-04:00,PFE,positive
1000845.0,"BMO Downgrades Pfizer After Q3 Print, Says Risk-Reward 'Fairly Balanced'",2018-11-01 10:54:00-04:00,PFE,neutral
1000846.0,"High-Dividend, Wide Moat ETFs Debut",2018-11-01 10:12:00-04:00,PFE,neutral
1000847.0,"Benzinga's Top Upgrades, Downgrades For November 1, 2018",2018-11-01 09:48:00-04:00,PFE,positive
1000848.0,Attention Biotech Investors: Mark Your Calendar For These November PDUFA Dates,2018-11-01 09:26:00-04:00,PFE,neutral
1000849.0,Hearing Pfizer Considering Sale Of Its Women's Health Portfolio,2018-11-01 08:49:00-04:00,PFE,neutral
1000850.0,A Peek Into The Markets: US Stock Futures Rise As Investors Await Earnings,2018-11-01 07:04:00-04:00,PFE,positive
1000851.0,BMO Capital Downgrades Pfizer to Market Perform,2018-11-01 06:33:00-04:00,PFE,neutral
1000852.0,From Pfizer Q3 Earnings Conference Call: Sees Taking Price Increase Decisions In Jan.,2018-10-30 10:48:00-04:00,PFE,positive
1000853.0,Wild Times: Market Seems To Seek Solid Ground After Monday's Manic,2018-10-30 10:45:00-04:00,PFE,positive
1000854.0,From Pfizer Conference Call; CEO Says Hopes Trump Administration Plans To Base Medicare Part B Drug Prices On Cheaper Prices Paid Outside US,2018-10-30 10:42:00-04:00,PFE,positive
1000855.0,From Pfizer Conference Call: CEO Says 'We Continue Not To See The Need For Any Large Scale M&A Activity At This Time',2018-10-30 10:25:00-04:00,PFE,neutral
1000856.0,"From Pfizer Conference Call: CEO Says 'We Are Supportive Of Developing A Market-Based alternative To The Current Buy-And-Bill System...A System Facilitated By Many Vendors, Not Just One Or Two PBM's'",2018-10-30 10:19:00-04:00,PFE,positive
1000857.0,"The Daily Biotech Pulse: Pfizer And Allergan Earnings, CFO Departures At Acadia And Assertio",2018-10-30 08:00:00-04:00,PFE,neutral
1000858.0,Pfizer Reaffirms FY18 Adj. EPS Guidance $2.98-$3.02,2018-10-30 06:46:00-04:00,PFE,neutral
1000859.0,"Pfizer, Inc. Q3 EPS $0.78 Beats $0.75 Estimate, Sales $13.298B Miss $13.55B Estimate",2018-10-30 06:45:00-04:00,PFE,negative
1000860.0,A Peek Into The Markets: US Stock Futures Gain Ahead Of Earnings,2018-10-30 06:20:00-04:00,PFE,positive
1000861.0,"14 Stocks To Watch For October 30, 2018",2018-10-30 04:36:00-04:00,PFE,neutral
1000862.0,"Earnings Scheduled For October 30, 2018",2018-10-30 04:01:00-04:00,PFE,neutral
1000863.0,Pfizer's Q3 Earnings Preview,2018-10-29 14:18:00-04:00,PFE,neutral
1000864.0,"Benzinga's Week Ahead: Can Facebook, Apple Earnings Rescue The Stock Market?",2018-10-29 13:10:00-04:00,PFE,positive
1000865.0,"These Are The Biggest Stocks Reporting Earnings This Week, And Their Recent Track Records",2018-10-29 10:39:00-04:00,PFE,neutral
1000866.0,GlaxoSmithKlein's and Pfizer's ViiV Gives an Update on its Two-Drug HIV Regimen,2018-10-29 06:24:00-04:00,PFE,neutral
1000867.0,"Novartis, Pfizer Announce Clinical Collaboration to Advance Treatment of NASH",2018-10-29 04:08:00-04:00,PFE,neutral
1000868.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs",2018-10-27 10:23:00-04:00,PFE,neutral
1000869.0,"Pfizer, Lilly Announce Complete Results from First Study in Ongoing Phase 3 Program for Tanezumab Demonstrated Significant Improvement in Pain and Function in Osteoarthritis Patients",2018-10-24 03:46:00-04:00,PFE,positive
1000870.0,How To Use Pivot Points In Your Trading,2018-10-23 15:17:00-04:00,PFE,neutral
1000871.0,"Pfizer, Bain Capital Report Formation Of New Central Nervous System Co., Cerevel Therapeutics; Bain Committed $350M",2018-10-23 08:33:00-04:00,PFE,neutral
1000872.0,Allogene Therapeutics 13D Filing From Pfizer Shows 18.7% Stake,2018-10-22 16:35:00-04:00,PFE,neutral
1000873.0,"Pfizer On Saturday Presented Overall Survival Data From PALOMA-3 Trial Of IBRANCE (palbociclib) In Patients With HR+, HER2- Metastatic Breast Cancer",2018-10-22 07:49:00-04:00,PFE,negative
1000874.0,"The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut",2018-10-19 08:28:00-04:00,PFE,positive
1000875.0,"Mylan Highlights US Launch Of Medroxyprogesterone Acetate Injectable Suspension USP, 150 mg/mL Single-Dose vial, Generic Version Of Pfizer's Depo-Provera",2018-10-18 16:50:00-04:00,PFE,neutral
1000876.0,"GlaxoSmithKline And Pfizer Joint Venture, ViiV, Submits HIV 2DR Regulatory Application To FDA",2018-10-18 11:03:00-04:00,PFE,neutral
1000877.0,Merck Says 'Pivotal Phase 3 KEYNOTE-426 Trial Met Both Primary Endpoints; Data to be Filed with Global Regulatory Authorities',2018-10-18 06:58:00-04:00,PFE,neutral
1000878.0,"Merck Reports KEYTRUDA In Combo With Pfizer's Inlyta Improved Overall Survival, Progression-Free Survival As First-Line Therapy For Advanced, Metastatic Renal Cell Carcinoma",2018-10-18 06:57:00-04:00,PFE,positive
1000880.0,"Midterms And The Stock Market: Potential Winners, Losers From The Coming Election",2018-10-13 12:21:00-04:00,PFE,negative
1000881.0,"Stocks Which Set New 52-Week High Yesterday, October 9th",2018-10-10 10:57:00-04:00,PFE,neutral
1000882.0,"The Daily Biotech Pulse: Novartis Blood Disorder Drug Improves Patient Outcomes, Audentes To Offer Shares",2018-10-10 07:56:00-04:00,PFE,positive
1000883.0,Myriad Announces New Laboratory Agreement with Pfizer; Myriad Will Provide BRACAnalysis CDx Testing In Phase 2 Study Evaluating Pfizer's Talazoparib,2018-10-10 07:07:00-04:00,PFE,positive
1000884.0,"The Daily Biotech Pulse: Affimed's Cancer Drug Placed On Clinical Hold, Celgene's Positive Scalp Psoriasis Trial",2018-10-09 08:03:00-04:00,PFE,negative
1000885.0,"Stocks That Made New 52-Week Highs So Far Today Include: Ameren, Pfizer, Eli Lilly, Envision Healthcare, AES, McCormick, Archer-Daniels Midland, and Ball Corp.",2018-10-08 13:32:00-04:00,PFE,neutral
1000886.0,"Stocks Which Set New 52-Week High Friday, October 5th",2018-10-08 09:22:00-04:00,PFE,neutral
1000887.0,"IPO Outlook For The Week: Biotechs, Batteries And Business Solutions",2018-10-07 15:41:00-04:00,PFE,positive
1000888.0,"Stocks Which Set New 52-Week High Yesterday, October 3rd",2018-10-04 11:18:00-04:00,PFE,neutral
1000889.0,"The Daily Biotech Pulse: AtriCure's Guidance, Guardant Health And Kodiak To Debut",2018-10-04 07:59:00-04:00,PFE,neutral
1000890.0,"Stocks Which Set New 52-Week High Yesterday, October 1st",2018-10-02 09:20:00-04:00,PFE,neutral
1000891.0,"The Daily Biotech Pulse: TransEnterix's Positive Pre-Announcement, Merit Medical Opens Wallet, GW Pharma To Offer ADS Shares",2018-10-02 09:10:00-04:00,PFE,positive
1000892.0,"Pfizer Confirms CEO Ian Read to Step Down End of Year, COO Albert Bourla to Become CEO",2018-10-01 06:47:00-04:00,PFE,neutral
1000893.0,"Pfizer CEO to Step Aside at End of Year, COO to Become CEO",2018-10-01 06:42:00-04:00,PFE,neutral
1000894.0,REMINDER: Pfizer Has FDA PDUFA Date For Dacomitinib Due By End of September (Exact Date Not Provided),2018-09-28 08:56:00-04:00,PFE,neutral
1000895.0,"The Daily Biotech Pulse: FDA Nods For Adamis, Eli Lilly, Pfizer; Spero, Obseva Report Positive Trial Results",2018-09-28 08:10:00-04:00,PFE,positive
1000896.0,FDA Approves Pfizer's VIZIMPRO (dacomitinib) In Lung Cancer Patients,2018-09-27 17:42:00-04:00,PFE,negative
1000897.0,"Analyst: Amarin's Vascepa Results Create Unicorn Potential, M&A Opportunity",2018-09-25 12:43:00-04:00,PFE,positive
1000898.0,"Stocks Which Set New 52-Week High Yesterday, September 24th",2018-09-25 09:06:00-04:00,PFE,neutral
1000899.0,"The Daily Biotech Pulse: Syndax Lung Cancer Trial Disappoints, Gemphire To Trim Workforce, Opiant's Offering",2018-09-25 08:30:00-04:00,PFE,negative
1000900.0,"Stocks That Made New 52-Week Highs So Far Today Include: Amgen, Ross Stores, Marathon Petroleum, Marathon Oil, Medtronic, Humana, Pfizer, Boston Scientific, Edward Lifesciences, and Abbott Labs",2018-09-24 13:13:00-04:00,PFE,neutral
1000901.0,"Stocks Which Set New 52-Week High Friday, September 21",2018-09-24 09:43:00-04:00,PFE,neutral
1000902.0,"Stocks That Made New 52-Week Highs So Far Today Include: Mosaic, Cooper Companies, Pfizer, Gartner, Yum Brands, Danaher, Anthem, Nike, Cisco, Honeywell, Advance Auto Parts, and Clorox",2018-09-21 12:55:00-04:00,PFE,neutral
1000903.0,"The Daily Biotech Pulse: Exelixis Liver Cancer Drug On Track For European Approval, Medtronic Goes Shopping, Opiant Snags BARDA Funding",2018-09-21 08:51:00-04:00,PFE,negative
1000904.0,"Stocks Which Set New 52-Week High Yesterday, September 20th",2018-09-21 08:16:00-04:00,PFE,neutral
1000905.0,Merck Or Pfizer: Which Is The Better Large-Cap Pharma Stock?,2018-09-20 15:55:00-04:00,PFE,positive
1000906.0,"Stocks That Made New 52-Week Highs So Far Today Include: Corning, Visa, Pfizer, ADP, Anthem, Microsoft, Nike, Sherwin-Williams, Lowe's, Honeywell, Yum Brands, Medtronic, ConocoPhillips, Amgen, Cooper Companies, and Boston Scientific",2018-09-20 12:04:00-04:00,PFE,neutral
1000907.0,"Stocks Which Set New 52-Week High Yesterday, September 19th",2018-09-20 11:24:00-04:00,PFE,neutral
1000908.0,"The Daily Biotech Pulse: Adverum Snags Fast Track Designation, Crispr To Offer Shares, Elanco Animal Health To Debut",2018-09-20 09:02:00-04:00,PFE,positive
1000909.0,"Pfizer Reports Its 20-Valent Pneumococcal Conjugate Vaccine For Prevention Of Invasive Disease, Pneumonia In Adults Aged 18+ Was Granted Breakthrough Therapy Designation",2018-09-20 08:01:00-04:00,PFE,positive
1000910.0,"The Daily Biotech Pulse: Johnson & Johnson's Generic Unit Files NDA For Urinary Tract Cancer Drug, G1 Therapeutics Prices Offering",2018-09-19 08:47:00-04:00,PFE,negative
1000911.0,"FDA Issues New Safety Measures For Immediate-Release, Extended-Release, and Long-Acting Opioid Analgesics",2018-09-18 15:17:00-04:00,PFE,positive
1000912.0,"Stocks That Made New 52-Week Highs So Far Today Include: Allegion, Boston Scientific, Arthur J. Gallagher, United Technologies, Waste Management, Qualcomm, Pfizer, Mastercard, Nike, Lowe's, Union Pacific, Norfolk Southern, and Aetna",2018-09-18 14:21:00-04:00,PFE,neutral
1000913.0,"Stocks Which Set New 52-Week High Yesterday, September 17th",2018-09-18 09:25:00-04:00,PFE,neutral
1000914.0,"UPDATE: Pfizer On Tafamidis Says '29% and 31% reduction in the risk of death observed in wild-type and hereditary sub-groups, respectively'",2018-09-18 09:04:00-04:00,PFE,negative
1000915.0,Pfizer Reports Results Of New Phase 3 Analyses Of Tafamidis Favored Candidate Across All Sub Groups,2018-09-18 09:03:00-04:00,PFE,positive
1000916.0,"The Daily Biotech Pulse: Morphosys Expands Collaboration, Osiris Announces Product Launch, Argenx To Offer Shares",2018-09-18 08:44:00-04:00,PFE,positive
1000917.0,"Stocks Which Set New 52-Week High Friday, September 14th",2018-09-17 09:28:00-04:00,PFE,neutral
1000918.0,Pfizer to Evaluate Atomwise's Platform to Select Drug Candidates for Up to 3 Proteins,2018-09-17 08:28:00-04:00,PFE,neutral
1000919.0,"Stocks Which Set New 52-Week High Yesterday, September 13th",2018-09-14 09:26:00-04:00,PFE,neutral
1000920.0,"The Daily Biotech Pulse: FDA Nod For STAAR, Supernus Opens Wallet, Principia Biopharma To Debut",2018-09-14 08:38:00-04:00,PFE,neutral
1000921.0,"Stocks That Made New 52-Week Highs So Far Today Include: NiSource, Pfizer, United Continental, UDR, Kellogg, Arthur J. Gallagher, PerkinElmer, Paypal, Thermo Fisher, Honeywell, Visa, American Express, Nike, Intuit, Boston Scientific, Microsoft, and AMD",2018-09-13 11:43:00-04:00,PFE,positive
1000922.0,"Stocks Which Set New 52-Week High Yesterday, September 12",2018-09-13 09:44:00-04:00,PFE,neutral
1000923.0,"The Daily Biotech Pulse: Progenics Posts Mixed Trial Results, Antitrust Nod For Galapagos-MorphoSys Collaboration, New CEO For Biopharmx",2018-09-13 08:42:00-04:00,PFE,neutral
1000924.0,"Stocks That Made New 52-Week Highs So Far Today Include: AMD, Salesforce, Jacobs Engineering, Church & Dwight, Simon Property Group, Verizon, Lowe's, Hormel, Adobe, Kohl's, Total System Services, Union Pacific, Home Depot, American Express, & Pfizer",2018-09-12 15:35:00-04:00,PFE,neutral
1000925.0,Investors Try To Read The Trade Tea Leaves In The Latest IMX Report,2018-09-12 15:15:00-04:00,PFE,neutral
1000926.0,"Market Appears To Be in Wait-and-See Mode Ahead of Apple, Central Bank Events",2018-09-12 10:27:00-04:00,PFE,neutral
1000927.0,Investor Movement Index August Summary,2018-09-11 11:08:00-04:00,PFE,neutral
1000928.0,Health Care Has Been On Fire. Will The Uptrend Continue?,2018-09-07 14:40:00-04:00,PFE,positive
1000929.0,"CBS, Constellation Brands, Pfizer, Taiwan Semi: 'Fast Money' Picks For September 7",2018-09-07 07:32:00-04:00,PFE,neutral
1000930.0,Credit Suisse Joins Consensus To Prescribe Sarepta,2018-09-06 14:47:00-04:00,PFE,positive
1000931.0,"Pfizer Receives Breakthrough Therapy Designation from FDA for PF-06651600, Co. Announces Phase 2 Data Is Accepted For Late-Breaker News Session At 2018 EADV Congress",2018-09-05 08:50:00-04:00,PFE,positive
1000932.0,"The Daily Biotech Pulse: Biohaven In-Licenses Drug, Retrophin's Debt Offering, ProQR And Bluebird Report Positive Trial Results",2018-09-05 08:28:00-04:00,PFE,positive
1000933.0,Pfizer Estimates its Own Brexit Costs at $100M,2018-09-04 05:03:00-04:00,PFE,neutral
1000934.0,Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates,2018-08-31 15:06:00-04:00,PFE,neutral
1000935.0,Pfizer Reports Termination Of PF-06252616 Studies,2018-08-30 08:00:00-04:00,PFE,neutral
1000936.0,Pfizer Press Earlier Announced Voluntary Nationwide Recall Of One Lot of Children's Advil Bubble Gum Flavored 4 Oz. Bottle,2018-08-28 11:31:00-04:00,PFE,neutral
1000937.0,Hearing Pfizer Announces Nationwide Recall Of Children's Advil,2018-08-28 11:23:00-04:00,PFE,neutral
1000938.0,"The Daily Biotech Pulse: Regulatory Roadblock For Akcea-Ionis, Affimed's Alliance, FDA Nod For Tetraphase's Antibiotic",2018-08-28 08:13:00-04:00,PFE,neutral
1000939.0,Pfizer Slips Despite Mostly Positive Tafamidis Data; 4 Pharma Stocks Make Sympathy Moves,2018-08-27 14:59:00-04:00,PFE,negative
1000940.0,Eidos Therapeutics shares now down 31.9%; Drop is being attributed to rival company Pfizer's positive clinical data from its trial of tafamidis.,2018-08-27 12:26:00-04:00,PFE,positive
1000941.0,"PreMarket Prep Opening NYSE Imbalance Update: SYSCO 161K Share Sell Imbalance, Pfizer 63K Sell Imbalance",2018-08-27 09:12:00-04:00,PFE,positive
1000942.0,Pfizer Earlier Announced Primary Results From Phase 3 Transthyretin Amyloid Cardiomyopathy Study; Study Showed Tafamidis Significantly Reduced Combination Of All-Cause Mortality And Cardiovascular-Related Hospitalizations,2018-08-27 08:31:00-04:00,PFE,neutral
1000943.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Results",2018-08-26 15:40:00-04:00,PFE,neutral
1000944.0,"Barron's Picks And Pans: Electronic Arts, GlaxoSmithKline, Microsoft, Tesla And More",2018-08-25 18:16:00-04:00,PFE,neutral
1000945.0,"The Daily Biotech Pulse: Novartis Breast Cancer Trial Meets Endpoint, Medpace's Offering, Dexcom Buys TypeZero",2018-08-23 08:23:00-04:00,PFE,negative
1000946.0,"Morgan Stanley Maintains Overweight on Pfizer, Raises Price Target to $45",2018-08-23 07:43:00-04:00,PFE,negative
1000947.0,"Barclays Maintains Equal-Weight on Pfizer, Raises Price Target to $40",2018-08-23 07:37:00-04:00,PFE,neutral
1000948.0,"Pfizer and Astellas Pharmas Amed Protocals To 2 Phase 3 Trials (ARCHES and EMBARK), Moves Up Anticipated Completion Dates; ARCHES Date Changed From April 2020 to Late 2018, EMBARK Date Changed From March 2021 to Mid-2020",2018-08-22 17:02:00-04:00,PFE,neutral
1000949.0,Stifel Drops Bullish Zoetis Thesis After 108% Outperformance,2018-08-22 09:40:00-04:00,PFE,neutral
1000950.0,From Exact Sciences Call To Discuss Cologuard Deal With Pfizer: Sees Deal Impacting Cologuard Sales Throughout 2019,2018-08-22 09:20:00-04:00,PFE,neutral
1000951.0,Exact Sciences Shares Unaffected Following Comment By CEO On Co. Conference Call To Discuss Pfizer Deal For Cologuard: Pfizer Deal Will Have 'Very Little' Impact On Cologuard Sales This Year,2018-08-22 08:17:00-04:00,PFE,positive
1000952.0,24 Stocks Moving In Wednesday's Pre-Market Session,2018-08-22 08:00:00-04:00,PFE,neutral
1000953.0,"Exact Sciences And Pfizer Enter Into U.S. Promotion Agreement For Cologuard; Pfizer Will Join Exact Sciences' Sales Reps I Reaching Both Physicians And Health systems, Will Actively Help In Extending Cologuard Marketing Campaign",2018-08-22 06:12:00-04:00,PFE,positive
1000954.0,Pfizer Is Coordinating With The FDA To Extend Expiration Dates Of Specific Lots Of EpiPen Auto Injectors And Its Authorized Generic Version After Review Of Stability  Data,2018-08-21 10:21:00-04:00,PFE,positive
1000955.0,"The Daily Biotech Pulse: Merck's Keytruda Secures Approval For Expanded Label, ProPhase Labs Q2 Loss Narrows",2018-08-21 08:40:00-04:00,PFE,positive
1000956.0,"BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza, BioNTech To Receive $120M Upfront With $305M IN Potential Milestone Payments Along With Double-Digit Royalties",2018-08-16 06:08:00-04:00,PFE,positive
1000957.0,"Shares of GlaxoSmithKline are up 1.5% and shares of Pfizer are up 0.7% after ViiV Healthcare, a joint venture between the two companies, announced positive 48-week study results for HIV treatment regimen.",2018-08-15 11:38:00-04:00,PFE,positive
1000958.0,"ViiV Healthcare Announces Positive 48-week Results for First Pivotal, Phase III Study for Novel, Long-acting, Injectable HIV-treatment Regimen",2018-08-15 04:34:00-04:00,PFE,positive
1000959.0,Tudor Investment Corporation Shows New 28.23K Share Stake In Pfizer,2018-08-14 15:48:00-04:00,PFE,positive
1000960.0,"Goldman Drops Alnylam From Conviction List, But Continues To See 'Blockbuster Potential'",2018-08-13 14:14:00-04:00,PFE,positive
1000961.0,PreMarket Prep Opening NYSE Imbalance Update: Pfizer 125k Shares To Sell; Alibaba 52k To Sell; GE 153k To Sell; Deutsche Bank 14k to sell: Taiwan Semiconductor 81k To Sell,2018-08-10 08:37:00-04:00,PFE,positive
1000962.0,UPDATE: Pfizer 10-Q Shows Dept. Of Justice Requested In Jul. 2018 Documents Related To Contracts With The Iraqi Ministry Of Health; Co. To Comply With Request,2018-08-09 16:42:00-04:00,PFE,positive
1000963.0,Pfizer 10-Q Just Out,2018-08-09 16:41:00-04:00,PFE,neutral
1000964.0,"Stocks Which Set New 52-Week High Yesterday, August 8th",2018-08-09 11:03:00-04:00,PFE,neutral
1000965.0,"The Daily Biotech Pulse: Ampio Slides On Offering, Sangamo's Positive Trial Results, Insys Earnings",2018-08-09 08:39:00-04:00,PFE,positive
1000966.0,PreMarket Prep Opening NYSE Imbalance Update: Pfizer 237k Shares To Sell; GE 79k To Sell; Alibaba 24k To Buy,2018-08-09 08:35:00-04:00,PFE,positive
1000967.0,"Stocks That Made New 52-Week Highs So Far Today Include: Medtronic, Amazon, Pfizer, AES, W.W. Grainger, Centene, Chipotle, Emerson Electric, Zoetis, Michael Kors, United Continental, VF, Aetna, Ross Stores, and UnitedHealth Group",2018-08-08 12:03:00-04:00,PFE,positive
1000968.0,"Stocks Which Set New 52-Week High Yesterday, August 7th",2018-08-08 11:01:00-04:00,PFE,neutral
1000969.0,Mylan CEO On Conf. Call Says They Have Good Months Of Epipen Supply From Pfizer And Then Suddenly Get Erratic Supply; Says They're Working Closely With Pfizer,2018-08-08 10:44:00-04:00,PFE,positive
1000970.0,"The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos' Maiden Earnings, Paratek Awaits Adcom Verdict",2018-08-08 08:15:00-04:00,PFE,positive
1000971.0,"Stocks That Made New 52-Week Highs Earlier Today Include: SL Green Realty, Verisk Analytics, Medtronics, Pfizer, Conoco Phillips, Archer-Daniels, Eli Lilly, Merck, Phillips 66, Costco, Advance Auto Parts, Norfolk Southern, CSX, Zoetis, Apple, and Disney",2018-08-07 11:49:00-04:00,PFE,neutral
1000972.0,"Stocks Which Set New 52-Week High Yesterday, August 6th",2018-08-07 11:27:00-04:00,PFE,neutral
1000973.0,"The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel",2018-08-07 08:23:00-04:00,PFE,negative
1000974.0,"AT&T, Disney, Pfizer, Wynn Resorts: 'Fast Money' Picks For August 7",2018-08-07 07:26:00-04:00,PFE,neutral
1000975.0,52 Biggest Movers From Yesterday,2018-08-07 05:19:00-04:00,PFE,neutral
1000976.0,"UPDATE: Gemphire Says Royalty Period Has Been Extended, Royalty Rates Have Increased 'Slightly,' From High Single Digits To Mid-Teens",2018-08-06 16:16:00-04:00,PFE,positive
1000977.0,"UPDATE: Gemphire Adjustment To Gemcabene Deal With Pfizer Includes Extension Of Date For Deadline For First Commercial Sale Of Gemcabene: Pfizer Has Right To Terminate License If First Sale Has Not Occurred By Apr. 2024, Up From Apr. 2021 Previously",2018-08-06 16:15:00-04:00,PFE,neutral
1000978.0,"Gemphire Reports Amended, Restated License Deal With Pfizer For Gemcabene",2018-08-06 16:14:00-04:00,PFE,neutral
1000979.0,"Stocks That Made New 52-Week Highs So Far Today Include: CSX, Jacobs Engineering, Medtronic, United Continental, Cintas, Advance Auto Parts, O'Reilly Automotive, Robert Half, Norfolk Southern, Verisk Analytics, NextEra Energy, Pfizer, Apple, & Illumina",2018-08-06 15:50:00-04:00,PFE,positive
1000980.0,"Stocks Which Set New 52-Week Highs Friday, August 3rd",2018-08-06 13:02:00-04:00,PFE,neutral
1000981.0,44 Stocks Moving In Monday's Mid-Day Session,2018-08-06 12:39:00-04:00,PFE,neutral
1000982.0,PreMarket Prep Opening NYSE Imbalance Update: Berkshire Hathaway 101k Shares To Buy; Pfizer 161k To Sell; Disney 69k Shares To Buy,2018-08-06 08:52:00-04:00,PFE,positive
1000983.0,Benzinga Pro's 5 Stocks To Watch Today,2018-08-06 08:51:00-04:00,PFE,neutral
1000984.0,Antares Pharma Announces a Development Agreement with Pfizer for Drug Rescue Pen,2018-08-06 07:09:00-04:00,PFE,positive
1000985.0,"Stocks That Made New 52-Week Highs Earlier Today Include: Pfizer, AES, Simon Property Group, HCA Healthcare, Church & Dwight, Kellogg, Advanced Auto Parts, McCormick, Target, O'Reilly Automotive, Ross Stores, Mosaic, and CF Industries",2018-08-03 11:21:00-04:00,PFE,positive
1000986.0,"Stocks Trading Ex Dividend For Thurs., Aug. 2, 2018",2018-08-02 11:10:00-04:00,PFE,neutral
1000987.0,"Stocks Which Set New 52-Week High Yesterday, August 1st",2018-08-02 10:56:00-04:00,PFE,neutral
1000988.0,"Stocks That Have Made New 52 Week Highs Thus Far Today Include: Robert Half, Eli Lilly, Pfizer, Phillips 66, Humana, HCA Healthcare, Genworth, Republic Services, Illumina, Aflac, Medtronic, Waste Management, and Apple",2018-08-01 13:32:00-04:00,PFE,negative
1000989.0,"Stocks Which Set New 52-Week High Yesterday, July 31",2018-08-01 12:04:00-04:00,PFE,neutral
1000990.0,"Price Action In Several Major Healthcare Names Mixed, Stocks Appear Largely Unaffected Following Late-Tues. NY Times Article 'Justice Dept. Investigating Claims That Drug Companies Funded Terrorism in Iraq'",2018-08-01 10:59:00-04:00,PFE,negative
1000991.0,"Morgan Stanley Buys Into Sarepta Amid Sell-Off, Sees $600M Recurring Opportunity In DMD Candidate",2018-08-01 10:03:00-04:00,PFE,positive
1000992.0,"BMO Capital Maintains Outperform on Pfizer, Raises Price Target to $44",2018-08-01 09:41:00-04:00,PFE,neutral
1000993.0,"Benzinga's Biotech Pulse: Pfizer's Xeljanz Gets EU Nod, NewLink Losses Narrow, Neuralstem Commences Stroke Drug Trial",2018-08-01 09:01:00-04:00,PFE,negative
1000994.0,"Credit Suisse Maintains Neutral on Pfizer, Raises Price Target to $40",2018-08-01 08:59:00-04:00,PFE,positive
1000995.0,"Apple, Caterpillar, CBS, Pfizer: 'Fast Money' Picks For August 1",2018-08-01 07:46:00-04:00,PFE,neutral
1000996.0,XELJANZ Receives EU Marketing Authorization for Moderately to Severely Active Ulcerative Colitis,2018-08-01 03:44:00-04:00,PFE,negative
1000997.0,"'$PFE CEO Read also downplays prospects of a big deal, saying ""we'd be better off focusing on developing our pipeline.""'-WSJ Reporter Jonathan Rockoff",2018-07-31 13:14:00-04:00,PFE,positive
1000998.0,Pfizer CEO Says He Sees A 'Huge Sense Of Urgency' In Trump Admin To Act On Drug Rebates,2018-07-31 10:53:00-04:00,PFE,positive
1000999.0,"A Peek Into The Markets: US Stock Futures Up Ahead Of Earnings, Economic Data",2018-07-31 07:01:00-04:00,PFE,neutral
1001000.0,Pfizer Continues To Evaluate Strategic Alternatives For Consumer Healthcare Business; Decision Expected In 2018,2018-07-31 06:50:00-04:00,PFE,neutral
1001001.0,Pfizer Cuts FY18 Sales Guidance From $53.5B-$55.5B To $53B-$55B vs $54.29B Est.,2018-07-31 06:48:00-04:00,PFE,negative
1001002.0,Pfizer Raises FY18 Adj. EPS Guidance From $2.90-$3.00 To $2.95-$3.05 vs $2.95 Est.,2018-07-31 06:47:00-04:00,PFE,neutral
1001003.0,"Pfizer Q2 Adj. EPS $0.81 Beats $0.74 Estimate, Sales $13.5B Beat $13.31B Estimate",2018-07-31 06:46:00-04:00,PFE,neutral
1001004.0,"Pfizer Receives European Approval For Oncology Biosimilar, TRAZIMERA (trastuzumab)",2018-07-31 06:00:00-04:00,PFE,positive
1001005.0,"12 Stocks To Watch For July 31, 2018",2018-07-31 04:46:00-04:00,PFE,neutral
1001006.0,"Earnings Scheduled For July 31, 2018",2018-07-31 04:37:00-04:00,PFE,neutral
1001007.0,Pfizer Q2 Earnings Preview,2018-07-30 15:43:00-04:00,PFE,neutral
1001008.0,"The Week Ahead: Apple And Tesla Earnings, FOMC Meeting, Sonos IPO",2018-07-30 13:46:00-04:00,PFE,neutral
1001009.0,"Apple To Report Earnings Amid A Busy Week Filled With Economic Data, Fed Meeting And More",2018-07-30 10:57:00-04:00,PFE,neutral
1001010.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs",2018-07-28 14:04:00-04:00,PFE,neutral
1001011.0,"Caterpillar Earnings Preview: Economic Outlook Seems Good, Tariffs Adding Uncertainty",2018-07-27 11:26:00-04:00,PFE,positive
1001012.0,"Sarepta's Clinical Hold Could Be A Solid Biosciences Catalyst, Says Bullish Chardan Analyst",2018-07-26 10:30:00-04:00,PFE,positive
1001013.0,"Pfizer Shares Spike ~0.5% As Traders Circulate Questionable, Unconfirmed Chatter Of Activist Interest",2018-07-26 09:59:00-04:00,PFE,positive
1001014.0,"GlycoMimetics 8-K Shows Pfizer Said Ongoing Phase 3 Trial With Rivipansel Is ~75% Enrolled, Pfizer Delayed Timeline For Complete Enrollment From 2H'18 To Early 2019, Top-Line Data Available From End OF 2018 To Q2'19",2018-07-25 08:41:00-04:00,PFE,negative
1001015.0,"Pfizer To Build Sterile Injectable Facility In Michigan, Investing $465M And Creating More Than 450 Jobs With Production Beginning In 2024",2018-07-24 13:43:00-04:00,PFE,positive
1001016.0,Reuters Reports 'Dutch trial with Viagra halted after 11 babies die',2018-07-24 13:23:00-04:00,PFE,negative
1001017.0,"Pfizer And GlaxoSmithKline Joint Venture, ViiV Healthcare Presents Phase III Data at AIDS 2018 From GEMINI Studies Showing Two-Drug Regimen Of Dolutegravir And Lamivudine Has Similar Efficacy To Three-Drug Regimen In Treatment Of Naïve HIV Patient",2018-07-24 08:18:00-04:00,PFE,neutral
1001018.0,"Leap Therapeutics Announces Collaboration with Merck and Pfizer to Evaluate Combination of TRX518, Avelumab, and Chemotherapy in Advanced Solid Tumors",2018-07-23 07:31:00-04:00,PFE,positive
1001019.0,FDA Approves Pfizer's Biosimilar NIVESTYM (filgrastim-aafi),2018-07-20 16:25:00-04:00,PFE,positive
1001020.0,Merck Announces Plans To Cut Drug Prices,2018-07-20 11:49:00-04:00,PFE,negative
1001021.0,"'Thank you to Novartis for not increasing your prices on prescription drugs. Likewise to Pfizer. We are making a big push to actually reduce the prices, maybe substantially, on prescription drugs.' -Tweet From Pres Trump",2018-07-19 06:30:00-04:00,PFE,positive
1001022.0,Benzinga Pro's 5 Stocks To Watch Today,2018-07-18 08:32:00-04:00,PFE,neutral
1001023.0,"PFizer, Eli Lilly Report Phase 3 Trial Of Tanezumab Met All Thre Co-Primary Endpoints",2018-07-18 06:46:00-04:00,PFE,neutral
1001024.0,Pfizer Reports Initiation Of Pivotal Phase 3 Program For Investigation Hemophilia B Gene Therapy,2018-07-16 10:32:00-04:00,PFE,neutral
1001025.0,PreMarket Prep Opening NYSE Imbalance Update: ExxonMobil 55k Shares To Sell; Pfizer 50k To Sell; Merck 26k To Sell; Coca-Cola 54k To Sell; Johnson & Johnson 54k To Sell; Ford 103k To Sell; Kroger 90k To Sell,2018-07-16 09:02:00-04:00,PFE,positive
1001026.0,"Astellas Pharma Inc., Pfizer Announce U.S. FDA Approves XTANDI",2018-07-13 14:30:00-04:00,PFE,positive
1001027.0,"Canopy Growth, Delta, GE, Pfizer: 'Fast Money' Picks For July 12",2018-07-12 07:27:00-04:00,PFE,positive
1001028.0,Pfizer Separates Consumer Health Care Unit,2018-07-11 12:35:00-04:00,PFE,positive
1001029.0,"Hearing Trump, Pfizer's CEO Read Spoke For 10-15 Minutes About Price Hikes On Tuesday; Admin Officials Felt Pfizer Price Incrases Had Complicated Push Ford Admin's Drug Price Plan",2018-07-11 10:45:00-04:00,PFE,neutral
1001030.0,"Pfizer Shares Nearly Flat Premarket As The Co. Announced That They Will Organize The Co. Into 3 Separate Units Called Innovative Medicines, Established Medicines And Consumer Healthcare",2018-07-11 09:13:00-04:00,PFE,positive
1001031.0,"Benzinga's Daily Biotech Pulse: Pfizer To Defer Price Hikes, Idera-BioCryst Merger Falls Through, ArQule To Offer Shares",2018-07-11 08:15:00-04:00,PFE,neutral
1001032.0,Pfizer's Announces It Will Defer Company's Price Increases,2018-07-11 04:09:00-04:00,PFE,negative
1001033.0,"@realDonaldTrump Tweet Earlier: Just talked with Pfizer CEO and @SecAzar on our drug pricing blueprint. Pfizer is rolling back price hikes, so American patients don't pay more. We applaud Pfizer for this decision",2018-07-10 20:28:00-04:00,PFE,positive
1001034.0,This ETF Is Looking Healthy (For Now),2018-07-10 09:17:00-04:00,PFE,positive
1001035.0,Health Care Sector Outlook: Checking In Ahead Of Q2 Earnings Reports,2018-07-09 14:39:00-04:00,PFE,positive
1001036.0,"Trump Tweets (2/2): , while at the same time giving bargain basement prices to other countries in Europe & elsewhere. We will respond!",2018-07-09 13:10:00-04:00,PFE,positive
1001037.0,Trump Tweets (1/2): 'Pfizer & others should be ashamed that they have raised drug prices for no reason. They are merely taking advantage of the poor & others unable to defend themselves',2018-07-09 13:10:00-04:00,PFE,negative
1001038.0,A Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The Year,2018-07-05 12:25:00-04:00,PFE,neutral
1001039.0,PreMarket Prep Opening NYSE Imbalance Update: Coca-Cola 146k Shares To Sell; Pfizer 147k To Sell; IBM 76k To Sell; BofA 75K To Sell,2018-07-02 08:38:00-04:00,PFE,positive
1001040.0,Pfizer's XELJANZ Receives Marketing Authorization in the European Union for Active Psoriatic Arthritis,2018-06-28 13:49:00-04:00,PFE,positive
1001041.0,Pfizer Reports FDA Granted Priority Review For Co.'s New Drug Application For Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia,2018-06-27 08:06:00-04:00,PFE,positive
1001042.0,Analyst: Solid Biosciences A Solid Buy On Sarepta's Progress,2018-06-25 08:53:00-04:00,PFE,positive
1001043.0,PFizer Reports Phase 3 PALOMA-3 Trial Missed Statistical Significance In Overall Survival Endpoint,2018-06-25 08:08:00-04:00,PFE,neutral
1001044.0,Why GE's Removal From The Dow Could Help Investors,2018-06-20 12:57:00-04:00,PFE,positive
1001045.0,Deciphera Pharma Hit With Sell-Side Downgrade On Valuation After 50% Gain,2018-06-19 09:34:00-04:00,PFE,positive
1001046.0,Myriad's BRACAnalysis CDx Supplementary PMA Accepted by FDA for Review as a Companion Diagnostic for Talazoparib in Metastatic Breast Cancer,2018-06-18 07:23:00-04:00,PFE,negative
1001047.0,PreMarket Prep Opening NYSE Imbalance Update: Twitter 131k Shares To Buy; General Electric 108k To Buy; AT&T 182k To Buy; Verizon 70k Buy; Pfizer 85k To Buy; IBM 73k Shares To Sell,2018-06-12 09:07:00-04:00,PFE,positive
1001048.0,"Pharma Stock Roundup: Merck, Eli Lilly, AbbVie And More",2018-06-08 16:33:00-04:00,PFE,neutral
1001049.0,UPDATE: Pfizer Says New Drug Application In US For Talazoparib Granted FDA Priority Review,2018-06-07 08:06:00-04:00,PFE,positive
1001050.0,"Pfizer Reports FDA, EMA Accepted Regulatory Submissions For Review Of Talazoparib For Metastatic Breast Cancer Patients With Inherited BRCA Mutation",2018-06-07 08:00:00-04:00,PFE,negative
1001051.0,UPDATE: Pfizer Ventures Seeks To Invest ~25% Of $150M In Available Capital In Early-Stage Neuroscience Cos.,2018-06-06 08:15:00-04:00,PFE,neutral
1001052.0,"Pfizer Reports Plan To Invest $600M In Biotech, Other Emerging Growth Cos. Through Its Pfizer Ventures Investment Vehicle",2018-06-06 08:15:00-04:00,PFE,positive
1001053.0,"Watching Shares of Allergan As Traders In Chatrooms Circulate Chatter Of A Potential Bid From Pfizer, Unconfirmed",2018-06-05 14:15:00-04:00,PFE,positive
1001054.0,At ASCO: Pfizer Announces ARCHER 1050 Dacomitinib Trial Data Shows Median 34.1 Months Overall Survival,2018-06-04 17:38:00-04:00,PFE,neutral
1001055.0,Merck Gives an Update on its Pivotal Trial of JAVELIN into ASCO,2018-06-04 08:24:00-04:00,PFE,neutral
1001056.0,"Donald Trump Tweets: 'We had Repeal & Replace done (and the saving to our country of one trillion dollars) except for one person, but it is getting done anyway'...'less expensive plans will be announced this month. Drug prices coming down & Right to Try!'",2018-06-04 08:22:00-04:00,PFE,neutral
1001057.0,The Week Ahead In Biotech: ASCO Presentations Dominate The Headlines,2018-06-03 19:27:00-04:00,PFE,negative
1001058.0,"Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, TRAZIMERA",2018-06-01 07:31:00-04:00,PFE,positive
1001060.0,U.S. FDA Expands Approval Of Pfizer's Xeljanz To Include Adults With Moderately To Severely Active Ulcerative Colitis,2018-05-30 11:56:00-04:00,PFE,positive
1001061.0,Pfizer's XALKORI Receives FDA Breakthrough Therapy Designation in Two New Indications,2018-05-29 08:01:00-04:00,PFE,neutral
1001062.0,Novartis Gets Approval For Remicade Biosimilar In Europe,2018-05-25 13:51:00-04:00,PFE,positive
1001063.0,Justice Dept. Says Pfizer Agrees To Pay $23.85M To Resolve Allegations That It Paid Kickbacks Through A Co-Pay Assistance Foundation,2018-05-24 10:06:00-04:00,PFE,positive
1001064.0,Pfizer Reports FDA Granted Breakthrough Therapy Designation For Tafamidis For Treatment Of Patients With Transthyretin Cardiomyopathy,2018-05-23 08:04:00-04:00,PFE,positive
1001065.0,Pfizer Reports Study Of Prevnar 13 In Adults Age 65+ Showed Association With Reduced Risk Of Hospitalization From Vaccine-Type Community-Acquired Pneumonia In Older Adults,2018-05-22 13:32:00-04:00,PFE,negative
1001066.0,Pfizer Begins Phase 1/2 Study To Evaluate Respiratory Syncytial Virus (RSV) Vaccine,2018-05-22 08:06:00-04:00,PFE,neutral
1001067.0,"Spark Therapeutics, Pfizer Announce Data from 15 Participants with Hemophilia B Showing Persistent and Sustained Factor IX Levels with No Serious Adverse Events",2018-05-22 03:47:00-04:00,PFE,negative
1001068.0,12 Dow 30 Companies With Above-Average Salaries,2018-05-19 17:21:00-04:00,PFE,neutral
1001069.0,"UPDATE: FDA Offers Guidelines, Background For Reference Listed Drug Access Inquiries, Related To Claim Of Blocking Generic Rivals",2018-05-17 12:38:00-04:00,PFE,negative
1001070.0,"FDA Commissioner Scot Gottlieb Highlights List Of Cos. Which Have Potentially Blocked Access To Samples Of Their Branded Products: Pfizer, Biogen, INSYS, VIVUS, Valeant, Corcept Therapeutics",2018-05-17 09:57:00-04:00,PFE,negative
1001071.0,PreMarket Prep Opening NYSE Imbalance Update: Alibaba 118k Shares To Sell; Pfizer 111k To Sell; Square 60k To Sell; Walmart 51k To Buy; GE 107k To Buy,2018-05-17 08:52:00-04:00,PFE,positive
1001072.0,Pfizer Reports LYRICA Oral Solution CV Phase 3 Trial In Pediatric Epilepsy Met Primary Endpoint,2018-05-17 08:03:00-04:00,PFE,positive
1001073.0,Pfizer Reports Biosimilar RETACRIT Approved By FDA,2018-05-15 14:40:00-04:00,PFE,positive
1001074.0,FDA Says It Granted Approval of Retacrit To Pfizer Co. Hospira,2018-05-15 11:46:00-04:00,PFE,positive
1001075.0,"Jim Cramer Gives His Opinion On Exxon Mobil, Pfizer And Cisco",2018-05-09 07:12:00-04:00,PFE,neutral
1001076.0,UPDATE: Pfizer Says Apr. EpiPen Shipments Exceeded Projections,2018-05-08 15:18:00-04:00,PFE,neutral
1001077.0,"Pfizer, Manufacturer Of Mylan's EpiPen, Says It Is Currently Shipping Product, Shipments Have Been Increasing Over Last Few Months",2018-05-08 15:17:00-04:00,PFE,neutral
1001078.0,"Mylan Says Is Currently Receiving Continual Supply Of EpiPen From Meridian Medical Technologies, Informed FDA 'Few Months Ago' It Had Intermittent Supply Constraints, Cited Manufacturing Delays From Pfizer",2018-05-08 15:00:00-04:00,PFE,neutral
1001079.0,"Mylan Shares Drop Sharply, Hearing Epipen Is Said To Be In Short Supply After Manufacturing Issues",2018-05-08 13:54:00-04:00,PFE,neutral
1001080.0,Xtalpi Announces Strategic Research Partnership With Pfizer TO Develop A Hybrid Physics And AI-Powered Software Platform,2018-05-08 10:33:00-04:00,PFE,neutral
1001081.0,Portola Pharma Rips 20% Higher After FDA Approves Andexxa Antidote,2018-05-04 14:14:00-04:00,PFE,positive
1001082.0,PreMarket Prep Opening NYSE Imbalance Update: Coca-Cola 155k Shares To Buy; Alibaba 87k To Buy; AT&T 46k to Buy; Pfizer 43k To Buy; General Electric 159k To Buy; Square 168k To Sell; Verizon 47k To Buy,2018-05-03 09:06:00-04:00,PFE,positive
1001083.0,Mid-Afternoon Market Update: NASDAQ Up 0.5%; Inogen Shares Spike Higher,2018-05-01 15:01:00-04:00,PFE,positive
1001084.0,Mid-Day Market Update: Crude Oil Down 1.8%;  Nutrisystem Shares Climb On Upbeat Earnings,2018-05-01 12:15:00-04:00,PFE,negative
1001085.0,Mid-Morning Market Update: Markets Open Lower; Pfizer Posts Mixed Q1 Results,2018-05-01 10:38:00-04:00,PFE,negative
1001086.0,"Apple Results, Fed Decision, Jobs Report In Focus; Merck, Pfizer Reports Mixed",2018-05-01 10:23:00-04:00,PFE,neutral
1001087.0,"Pfizer CEO Says Co. Hasn't Received An Acceptable Offer For Its Consumer Health Business, May Decide To Retain It",2018-05-01 10:12:00-04:00,PFE,negative
1001088.0,Pfizer Has Not Received Acceptable Offer For Its Consumer Health Unit,2018-05-01 10:11:00-04:00,PFE,negative
1001089.0,"A Peek Into The Markets: US Stock Futures Flat, Apple Earnings In Focus",2018-05-01 07:56:00-04:00,PFE,neutral
1001090.0,"Benzinga's Daily Biotech Pulse: Karyopharm's STORM Study, Inogen Rallies On Earnings",2018-05-01 07:51:00-04:00,PFE,neutral
1001091.0,Pfizer Reaffirms FY18 Guidance,2018-05-01 06:50:00-04:00,PFE,neutral
1001092.0,"Pfizer Reports Q1 Adj. EPS $0.77 Beats $0.75 Est., Sales $12.91B Misses $13.15B Est.",2018-05-01 06:49:00-04:00,PFE,negative
1001093.0,"15 Stocks To Watch For May 1, 2018",2018-05-01 05:02:00-04:00,PFE,neutral
1001094.0,"Earnings Scheduled For May 1, 2018",2018-05-01 04:59:00-04:00,PFE,neutral
1001095.0,Upcoming Earnings: Tech Giant Apple Reports After Tuesday's Close,2018-04-30 12:14:00-04:00,PFE,neutral
1001096.0,Pharmaceutical Earnings: Pfizer And Merck Are Slated To Report Tuesday Morning,2018-04-30 11:58:00-04:00,PFE,neutral
1001097.0,"Busy Week Begins With McDonald's Beating Estimates; Fed Meeting, Jobs Data Loom",2018-04-30 10:07:00-04:00,PFE,negative
1001098.0,"The Week Ahead In Biotech: PDUFA Dates, Clinical Trials, Merck And Pfizer Earnings On Tap",2018-04-29 08:11:00-04:00,PFE,neutral
1001099.0,Upcoming Earnings: McDonald's Reports On Monday As It Continues On New Growth Plan,2018-04-27 15:38:00-04:00,PFE,positive
1001100.0,Earnings Preview: Oil Giants Chevron And ExxonMobil Report Friday Morning,2018-04-26 12:18:00-04:00,PFE,neutral
1001101.0,PreMarket Prep Opening NYSE Imbalance Update: Verizon 90k Shares To Sell; Pfizer 164k Shares To Sell; Bank Of America 105k Shares To Sell; Altria 68 To Sell; Walmart 19k To Sell; Square 203k Shares To Buy,2018-04-25 08:51:00-04:00,PFE,positive
1001102.0,Earnings Preview: Checking In On The Automakers With Reports From Ford And GM Coming Up,2018-04-24 12:54:00-04:00,PFE,neutral
1001103.0,"Top Ideas From The 2018 Sohn Conference: Box, Bitcoin, Facebook, Palo Alto And More",2018-04-23 18:23:00-04:00,PFE,positive
1001104.0,"'Palihapitiya: major companies are already using $BOX services, everything from $PFE to $AMZN, etc. It has 10 million paid subscribers and has been consistently growing revenue. #sohn2018'- MarketWatch's Ryan Vlastelica Tweet",2018-04-23 13:17:00-04:00,PFE,positive
1001105.0,"From Sohn Conference: Ecor1's Nodelman On Ascendis Pharma Highlighted 10 Potential Buyers Of Co., Including Eli Lilly, Pfizer",2018-04-23 10:58:00-04:00,PFE,neutral
1001106.0,Pfizer Granted FDA Breakthrough Therapy Designation for TRUMENBA,2018-04-23 08:06:00-04:00,PFE,positive
1001107.0,Pfizer Gets Feedback from the RDA that Additional Information is Needed for its Trastuzumab Biosimilar,2018-04-23 07:48:00-04:00,PFE,neutral
1001108.0,Pfizer Received A Complete Response Letter From The FDA In Response To the Biologics License Application For The Co.'s Proposed trastumzumab Biosimilar,2018-04-23 07:46:00-04:00,PFE,neutral
1001109.0,"Pfizer's MYLOTARG Approved In The EU For The Treatment Of Previously Untreated, De Novo, CD33-positive Acute Myeloid Leukemia In Combination With Chemotherapy",2018-04-23 07:33:00-04:00,PFE,positive
1001110.0,"FDA Staff Review Of Eli Lilly's Rheumatoid Arthritis Treatment Says Supportive Of 2mg Dose, But Not 4mg Dose",2018-04-19 07:58:00-04:00,PFE,positive
1001111.0,"Health Canada Is Working With FDA, Pfizer Related To Addressing Canadian Shortage Of Mylan's Epipen",2018-04-17 14:50:00-04:00,PFE,negative
1001112.0,Pfizer Reports Dosing Of First Patient In Investigational Mini-Dystrophin Gene Therapy For Treatment Of Duchenne Muscular Dystrophy,2018-04-12 08:00:00-04:00,PFE,neutral
1001113.0,PreMarket Prep Opening NYSE Imbalance Update: Pfizer 149k Shares To Buy: ExxonMobil 81k Shares To Buy; Merck 50k Shares To Buy; General Electric 114k Shares To Sell; Ford 42k Shares To Buy,2018-04-11 08:59:00-04:00,PFE,positive
1001114.0,Pfizer Reports  Data Monitoring Committee For Phase 3 ATLAS Trial Recommended Stopping The Trail At A Planned Interim Analysis Due To Futility,2018-04-10 14:03:00-04:00,PFE,positive
1001115.0,"Benzinga's Top Upgrades, Downgrades For April 5, 2018",2018-04-05 09:23:00-04:00,PFE,positive
1001116.0,"The Market In 5 Minutes: Ackman, Amazon, AMD And More",2018-04-05 09:00:00-04:00,PFE,positive
1001117.0,Barclays Downgrades Pfizer to Equal-Weight,2018-04-05 06:39:00-04:00,PFE,neutral
1001118.0,Pfizer Announces U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Dacomitinib,2018-04-04 08:00:00-04:00,PFE,positive
1001119.0,Pfizer In Discussions With P&G Related To Sale Of Consumer Business,2018-04-03 10:29:00-04:00,PFE,neutral
1001120.0,"Pfizer, Allogene Therapeutics Enter into Asset Contribution Agreement for Pfizer's Allogeneic CAR T Immuno-oncology Portfolio",2018-04-03 08:02:00-04:00,PFE,positive
1001121.0,"With Alnylam Pharma Down More Than 15%, Analyst Says Buy The Dip",2018-04-02 14:04:00-04:00,PFE,neutral
1001122.0,UPDATE: B. Riley FBR Offered 3 Reasons To Buy The Weakness In Alnylam Following Pfizer News On ATTR-ACT,2018-04-02 11:19:00-04:00,PFE,negative
1001123.0,"Smoking Is Just One Way To Use Marijuana: An Introduction To Vaporizers, Edibles, Oils, Tinctures, Dabs And Other Cannabis Products",2018-03-30 09:37:00-04:00,PFE,neutral
1001124.0,"Alnylam Pharma Shares Down ~3.5% Over Last Few Mins, Ionis Pharma Down 2.8%, Akcea Down 2.5% Following Results From Pfizer Related To Its Tafamidis News",2018-03-29 12:58:00-04:00,PFE,positive
1001125.0,"Pfizer Announces Results From Phase 3 ATTR-ACT Study of Tafamidis, Met Its Primary Endpoint",2018-03-29 12:45:00-04:00,PFE,neutral
1001126.0,GlaxoSmithKline To Buy Novartis' Stake in Consumer Health Care JV For $13 Billion,2018-03-27 10:53:00-04:00,PFE,positive
1001127.0,Pfizer Reports Top-Line Results From CHANTIX/CHAMPIX Study In Adolescent Smokers: Did Not Meet Primary Endpoint,2018-03-23 08:00:00-04:00,PFE,neutral
1001128.0,"Glaxo, Pfizer's ViiV Healthcare Reports Winning Of Positive CHMP Opinion For Juluca In Europe Recommending Marketing Authorization",2018-03-23 07:32:00-04:00,PFE,positive
1001129.0,"ICYMI: GameStop, Omeros, Congress Impacts Biotechs",2018-03-23 06:56:00-04:00,PFE,neutral
1001130.0,GlaxsoSmithKline did Not Submit Final Bid for Pfizer's Consumer Healthcare Unit,2018-03-23 06:15:00-04:00,PFE,neutral
1001131.0,"Pfizer Says Continues to Evaluate Potential Strategic Alternatives for Consumer Healthcare Business, Including Spin-off, Sale; Says Expects Decision in 2018",2018-03-23 04:56:00-04:00,PFE,neutral
1001132.0,Biotech Winners And Losers From Congress' Latest Funding Bill,2018-03-22 11:46:00-04:00,PFE,negative
1001133.0,Reckitt Benckiser Ends Discussions with Pfizer over Purchase of Consumer Healthcare Business,2018-03-22 04:29:00-04:00,PFE,neutral
1001134.0,Checking In On The Healthcare Sector Ahead Of Q1 Earnings Season,2018-03-20 11:29:00-04:00,PFE,neutral
1001135.0,U.S. FDA Grants Priority Review for a Supplemental New Drug Application (sNDA) for XTANDI,2018-03-19 16:15:00-04:00,PFE,positive
1001136.0,BioDuro Partnership with Pfizer Inc. Leads to Creation of a Shelf-Stable Fluorosulfation Reagent,2018-03-19 07:05:00-04:00,PFE,positive
1001137.0,Biogen to Acquire a Phase 2b Ready Asset for Cognitive Impairment from Pfizer for $75M Upfront and Up to $515M in Milestones and Royalties,2018-03-12 07:34:00-04:00,PFE,positive
1001138.0,"The Week Ahead In Biotech: Earnings, PDUFA Dates And More",2018-03-11 16:58:00-04:00,PFE,neutral
1001139.0,Pfizer Release Confirms FDA Panel On XELJANZ For Moderately-To-Severely Active UC Voted In Favor (15-0) On 2 Dosing Questions,2018-03-08 16:52:00-05:00,PFE,positive
1001140.0,FDA Advisory Panel Votes In Favor Of Pfizer's Xeljanz For Patients With Moderate to Severe Ulcerative Colitis,2018-03-08 14:18:00-05:00,PFE,neutral
1001141.0,REMINDER: Pfizer Has FDA AdCom Meeting Regarding Xeljanz for Ulcerative Colitis Today,2018-03-08 07:32:00-05:00,PFE,neutral
1001142.0,Height Casts 65% Odds That Congress Rolls Back Pharma Discounts,2018-03-07 11:31:00-05:00,PFE,neutral
1001143.0,PreMarket Prep Opening Imbalance Update: Square 215k Shares To Sell; Salesforce 43K To Sell; GE 96k To Buy; Alibaba 68k To Sell; Twitter 25k To Sell; Pfizer 56k To Sell; ConocoPhillips 27k To Sell,2018-03-07 08:35:00-05:00,PFE,positive
1001144.0,The Week Ahead: Discount Retailers Close Out Earnings Season,2018-03-05 14:17:00-05:00,PFE,neutral
1001145.0,"The Week Ahead In Biotech: Earnings, PDUFA Dates And More",2018-03-02 14:12:00-05:00,PFE,neutral
1001146.0,Vetr Crowd Upgrades Pfizer,2018-03-02 07:21:00-05:00,PFE,neutral
1001147.0,Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates,2018-02-28 10:08:00-05:00,PFE,neutral
1001148.0,Pfizer Filing Shows Registration For Mixed Securities Shelf Offering,2018-02-26 16:14:00-05:00,PFE,positive
1001149.0,"Pfizer Receives Positive CHMP Opinion for Two Hematology Medicines, MYLOTARG and BOSULIF",2018-02-23 09:00:00-05:00,PFE,positive
1001150.0,Pfizer Says EMA Has Recommended Against Expanding Use Of SUTENT To Include Adjuvant Treatment Of Adult Patients At High Risk Of RCC Following Nephrectomy,2018-02-23 08:33:00-05:00,PFE,negative
1001151.0,Solid Biosciences Snags Bullish Initiation As It Develops Gene Therapy For Muscular Dystrophy,2018-02-21 09:18:00-05:00,PFE,positive
1001152.0,Goldman Sachs Gets Firm On Solid Biosciences,2018-02-20 13:25:00-05:00,PFE,positive
1001153.0,How McKesson Will Stand The Test Of Amazon,2018-02-20 11:06:00-05:00,PFE,positive
1001154.0,PreMarket Prep Opening NYSE Imbalance Update: 186k Shares To Sell; MS 60k sell; Twitter 68k Share To Sell; Nike 41k Shares To Sell; Square 41 Shares To Buy; Pfizer 81k Shares To Sell,2018-02-20 08:33:00-05:00,PFE,positive
1001155.0,Spark Therapeutics to Manufacture and Deliver SPARK-9001 to Pfizer in a $14M Agreement,2018-02-20 07:56:00-05:00,PFE,positive
1001156.0,Deciphera Pharma Scores A Sell-Side Recommendation,2018-02-16 12:59:00-05:00,PFE,neutral
1001157.0,Cramer Looks At The Dow's Biggest Losers,2018-02-14 10:31:00-05:00,PFE,negative
1001158.0,Pfizer Receives Breakthrough Therapy Designation from FDA for PF-04965842,2018-02-14 08:32:00-05:00,PFE,neutral
1001159.0,Premarket Opening NYSE Imbalance Update: Pfizer 217k Shares To Buy; ExxonMobil 176k Shares To Buy; Proctor & Gamble 123k Shares To Buy; General Electric 339k Shares To Buy; American Express 20k Shares To Buy; Boeing 32k Shares To Buy,2018-02-12 08:56:00-05:00,PFE,positive
1001160.0,"U.S., EU and Japan Health Authorities Accept Regulatory Submissions for Review of Pfizer's Third-Generation ALK Inhibitor Lorlatinib, U.S. New Drug Application Granted FDA Priority Review",2018-02-12 08:10:00-05:00,PFE,positive
1001161.0,Pfizer Announces the FDA Accepted and Granted Priority Review to the Company's NDA for Lorlantinib,2018-02-12 08:03:00-05:00,PFE,positive
1001162.0,The Alzheimer's Drug Pipeline: High Failure Rates In Research On An Increasingly Common Disease,2018-02-08 09:41:00-05:00,PFE,negative
1001163.0,PreMarket Opening NYSE Imbalance Update: Twitter 206k Shares To Buy; Alibaba 60k Shares To Buy; Proctor Gamble 25k Shares Buy; Pfizer 35k Shares To Buy; Ford 71k Shares To Buy; JP Morgan 33k Shares To Buy; Square 63k Shares To Buy,2018-02-08 08:35:00-05:00,PFE,positive
1001164.0,GSK Says ‍ViiV Healthcare Launches New Two-Drug HIV Study,2018-02-08 04:42:00-05:00,PFE,neutral
1001165.0,Worst Day In 6 Years Offers 8 Great Buying Opportunities,2018-02-06 09:39:00-05:00,PFE,positive
1001166.0,"Astellas, Pfizer Report Phase 3 PROSPER Trial Shows XTANDI Significantly Reduced Risk Of Metastasis, Death By ~71% In Men With Non-Metastatic Castration-Resistant Prostate Cancer",2018-02-05 17:12:00-05:00,PFE,negative
1001167.0,"Barclays Maintains Overweight on Pfizer, Raises Price Target to $41.00",2018-01-31 11:50:00-05:00,PFE,negative
1001168.0,Mid-Afternoon Market Update: Dow Falls Over 300 Points; Callidus Software Shares Rise On Acquisition News,2018-01-30 14:32:00-05:00,PFE,positive
1001169.0,"CNBC's Meg Tirrell Tweets 'Spoke w $PFE mgmt team after the call...about gene therapy safety concerns...pointed out none with $PFE $AVXS $ONCE $BMRN studies. Said...surprised Wilson & $SLDB ""didn't have any way to resolve"" concerns [properly]'",2018-01-30 12:48:00-05:00,PFE,positive
1001170.0,Mid-Day Market Update: Crude Oil Down 2%; Thomson Reuters Shares Spike Higher,2018-01-30 12:00:00-05:00,PFE,negative
1001171.0,Hang On: Rate Fears In Focus As Futures Point Lower After Monday's Big Losses,2018-01-30 10:47:00-05:00,PFE,negative
1001172.0,From Pfizer Q4 Earnings Conference Call: Co. To Repatriate Majority Of Its Overseas Cash During '18,2018-01-30 10:36:00-05:00,PFE,neutral
1001173.0,Mid-Morning Market Update: Markets Open Lower; Pfizer Beats Q4 Expectations,2018-01-30 10:18:00-05:00,PFE,negative
1001174.0,Benzinga Pro's 7 Stocks To Watch Today,2018-01-30 09:19:00-05:00,PFE,neutral
1001175.0,PreMarket Opening NYSE Imbalance Update: Coke 104k Shares To Sell; JP Morgan 111k To Sell; BofA 260k To Sell; Pfizer 361k to Sell; CVS 28k To Sell; Alibaba 86k To Sell; Juniper 33k To Sell; Twitter 95k To Buy,2018-01-30 09:11:00-05:00,PFE,positive
1001176.0,A Peek Into The Markets: U.S. Stock Futures Tumble Ahead Of Fed Meeting,2018-01-30 07:01:00-05:00,PFE,neutral
1001177.0,"Pfizer Sees FY18 Adj. EPS $2.90 to $3.00 vs $2.78 Est., Sales $53.5B to $55.5B vs $53.9B Est.",2018-01-30 06:49:00-05:00,PFE,neutral
1001178.0,"Pfizer Reports Q4 Adj. EPS $0.62 vs $0.56 Est., Sales $13.70B vs $13.68B Est.",2018-01-30 06:48:00-05:00,PFE,neutral
1001179.0,"10 Stocks To Watch For January 30, 2018",2018-01-30 04:24:00-05:00,PFE,neutral
1001180.0,"Earnings Scheduled For January 30, 2018",2018-01-30 04:02:00-05:00,PFE,neutral
1001181.0,"The Week Ahead: Big Tech Earnings, Fed Rate Decision Likely To Dominate Headlines",2018-01-29 14:45:00-05:00,PFE,negative
1001182.0,"PFE, LLY, MRK Write Up 'Scripts For Q4",2018-01-29 10:52:00-05:00,PFE,neutral
1001183.0,"Fed, Earnings Are Meaty Filling Between Slices Of Job, Price Data",2018-01-29 09:55:00-05:00,PFE,neutral
1001184.0,"J&J No Longer Candidate For Purchase Of Pfizer's Consumer Unit; GlaxoSmithKline, Reckitt Benickser Working With Banks To Make A Bid",2018-01-25 09:34:00-05:00,PFE,negative
1001185.0,Pfizer Reports Top-Line Results For Potential Biosimilar To Rituxan/MabThera: REFLECTIONS B3281006 Study Showed 'Equivalence in Patients with Indolent Follicular Lymphoma',2018-01-24 08:31:00-05:00,PFE,neutral
1001186.0,"Ford Earnings Preview: After Last Week's Wall Street Presentation, Not Much New Expected",2018-01-23 11:20:00-05:00,PFE,neutral
1001187.0,Biotech M&A Off To A Strong Start In 2018: More Deals To Follow?,2018-01-23 10:58:00-05:00,PFE,positive
1001188.0,"J&J Shares Unaffected Amid Word US Appeals Court Invalidated Co. Patent On Remicade, Ruling Prevents Co. From Challenging Pfizer's '16 Launch Of Cheaper Version Of Remicade",2018-01-23 10:41:00-05:00,PFE,positive
1001189.0,A CURE For The Typical Healthcare Trade,2018-01-22 16:55:00-05:00,PFE,neutral
1001190.0,The Top 10 Value Stocks In The S&P 500,2018-01-19 13:12:00-05:00,PFE,positive
1001191.0,Pfizer Partners with Foundation Medicine to Develop Companion Diagnostics for its Oncology Portfolio,2018-01-16 07:07:00-05:00,PFE,neutral
1001192.0,A Strategy That Beat The S&P 500: Here Are Your 2018 'Dogs Of The Dow',2018-01-11 17:14:00-05:00,PFE,neutral
1001193.0,Key Takeaways From The J.P. Morgan Healthcare Conference,2018-01-11 12:06:00-05:00,PFE,neutral
1001194.0,Basilea Announces Completion of License Agreement Extension With Pfizer for Antifungal Cresemba for China and Asia Pacific,2018-01-10 04:01:00-05:00,PFE,positive
1001195.0,Vetr Crowd Upgrades Pfizer To Buy,2018-01-09 17:47:00-05:00,PFE,neutral
1001196.0,"GSK CEO On Pfizer Consumer Business, We Don't Need It, Wouldn't Overpay For It",2018-01-09 14:08:00-05:00,PFE,neutral
1001197.0,Alzheimer's Takes Another Hit As Pfizer Ends Research In The Area,2018-01-08 12:22:00-05:00,PFE,neutral
1001198.0,"JP Morgan Healthcare Conference Begins Today, Presenters Include: Gilead, Illumina, Seattle Genetics, Biogen, Incyte, Baxter, Regeneron, Walgreens, Alnylam, Edwards Lifesciences, Molina, Alexion, Celgene, Pfizer, Neurocrine Biosciences, and Jazz Pharma",2018-01-08 09:00:00-05:00,PFE,positive
1001199.0,"Argus Shares Eli Lilly's Optimism, Upgrades To Buy",2018-01-05 13:54:00-05:00,PFE,positive
1001200.0,The 'Bomb Cyclone' Portfolio: Winners And Losers,2018-01-05 11:58:00-05:00,PFE,negative
1001201.0,Arvinas Announces Research Collaboration and License Agreement with Pfizer for the Discovery and Development of Protein Degradation Drug Candidates,2018-01-04 03:59:00-05:00,PFE,negative
1001202.0,"The Market In 5 Minutes: South Korea Cracks Down On Crypto, Tim Cook's Big Payday, Jobless Claims Steady",2017-12-28 09:12:00-05:00,PFE,neutral
1001203.0,"Merck Shares Down 0.12%, Pfizer Shares Up 0.11%; Earlier Companies Together Announced FDA Approvla For Their Collaboration Treatment STEGLATRO, STEGLUJAN and SEGLUROMET",2017-12-26 15:48:00-05:00,PFE,positive
1001204.0,Merck's Diabetes Drugs Get FDA Nod As Adjunct Therapies,2017-12-26 12:45:00-05:00,PFE,neutral
1001205.0,The Companies That Led 2017's Biotech Rally,2017-12-22 09:50:00-05:00,PFE,neutral
1001206.0,Merck Reports FDA Granted Breakthrough Therapy Designation For Avelumab In Combo With INLYTA In Advanced Renal Cell Carcinoma,2017-12-21 13:01:00-05:00,PFE,positive
1001207.0,Shares of Pfizer Down 0.88% On Negative Article From The Daily Mail On Chantix,2017-12-20 14:24:00-05:00,PFE,negative
1001208.0,Pfizer Reports FDA Approved Co.'s BOSULIF For Treatment Of Patients With Newly-Diagnosed Ph+ CML,2017-12-19 16:12:00-05:00,PFE,positive
1001209.0,Pfizer Raises Qtr. Dividend From $0.32 To $0.34/Share,2017-12-18 11:45:00-05:00,PFE,neutral
1001210.0,Pfizer Reports $10B Buyback Plan,2017-12-18 11:44:00-05:00,PFE,neutral
1001211.0,"Lightning Round: Jim Cramer Shares His Thoughts On T-Mobile, Electronic Arts, And More",2017-12-15 07:33:00-05:00,PFE,positive
1001212.0,Pfizer Announces FDA Approval of XELJANZ and XELJANZ XR for the Treatment of Active Psoriatic Arthritis,2017-12-15 06:25:00-05:00,PFE,positive
1001213.0,"STAT News' Adam Feuerstein Responds To Tweet Highlighting '$PFE $AGN rumor - no source': 'The other day I heard $PFE for $BMY,' 'Also $ABBV for $BMY'",2017-12-14 10:05:00-05:00,PFE,negative
1001214.0,Pfizer Reports Initiation Of Phase 3 Program For PF-04965842 For Moderate-To-Severe Atopic Dermatitis,2017-12-14 07:38:00-05:00,PFE,neutral
1001215.0,Pfizer Reports FDA Approved New Biosimilar Medicine IXIFI,2017-12-13 18:05:00-05:00,PFE,positive
1001216.0,Pfizer Reports Phase 3 TRUMENBA Data Published In NEJM Showed All 5 Co-Primary Immunogenicity Endpoints Were Met,2017-12-13 17:08:00-05:00,PFE,neutral
1001217.0,PreMarket Opening NYSE Imbalance Update: AT&T 168k Shares To Sell; Nike 54k Shares To Sell; Square 33k To Buy; Disney 41k To Buy; US Steel 53k Shares To Sell; Pfizer 50k Shares To Sell; Merck 28k Shares To Buy;,2017-12-13 09:06:00-05:00,PFE,positive
1001218.0,Cellectis Up Premarket As Co. Announced Prelim. Data Yesterday From Servier and Pfizer's UCART19 Product Candidate Showing High Complete Remission Rate Across 2 Acute Lymphoblastic Leukemia Trials,2017-12-13 08:36:00-05:00,PFE,neutral
1001219.0,"FDA Extends Action Date For Pfizer's XELJANZ (Tofacitinib) By 3 Months, Estimates PDUFA Date June 2018",2017-12-12 16:54:00-05:00,PFE,positive
1001220.0,3 Stocks In Focus As Biotech M&A Hopes For 2018 Rise,2017-12-11 12:52:00-05:00,PFE,positive
1001221.0,"Spark Therapeutics, Pfizer Report Longer-Term Prelim. Data Showing Consistent, Sustained Factor IX Levels In Hemophilia B",2017-12-11 07:04:00-05:00,PFE,positive
1001222.0,Pfizer Reports Updated Data From Phase III Study On Ibrance,2017-12-08 12:40:00-05:00,PFE,neutral
1001223.0,Pfizer Reports Talazoparib Significantly Extended PFS In Phase 3 EMBRACA Trial Of Patients With Metastatic Breast Cancer,2017-12-08 08:31:00-05:00,PFE,negative
1001224.0,"Spark Therapeutics, Pfizer Publish Interim Data from Phase 1/2 Clinical Trial of Investigational Gene Therapy for Hemophilia B In NE Journal of Medicine",2017-12-06 17:06:00-05:00,PFE,positive
1001225.0,"Pfizer Gives Updates Data From its Phase 3 Trial of IBRANCE Plus LLetrozole in ER+, HER2- Metastatic Breast Cancer",2017-12-06 07:31:00-05:00,PFE,negative
1001226.0,GlaxoSmithKline Begins Phase III Study On Injection To Prevent HIV,2017-12-01 12:38:00-05:00,PFE,neutral
1001227.0,Premarket Opening NYSE Imbalance Update: General Electric 174k Shares To Sell; Alibaba 52k Shares To Buy; Twitter 43k Shares To Sell; Square 39k Shares To Buy; Snap 79k Shares To Sell; Pfizer 126k Shares To Sell; ExxonMobil 59k Shares To Sell,2017-12-01 08:56:00-05:00,PFE,positive
1001228.0,"Pfizer, Basilea to Develop and Commercialize CRESEMBA in China and Asia Pacific Region",2017-12-01 04:09:00-05:00,PFE,neutral
1001229.0,Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates,2017-11-30 08:34:00-05:00,PFE,neutral
1001230.0,A Lazarus Act For This Pharma ETF,2017-11-29 17:03:00-05:00,PFE,neutral
1001231.0,Pfizer Reportedly Wins UK Approval To Sell Viagra Without Prescription,2017-11-28 09:54:00-05:00,PFE,positive
1001232.0,"UPDATE: Merck, Pfizer On JAVELIN Trial Of Avelumab, Say, 'Safety profile was consistent with that observed in previously reported studies of avelumab; no new safety signals were identified'",2017-11-28 08:04:00-05:00,PFE,positive
1001233.0,"UPDATE: Merck, Pfizer Says Phase III JAVELIN Study Investigating Avelumab 'did not meet its pre-specified primary endpoint of superior overall survival compared to chemotherapy'",2017-11-28 08:04:00-05:00,PFE,positive
1001234.0,"Merck, Pfizer Offer Update Related To Phase III JAVELIN Gastric 300 Study In Patients With Pre-Treated Advanced Gastric Cancer",2017-11-28 08:03:00-05:00,PFE,negative
1001235.0,Premarket NYSE Imbalance Update: Square 447k Shares To Buy; AT&T 158k Shares To Sell; Pfizer 106k Shares To Sell; Alibaba 132k Shares To Buy; General Electric 181k Shares To Buy; HPQ 158k Shares To Sell; Nike 82K Shares To Sell; Pepsi 39k Shares To Sell;,2017-11-22 09:02:00-05:00,PFE,positive
1001236.0,These 2 Stocks Are Bill Stone's Pure Plays On Tax Reform,2017-11-20 13:20:00-05:00,PFE,positive
1001237.0,Pfizer Receives FDA Approval For SUTENT,2017-11-16 16:58:00-05:00,PFE,positive
1001238.0,FDA Says It's Granted The Approval Of Sutent to Pfizer,2017-11-16 15:20:00-05:00,PFE,positive
1001239.0,PreMarket NYSE Imbalance Update: GE 294k Shares To Buy; BABA 105k Shares To Buy; SQ 125k Shares To Buy; VZ 49k Shares To Sell; SNAP 59k Shares To Buy; PFE 88k Shares To Sell; BMY 39k Shares To Sell,2017-11-16 08:57:00-05:00,PFE,positive
1001240.0,Analyst: Is The Street Ignoring Pfizer And Its Upcoming Catalysts?,2017-11-13 11:23:00-05:00,PFE,negative
1001241.0,Pfizer Announces Albert Bourla COO,2017-11-13 09:21:00-05:00,PFE,neutral
1001242.0,"Lightning Round: Jim Cramer Is A Seller Of Pandora, Lost Faith In Chipotle",2017-11-10 07:46:00-05:00,PFE,positive
1001243.0,Pharma ETFs Down Post Q3 Earnings,2017-11-09 12:34:00-05:00,PFE,neutral
1001244.0,REMINDER: Pfizer Expecting FDA AdCom Meeting Today For Staphylococcus Aureus Vaccine,2017-11-07 09:11:00-05:00,PFE,neutral
1001245.0,Pre-Market Imbalance Update: General Electric 258k Shares To Buy; Alibaba 121k Shares To Buy; Square 168k Shares To Buy; Pfizer 41k Shares To Sell; Bristol-Myers 51k Shares To Sell; Disney 70k Shares To Buy,2017-11-07 08:58:00-05:00,PFE,positive
1001246.0,"Spark Therapeutics, Pfizer Amend License Agreement for Investigational SPK-9001 in Hemophilia B; Spark To Receive Up To An Additional $25M Per Terms Of Amendment",2017-11-07 07:30:00-05:00,PFE,positive
1001247.0,"Pharma Stock Roundup: Pfizer, Teva, Novartis, And More",2017-11-06 12:19:00-05:00,PFE,neutral
1001248.0,"The Week Ahead: Earnings Season Continues, Several IPOs, Notable Conferences On The Docket",2017-11-06 10:48:00-05:00,PFE,neutral
1001249.0,Pfizer Says It Still Believes Annual Eucrisa Sales Will Eventually Exceed $2B,2017-10-31 11:09:00-04:00,PFE,neutral
1001250.0,"Pfizer CEO On Conf. Call, Regarding Amazon, Says That Any Distribution That Would Cut Costs And Get Wide Availability Of Products To Patients Is Something The Whole Industry Would Be Interested In",2017-10-31 10:41:00-04:00,PFE,positive
1001251.0,"Meg Tirrell Tweets: ""We anticipate there will be broad interest from potential acquirers"" of consumer health unit, $PFE CEO says",2017-10-31 10:15:00-04:00,PFE,positive
1001252.0,11 Technical Levels Discussed On Tuesday's PreMarket Prep,2017-10-31 09:34:00-04:00,PFE,neutral
1001253.0,28 Stocks Moving In Tuesday's Pre-Market Session,2017-10-31 08:09:00-04:00,PFE,neutral
1001254.0,Here's What's Coming Up On PreMarket Prep For October 31,2017-10-31 08:04:00-04:00,PFE,neutral
1001255.0,"A Peek Into The Markets: U.S. Stock Futures Rise Ahead Of Mastercard, Kellogg Earnings",2017-10-31 07:14:00-04:00,PFE,neutral
1001256.0,Pfizer Narrows FY17 Sales Guidance From $52B-$54B To $52.4B-$53.1B,2017-10-31 06:46:00-04:00,PFE,neutral
1001257.0,Pfizer Raises FY17 Adj. EPS Outlook From $2.50-$2.60 As Of Jan. 31 To $2.58-$2.62,2017-10-31 06:46:00-04:00,PFE,neutral
1001258.0,"Pfizer Reports Q3 Adj. EPS $0.67 vs $0.64 Est., Sales $13.2B vs $13.19B Est.",2017-10-31 06:45:00-04:00,PFE,neutral
1001259.0,"12 Stocks To Watch For October 31, 2017",2017-10-31 04:46:00-04:00,PFE,neutral
1001260.0,"Earnings Scheduled For October 31, 2017",2017-10-31 04:12:00-04:00,PFE,neutral
1001261.0,"Najarian Brothers See Unusual Options Activity In Melco, Pfizer, Nvidia and Abbvie",2017-10-30 15:38:00-04:00,PFE,neutral
1001262.0,Upcoming Earnings: Pfizer Reports Tomorrow As Management Explores Alternatives For Consumer Healthcare,2017-10-30 13:32:00-04:00,PFE,neutral
1001263.0,"Pre-Market Imbalance Update: GE 526K To Sell, Alibaba 221K To Buy, GM 183K To Sell, Square 169K To Buy, BofA 136K To Sell, Twitter 116K To Sell, AT&T 108K To Buy, Pfizer 106K To Sell, Coca-Cola 59K To Sell, Verizon 51K To Sell, Mastercard 38K To Buy",2017-10-30 09:05:00-04:00,PFE,neutral
1001264.0,GSK's ViiV Healthcare Announces Positive Phase 3 Results from BRIGHTE Study of Fostemsavir in Heavily Treatment-experienced Patients with HIV,2017-10-27 04:28:00-04:00,PFE,positive
1001265.0,"Wall Street's M&A Chatter From October 25: Sprint-T-Mobile, Trade Desk, Pfizer, Dynegy",2017-10-26 07:35:00-04:00,PFE,neutral
1001266.0,"Pfizer Will Launch $15B+ Consumer Health Sale In Nov., Glaxo Has Hired Citi Related To Pfizer Unit Auction",2017-10-25 14:33:00-04:00,PFE,neutral
1001267.0,"Pre-Market Imbalance Update: GE 578K Shares To Sell, AT&T 198K To Sell, Square 128K Shares To Buy, Pfizer 93K To Sell, Alibaba 60K To Buy, GM 50K To Sell",2017-10-25 09:11:00-04:00,PFE,positive
1001268.0,Healthcare ETFs Set To Soar As Q3 Earnings Unfold,2017-10-24 12:35:00-04:00,PFE,neutral
1001269.0,"Pre-Market Imbalance Update: BofA 374K Shares To Sell, GE 131K To Sell, ExxonMobil 90K To Sell, Square 63K To Sell, Pfizer 62K To Sell, JP Morgan 62K To Sell, IBM 60K To Sell, Twitter 54K To Sell, Citi 52K To Sell",2017-10-19 09:17:00-04:00,PFE,positive
1001270.0,"Pre-Market Imbalance Update: IBM 219K Shares To Buy, Alibaba 133K To Buy, Coca-Cola 131K To Sell, Twitter 88K To Sell, Square 79K To Buy, AT&T 73K To Buy, Pfizer 71K To Sell, Ford 67K To Sell, J&J 55K To Sell",2017-10-18 09:06:00-04:00,PFE,positive
1001271.0,Pfizer Presents Phase 2 Results from Lorlatinib,2017-10-16 07:03:00-04:00,PFE,neutral
1001272.0,Pfizer Says They Saw Durable Responses Seen Against Long Tumors And Brian Metastases Across Multiple Lines Of Therapy In Phase 2 Study Of ALK-Inhibitor Lorlatinib in ALK-Positive and ROS1-Positive Advanced Non-Small Cell Lung Cancer,2017-10-16 07:03:00-04:00,PFE,negative
1001273.0,"Pharma Stock Roundup: Pfizer Mulls Options For Consumer Healthcare, Eli Lilly's Pipeline Setback",2017-10-13 12:19:00-04:00,PFE,neutral
1001274.0,3 Highlights From A Spark Therapeutics Fireside Chat,2017-10-13 09:36:00-04:00,PFE,positive
1001275.0,Pfizer Reports FDA Approval Of LYRICA ER Tablets CV,2017-10-12 08:02:00-04:00,PFE,positive
1001276.0,Why Jefferies Upgraded Johnson & Johnson,2017-10-11 15:47:00-04:00,PFE,neutral
1001277.0,A Deep Dive Into MannKind's Big Bet On Afrezza,2017-10-11 11:45:00-04:00,PFE,neutral
1001278.0,"Pre-Market Imbalance Update: GE 285K Shares To Sell, NIKE 78K Shares To Buy, Colgate-Palmolive 47K To Buy, Pfizer 45K To Sell, Alibaba 45K To Buy",2017-10-11 09:03:00-04:00,PFE,positive
1001279.0,These Were The Most Bought And Sold Stocks In September,2017-10-10 16:12:00-04:00,PFE,neutral
1001280.0,5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings,2017-10-10 12:52:00-04:00,PFE,positive
1001281.0,UPDATE: Pfizer Highlights Co.'s Consumer Healthcare Unit Had '16 Sales Of ~$3.4B,2017-10-10 06:45:00-04:00,PFE,neutral
1001282.0,Pfizer Reports Review Of Strategic Alternatives Related To Consumer Healthcare Unit,2017-10-10 06:45:00-04:00,PFE,neutral
1001283.0,Health Care Sector Back In Focus In Congress Ahead Of Q3 Earnings Result,2017-10-09 15:56:00-04:00,PFE,positive
1001284.0,"Pre-Market Imbalance Update: GE Shares 198K To Buy, Macy's 75K To Buy, Pfizer 71K To Sell, Merck 56K To Buy, Citi 50K To Buy, P&G 40K To Buy, ExxonMobil 38K To Sell, Barrick Gold 30K To Buy, BofA 28K To Buy, Chevron 25K To Sell, JP Morgan 10K To Buy",2017-10-09 09:14:00-04:00,PFE,positive
1001285.0,Heaps Of Healthy Health Care ETFs,2017-10-06 10:02:00-04:00,PFE,positive
1001286.0,"The South African Competition Commission is Still Investigating Complaints Against Pfizer, Genetech and Roche, According to Reuters",2017-10-04 07:37:00-04:00,PFE,negative
1001287.0,Meg Tirrell Tweets: Missed this Fri: federal court ruled Obama admn acted unlawfully in rules that resulted in $PFE abandoning $AGN deal uk.reuters.com/article/uk-usa…,2017-10-02 13:47:00-04:00,PFE,negative
1001288.0,The Market In 5 Minutes: Tragedy Rocks The Vegas Strip,2017-10-02 08:33:00-04:00,PFE,negative
1001289.0,"Jim Cramer Shares His Thoughts On DowDuPont, Pfizer And More",2017-09-29 09:02:00-04:00,PFE,positive
1001290.0,Notable Premarket Imbalances: SQ 77k To Buy; PFE 130k To Sell; BABA 44k sell; BAC 88; To Sell;,2017-09-25 09:02:00-04:00,PFE,neutral
1001291.0,Cramer's Guide To Profit From Market Rotations,2017-09-23 08:56:00-04:00,PFE,positive
1001292.0,The Street Has Finally Recognized The Exelixis Clinical Program Potential,2017-09-22 13:13:00-04:00,PFE,neutral
1001293.0,What Do Versartis' Troubles Mean For Opko Health?,2017-09-22 11:26:00-04:00,PFE,negative
1001294.0,Versartis' Somavaratan Still Has A Path Forward; Cantor Reiterates Buy,2017-09-22 09:20:00-04:00,PFE,neutral
1001295.0,Merck and Pfizer Get European Commission Approval for Bavencio,2017-09-21 06:25:00-04:00,PFE,positive
1001296.0,"Pfizer Should Outperform, Morgan Stanley Upgrades",2017-09-20 09:45:00-04:00,PFE,neutral
1001297.0,"Benzinga's Top Upgrades, Downgrades For September 20, 2017",2017-09-20 09:12:00-04:00,PFE,positive
1001298.0,Pfizer Reports Filing Of Suit In US District Court In Pennsylvania Against J&J Related To Allegations J&J 'Engaged in Unlawful Conduct to Stifle Competition From Inflectra',2017-09-20 09:12:00-04:00,PFE,positive
1001299.0,The Market In 5 Minutes,2017-09-20 07:50:00-04:00,PFE,neutral
1001300.0,A Peek Into The Markets: U.S. Stock Futures Flat; All Eyes On Fed Decision,2017-09-20 07:18:00-04:00,PFE,neutral
1001301.0,Morgan Stanley Upgrades Pfizer to Overweight,2017-09-20 06:08:00-04:00,PFE,negative
1001302.0,Morgan Stanley Upgrades Pfizer to Overweight from Equal-Weight; Raises PT to $39 from $35,2017-09-20 04:53:00-04:00,PFE,negative
1001303.0,"Pfizer Reports FDA Panel Voted 6 For, 6 Against Benefit-Risk Profile Of SUTENT",2017-09-19 13:17:00-04:00,PFE,neutral
1001304.0,"Pfizer, Astellas Announce Phase 3 Prosper Trial of Xtandi in Patients with Non-Metastatic Castration-Resistant Prostate Cancer Met Its Primary Endpoint​",2017-09-14 05:12:00-04:00,PFE,negative
1001305.0,"Morgan Stanley Healthcare Conference Concludes Today, Presenters Include Ironwood Pharmaceuticals, Sage Therapeutics, Pfizer, TherapeuticsMD, Alnylam, bluebird bio, and Cigna",2017-09-13 09:24:00-04:00,PFE,neutral
1001306.0,"Pre-Market Imbalance Update: Bristol-Myers Squibb 152K Shares To Sell, GE 145K To Sell, Pfizer 108K to Sell, Home Depot 102K Shares To Buy, Alibaba 101K Shares To Buy, USG 94K To Buy, Lowe's 48K To Buy, Heritage Insurance 43K To Buy, Rockwell Collins 38K",2017-09-11 08:57:00-04:00,PFE,positive
1001307.0,"Pfizer Reports Overall Survival Data Of XALKORI In Patients With ALK-Positive Advanced NSCLC: Median Survival Was Not Reached, Was 47.5 Months For Patients Randomized To Chemo",2017-09-11 07:02:00-04:00,PFE,positive
1001308.0,Pfizer Presents Positive Pivotal Data for PF-05280014 at ESMO 2017,2017-09-10 09:43:00-04:00,PFE,positive
1001309.0,What Pharmaceuticals Spend On Lobbying To Influence Trump,2017-09-09 16:28:00-04:00,PFE,negative
1001310.0,"This Drug, An Alternative To Marijuana And Ketamine, Could Treat Suicidal Depression And PTSD",2017-09-07 13:02:00-04:00,PFE,negative
1001311.0,Attention Biotech Investors: September Ushers In Another Slew Of PDUFA Catalysts,2017-09-01 14:03:00-04:00,PFE,neutral
1001312.0,Pfizer Receives FDA Approval For MYLOTARG,2017-09-01 11:09:00-04:00,PFE,positive
1001313.0,Pfizer's BOSULIF Regulatory Submissions Accepted by the FDA and European Medicines Agency,2017-08-29 07:06:00-04:00,PFE,positive
1001314.0,"Bristol-Myers Squibb, Pfizer Present Observational Real-World Data Analysis on Effectiveness and Safety of Eliquis vs to Warfarin in Select High-Risk Patients with NVAF",2017-08-28 04:22:00-04:00,PFE,positive
1001315.0,From A(erie) To Z(ynerba): Biotech Catalysts Lined Up For Second Half Of 2017,2017-08-25 09:07:00-04:00,PFE,neutral
1001316.0,"Sangamo Therapeutics, Pfizer Report First Patient Received Treatment In Phase 1/2 Trial Evaluating SB-525",2017-08-25 08:02:00-04:00,PFE,neutral
1001317.0,"Premarket Prep Host Dennis Dick Tweets: Notable opening imbalances: $SNAP +354K, $GE -262K, $PFE -122K, $JNJ -92K, $BABA +81K",2017-08-21 09:25:00-04:00,PFE,negative
1001318.0,"Bristol-Myers Squibb, Pfizer to Highlight Commitment to Reducing the Risk of Stroke Caused by Non-Valvular Atrial Fibrillation and Treating Deep Vein Thrombosis/Pulmonary Embolism  at ESC Congress 2017",2017-08-18 07:00:00-04:00,PFE,positive
1001319.0,Pfizer Granted Approval Of Besponsa From FDA,2017-08-17 13:28:00-04:00,PFE,positive
1001320.0,Market Reaction To Bristol-Myers' Mixed Clinical Results: 'A Little Excessive',2017-08-16 11:59:00-04:00,PFE,neutral
1001321.0,5 Biggest Price Target Changes For Tuesday,2017-08-15 10:18:00-04:00,PFE,neutral
1001322.0,13F From Tepper's Appaloosa Shows Liquidated ~3M Share Position In Pfizer,2017-08-14 16:25:00-04:00,PFE,positive
1001323.0,Pfizer 10-Q Just Filed,2017-08-10 16:24:00-04:00,PFE,neutral
1001324.0,"Pfizer, Sanofi, Glaxo Shares Unaffected Amid Comment From Mexican Anti-Trust Agency Official Suggesting Drugs Sold By Those Cos. Do Not Face Competition From Generics Readily Available Elsewhere",2017-08-09 10:56:00-04:00,PFE,positive
1001325.0,"Wall Street's M&A Chatter From August 4-7: Acadia Pharma, United Technologies-Rockwell Collins, United Therapeutics",2017-08-07 07:19:00-04:00,PFE,positive
1001326.0,Pfizer Reports FDA Advisory Committee Votes in Favor of XELJANZ 10 to 1,2017-08-03 14:10:00-04:00,PFE,positive
1001327.0,"Benzinga's Top Upgrades, Downgrades For August 2, 2017",2017-08-02 09:24:00-04:00,PFE,positive
1001328.0,BMO Capital Upgrades Pfizer to Outperform,2017-08-02 08:10:00-04:00,PFE,neutral
1001329.0,Mid-Afternoon Market Update: Crude Oil Down 2.5%; Horizon Global Shares Spike Higher,2017-08-01 14:30:00-04:00,PFE,negative
1001330.0,Key FDA Events To Watch Out For In August 2017,2017-08-01 12:39:00-04:00,PFE,neutral
1001331.0,Mid-Day Market Update: Pitney Bowes Drops On Earnings Miss; Lumber Liquidators Shares Climb,2017-08-01 12:03:00-04:00,PFE,positive
1001332.0,All Eyes On iPhone As Apple Kicks Off August With Earnings After Closing Bell,2017-08-01 10:27:00-04:00,PFE,neutral
1001333.0,Mid-Morning Market Update: Markets Open Higher; Pfizer Sales Miss Estimates,2017-08-01 10:11:00-04:00,PFE,negative
1001334.0,August PDUFA Dates: Biotech Investors Stay Tuned To A Month Of Plenty,2017-08-01 09:20:00-04:00,PFE,neutral
1001335.0,A Peek Into The Markets: U.S. Stock Futures Climb; Apple Earnings In Focus,2017-08-01 07:23:00-04:00,PFE,neutral
1001336.0,"Pfizer Raises FY 2017 EPS Guidance to $2.54-$2.60 from $2.50-$2.60 vs $2.55 Est., Reaffirms Sales Guidance",2017-08-01 06:48:00-04:00,PFE,neutral
1001337.0,Pfizer Raises Guidance,2017-08-01 06:47:00-04:00,PFE,neutral
1001338.0,"Pfizer Q2 EPS $0.67 vs $0.66 Est., Sales $12.9B vs $13.1B Est.",2017-08-01 06:47:00-04:00,PFE,neutral
1001339.0,"10 Stocks To Watch For August 1, 2017",2017-08-01 05:31:00-04:00,PFE,neutral
1001340.0,"Earnings Scheduled For August 1, 2017",2017-08-01 04:34:00-04:00,PFE,neutral
1001341.0,Earnings Preview: Pharma Giant Pfizer Reports Q2 Results Tomorrow Morning,2017-07-31 10:46:00-04:00,PFE,neutral
1001342.0,"Earnings Watch: Apple, Tesla, Pfizer, Activision-Blizzard On Tap For Next Week",2017-07-28 15:45:00-04:00,PFE,neutral
1001343.0,"Lightning Round: Jim Cramer Shares His Thoughts On Freeport-McMoRan, Pfizer And More",2017-07-28 07:17:00-04:00,PFE,positive
1001344.0,Why Is AstraZeneca Sinking Today?,2017-07-27 09:18:00-04:00,PFE,neutral
1001345.0,"Samsung, Amazon — Everyone Is Getting Into Pharmaceuticals",2017-07-27 08:36:00-04:00,PFE,positive
1001346.0,2 Ways To Trade This Week's Healthcare Earnings,2017-07-24 11:51:00-04:00,PFE,neutral
1001347.0,Pfizer Reports Top-Line Results From Comparative REFLECTIONS B7391003 Study For PF-05439535,2017-07-24 08:35:00-04:00,PFE,neutral
1001348.0,Merck and Pfizer's Avelumab Recommended for Approval by the EU Medicines Agency,2017-07-21 07:20:00-04:00,PFE,positive
1001349.0,Hearing Merck Has Said Corning Will Make Initial $500M Investment Related To Modernization Of Pharmaceutical Glass Packaging,2017-07-20 15:21:00-04:00,PFE,neutral
1001350.0,"Trump Says Merck, Pfizer And Corning Announce That Glass Packaging Will Be Made In America",2017-07-20 15:07:00-04:00,PFE,neutral
1001351.0,Analyst Prescribes Neutral Rating For Pfizer Shares,2017-07-20 10:57:00-04:00,PFE,positive
1001352.0,"Benzinga's Top Upgrades, Downgrades For July 20, 2017",2017-07-20 09:27:00-04:00,PFE,positive
1001353.0,The Market In 5 Minutes,2017-07-20 09:05:00-04:00,PFE,neutral
1001354.0,"Lightning Round: Jim Cramer Shares His Thoughts On GameStop, Pfizer And More",2017-07-20 07:34:00-04:00,PFE,positive
1001355.0,A Peek Into The Markets: U.S. Stock Futures Edge Higher Ahead Of Earnings,2017-07-20 07:06:00-04:00,PFE,neutral
1001356.0,Credit Suisse Downgrades Pfizer to Neutral,2017-07-20 06:30:00-04:00,PFE,positive
1001357.0,Pfizer Completes License Agreement for Exclusive Commercialization Rights in Europe for CRESEMBA to Treat Potentially Life-Threatening Fungal Infections Among Immunocompromised Patients,2017-07-20 04:10:00-04:00,PFE,positive
1001358.0,"Pre-Market Imbalance Update: Alibaba 120K Shares To Buy, AT&T 69K Shares To Sell, Target 67K to Buy, US Steel 44K To Buy, Colgate-Palmolive 36K To Sell, HP 32K To Sell, Pfizer 27K To Sell",2017-07-13 09:06:00-04:00,PFE,positive
1001359.0,Pfizer Reports FDA Acceptance Of SNDA For XELJANZ For Treatment Of Moderately To Severely Active Ulcerative Colitis,2017-07-13 08:01:00-04:00,PFE,positive
1001360.0,J&J To Commence Pharma Q2 Earnings Season: What's Up?,2017-07-12 14:44:00-04:00,PFE,neutral
1001361.0,5 Reasons To Be Increasing Your Large Cap Exposure Right Now,2017-07-12 11:50:00-04:00,PFE,neutral
1001362.0,Pfizer Reports FDA Panel Voted In Favor Of Co.'s MYLOTARG For Acute Myeloid Leukemia,2017-07-11 16:33:00-04:00,PFE,positive
1001363.0,The Royalty-Amassing Strategy Of Royalty Pharma,2017-07-10 16:11:00-04:00,PFE,neutral
1001364.0,"Pre-Market Imbalance Update: GE 357K Shares To Sell, NY Times 228K To Sell, BofA 73K Shares To Buy, Pfizer 48K To Sell, Visa 48K To Buy, Square 26K To Buy",2017-07-07 09:09:00-04:00,PFE,positive
1001365.0,"Healthcare Repeal Bad For GlaxoSmithKline, Other HIV Treatment Stocks",2017-07-05 12:17:00-04:00,PFE,negative
1001366.0,"Pre-Market Imbalance Update: Pfizer 454K Shares To Sell, NIKE 352K To Sell, Verizon 215K To Sell, ExxonMobil 182K To Sell, BofA 169K Shares To Buy, Chevron 145K To Sell, IBM 94K To Sell, General Mills 92K To Sell",2017-07-03 09:07:00-04:00,PFE,positive
1001367.0,UPDATE: Pfizer Reports BESPONSA PDUFA Goal Date Set For Aug. 2017,2017-06-30 07:41:00-04:00,PFE,neutral
1001368.0,Pfizer Reports BESPONSA Approved In EU For Adult Patients With Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia,2017-06-30 07:30:00-04:00,PFE,positive
1001369.0,"Jefferies Highlights A Pair Trade In Pharma: Buy ICON, Hold Tight On INC Research",2017-06-29 14:46:00-04:00,PFE,neutral
1001370.0,"Pfizer, Alcyone Lifesciences Enter Feasibility Study To Evaluate Alycone's Pulsar Delivery Platform Tech For Use In Gene Therapy",2017-06-29 08:31:00-04:00,PFE,neutral
1001374.0,Pfizer To Hire 80 Additional Employees To Support Research At New R&D Facility In Missouri,2017-06-27 09:05:00-04:00,PFE,positive
1001375.0,"A Surprisingly Clean, Straightforward Approval Gives Portola Pharma Shares A Shot Of Upside",2017-06-26 14:03:00-04:00,PFE,positive
1001376.0,Attention To Details: Neos' ADHD Portfolio,2017-06-26 09:05:00-04:00,PFE,neutral
1001379.0,"S&P Companies Spending 18% Less On Buybacks, But What Does It Mean For Investors?",2017-06-22 14:05:00-04:00,PFE,neutral
1001382.0,"Wall Street's M&A Chatter From June 21: Staples-Sycamore Partners, Diageo-Casamigos, Bristol-Myers, Acadia Pharma",2017-06-22 07:06:00-04:00,PFE,neutral
1001383.0,Pfizer Downgraded To 3 Stars By Vetr Crowd,2017-06-21 11:28:00-04:00,PFE,neutral
1001386.0,Pfizer Receives Expanded Health Canada Approval For Ibrance,2017-06-21 08:03:00-04:00,PFE,positive
1001389.0,Pfizer Reports Commencement Of Phase 1 Trial To Evaluate Investigational Group B Streptococcus Vaccine,2017-06-19 08:00:00-04:00,PFE,neutral
1001392.0,Pfizer Announces Overall Efficacy and Safety XELJANZ in The Lancet; Presented at #EULAR2017,2017-06-16 04:40:00-04:00,PFE,positive
1001393.0,"Regeneron Lower Day After 8-K Filing, Increased Competition For Pain Remedy",2017-06-15 15:09:00-04:00,PFE,negative
1001395.0,"Pre-Market Imbalance Update: Barrick Gold 193K Shares To Sell, BofA 102K To Sell, Verizon 77K Shares To Buy, GE 54K To Buy, AT&T 50K To Buy, General Mills 48K To Buy, Pfizer 45K To Sell",2017-06-15 08:50:00-04:00,PFE,positive
1001396.0,"Basilea Pharma Reports License Deal With Pfizer For Cresemba For Europe, Russia, Turkey, Israel",2017-06-14 13:18:00-04:00,PFE,neutral
1001400.0,"Pfizer, Eli Lilly Report Tanezumab Received FDA Fast Track Designation",2017-06-13 08:01:00-04:00,PFE,neutral
1001401.0,5 Biggest Price Target Changes For Monday,2017-06-12 10:10:00-04:00,PFE,neutral
1001402.0,"Pre-Market Imbalance Update: Pfizer 74K Shares To Sell, Citi 61K To Sell, JP Morgan 35K Shares To Buy, Merck 33K To Buy",2017-06-12 08:52:00-04:00,PFE,positive
1001403.0,"Merck, Pfizer Announce that Investigational SGLT-2 Inhibitor Ertugliflozin Met Primary Endpoint in Two Phase 3 Studies at #2017ADA",2017-06-11 11:52:00-04:00,PFE,negative
1001404.0,"Astellas and Pfizer Announce Amendment That Accelerates Anticipated PROSPER Top-Line Results By 2 Years, Target Sample Size Reduced To ~1,440 Patients With Completion Date Of Une 2017",2017-06-09 08:01:00-04:00,PFE,neutral
1001406.0,"Pfizer Japan, Eisai Launch Lyrica OD Tablet Formulation in Japan",2017-06-08 04:19:00-04:00,PFE,neutral
1001407.0,"Sangamo Therapeutics, Pfizer Report SB-525 Received Orphan Medicinal Production Designation from EMA",2017-06-07 07:31:00-04:00,PFE,neutral
1001408.0,Pfizer Receives FDA Fast Track Designation for Tafamidis,2017-06-06 08:00:00-04:00,PFE,neutral
1001409.0,"OxOnc Reports Co-Development Partner, Pfizer, Has Received Regulatory Approval in Both Japan, Taiwan to Market Crizotinib 200 mg/250 mg Capsules for Treatment of ROS1-Positive Advanced NSCLC",2017-06-02 10:10:00-04:00,PFE,positive
1001410.0,Hearing Appeals Court Has Upheld Dismissal of Suit Against Pfizer Which Claims Zoloft Causes Birth Defects,2017-06-02 08:54:00-04:00,PFE,negative
1001411.0,Consult Your Doctor: FDA Thinks Big Pharma Might Be Intentionally Confusing You With Too Much Information,2017-06-01 08:40:00-04:00,PFE,negative
1001412.0,"Pre-Market Imbalance Update: Pfizer 82K Shares to Buy, McDonald's 50K to Buy, Twitter 47K Shares to Sell",2017-06-01 08:34:00-04:00,PFE,positive
1001413.0,Adam Feuerstein Tweets 'I would say $PFE $MDVN deal is a cautionary tale that makes potential $TSRO suitors hesitant.',2017-05-31 16:11:00-04:00,PFE,neutral
1001414.0,"Pfizer Reports Acceptance of Regulatory Submissions by FDA, EMA for SUTENT for Adjuvant Treatment of Adult Patients at High Risk of Reccurent Renal Cell Carcinoma After Surgery",2017-05-31 08:31:00-04:00,PFE,positive
1001415.0,European Commission Approves Pfizer's Trumenba To Help Prevent Meningococcal Group B Disease,2017-05-30 10:02:00-04:00,PFE,positive
1001416.0,How Much The Opioid Epidemic Actually Costs The Non-User,2017-05-28 15:15:00-04:00,PFE,neutral
1001417.0,Amended 13D from Pfizer on pSivida Shows 4.7% Stake,2017-05-26 12:48:00-04:00,PFE,neutral
1001418.0,8-K from Pfizer Shows Co. Received Notice of Unsolicited Mini-Tender Offer by TRC Cap for Purchasing of Up to 4M Shares at $31.60/Share,2017-05-25 16:27:00-04:00,PFE,positive
1001419.0,FDA Advisory Committee Recommends Approval of Pfizer's Proposed Biosimilar to Epogen/Procrit Across All Indications,2017-05-25 13:17:00-04:00,PFE,positive
1001420.0,The Current State Of The Breast Cancer Treatment Space,2017-05-23 08:59:00-04:00,PFE,negative
1001421.0,Exclusive: Corium CEO Gives The Scoop On His Company's Latest Alzheimer's Data,2017-05-18 16:07:00-04:00,PFE,positive
1001422.0,Corium CEO Peter Staple In Benzinga.com Interview Regarding Corplex Alzheimer's Treatment: 'We know with a high degree of confidence that we have a bioequivalent product' To Pfizer's FDA-Approved Aricept,2017-05-18 16:00:00-04:00,PFE,positive
1001423.0,"Pre-Market Imbalance Update: Alibaba 160K Shares to Sell, BofA 121K to Sell, Chesapeake Energy 95K to Sell, Pfizer 84K to Sell, Colgate-Palmolive 75K to Sell, Wells Fargo 72K to Sell, Visa 51K to Sell, Mastercard 38K to Sell, Macy's 34K to Sell",2017-05-18 09:00:00-04:00,PFE,positive
1001424.0,Citi Prefers These 4 Stocks Over Pfizer On Bottom-Line Concerns,2017-05-16 11:15:00-04:00,PFE,neutral
1001425.0,"Benzinga's Top Upgrades, Downgrades For May 16, 2017",2017-05-16 09:12:00-04:00,PFE,positive
1001426.0,Citigroup Downgrades Pfizer to Sell,2017-05-16 07:35:00-04:00,PFE,neutral
1001427.0,"13F Shows Appaloosa Reduced Stake In Hain Celestial,  & Pfizer",2017-05-12 16:26:00-04:00,PFE,neutral
1001428.0,Mid-Afternoon Market Update: Crude Oil Up 1.25%; Straight Path Shares Plunge,2017-05-11 14:33:00-04:00,PFE,negative
1001429.0,12 Biggest Mid-Day Gainers For Thursday,2017-05-11 12:22:00-04:00,PFE,neutral
1001430.0,Mid-Day Market Update: Snap Tumbles After Q1 Report; Sangamo Shares Surge,2017-05-11 12:02:00-04:00,PFE,positive
1001431.0,Mid-Morning Market Update: Markets Open Lower; Macy's Profit Misses Expectations,2017-05-11 10:05:00-04:00,PFE,negative
1001432.0,A New ETF Is An Active Idea For Income,2017-05-11 08:26:00-04:00,PFE,positive
1001433.0,20 Stocks Moving In Thursday's Pre-Market Session,2017-05-11 08:17:00-04:00,PFE,neutral
1001434.0,"Sangamo+40% Premarket @$6.10 Following Wednesday Earnings Report, Co Announced Strategic Collaboration with Pfizer for Hemophilia A Phase 1/2 Therapy Program",2017-05-11 07:32:00-04:00,PFE,neutral
1001435.0,Sangamo Reports Strategic Collaboration with Pfizer for Hemophilia A Phase 1/2 Therapy Program,2017-05-10 16:04:00-04:00,PFE,neutral
1001436.0,Pfizer Issues Release Highlighting FDA Granted Approval for BAVENCIO for Common Type of Advanced Bladder Cancer,2017-05-09 15:55:00-04:00,PFE,positive
1001437.0,Hearing FDA Grants Accelerated Approval for Pfizer's Avelumab for Urothelial Carcinoma,2017-05-09 12:19:00-04:00,PFE,positive
1001438.0,Pershing Shows It Isn't Done With The Biotech World After Valeant,2017-05-08 12:42:00-04:00,PFE,neutral
1001439.0,Will TherapeuticsMD's Yuvvexy Pass The FDA Muster?,2017-05-07 14:29:00-04:00,PFE,neutral
1001440.0,Near-Term Events Cast Shadow Of Uncertainty On Bristol-Myers,2017-05-06 09:03:00-04:00,PFE,negative
1001441.0,Apple Is The World's Biggest Dividend Payer,2017-05-03 10:07:00-04:00,PFE,neutral
1001442.0,Pfizer Announces U.S. FDA Filing Acceptance of Supplemental New Drug Application for XELJANZ,2017-05-03 09:03:00-04:00,PFE,positive
1001443.0,Mid-Afternoon Market Update: Crude Oil Down 2.5%; Chegg Surges Higher,2017-05-02 14:43:00-04:00,PFE,negative
1001444.0,Mid-Day Market Update: Medpace Drops After Weak Earnings; Angie's List Shares Spike Higher,2017-05-02 12:07:00-04:00,PFE,negative
1001445.0,Pfizer Lower After Mixed Q1 Report,2017-05-02 11:45:00-04:00,PFE,negative
1001446.0,"Apple Earnings In Focus, But Fed Meeting, Auto Sales Also Could Grab Headlines",2017-05-02 10:58:00-04:00,PFE,neutral
1001447.0,Mid-Morning Market Update: Markets Mostly Flat; Pfizer Profit Beats Views,2017-05-02 10:10:00-04:00,PFE,positive
1001448.0,A Peek Into The Markets: U.S. Stock Futures Mostly Lower; Apple Earnings In Focus,2017-05-02 07:15:00-04:00,PFE,negative
1001449.0,"Pfizer Reaffirms FY 2017 Guidance, Sees EPS $2.50 to $2.60 vs $2.55 Est, Sales $52.0B to $54.0B vs $53.2B Est",2017-05-02 06:47:00-04:00,PFE,neutral
1001450.0,"Pfizer Q1 EPS $0.69 vs $0.67 Est, Sales $12.78B vs $13.09B Est",2017-05-02 06:46:00-04:00,PFE,neutral
1001451.0,"12 Stocks To Watch For May 2, 2017",2017-05-02 05:06:00-04:00,PFE,neutral
1001452.0,"Earnings Scheduled For May 2, 2017",2017-05-02 04:31:00-04:00,PFE,neutral
1001453.0,"Earnings Preview: Q1 Results From Pfizer, Merck, And Gilead Sciences This Week",2017-05-01 10:56:00-04:00,PFE,neutral
1001454.0,Feuerstein On Neurotrope: The Study Failed And There Was Never 'A Lot Of Hope Here',2017-05-01 09:24:00-04:00,PFE,negative
1001455.0,"Pre-Market Imbalance Update: AT&T 397K Shares to Sell, Verizon 213K to Sell, Pfizer 152K to Sell, Twitter 145K Shares to Buy, Coca-Cola 123K to Sell",2017-05-01 09:11:00-04:00,PFE,positive
1001456.0,"Looking For Action? Week Ahead Brings Heavy Load With Earnings, Data, Fed Meeting",2017-05-01 08:13:00-04:00,PFE,neutral
1001457.0,"Weed Vs. Opioids: Nontraditional And Traditional Biotech Take On Wall Street, But Who's Winning?",2017-04-30 12:38:00-04:00,PFE,positive
1001458.0,Drug Trials Heating Up In The Breast and Ovarian Cancer Treatment Space,2017-04-27 12:55:00-04:00,PFE,negative
1001459.0,Pfizer's Lorlatinib Granted Breakthrough Therapy Designation From FDA,2017-04-27 08:02:00-04:00,PFE,positive
1001460.0,"Jim Cramer Gives His Opinion On Tesla, Pfizer And UnitedHealth",2017-04-27 06:59:00-04:00,PFE,neutral
1001461.0,"Aquinnah Pharma Reports Received $10M Investment from Pfizer, AbbVie for Research Breakthrough Approach to Neurodegenerative Disease",2017-04-25 08:08:00-04:00,PFE,neutral
1001462.0,"Earnings: Caterpillar, Lockheed Martin, and Eli Lilly Report Tomorrow",2017-04-24 13:45:00-04:00,PFE,neutral
1001463.0,Pfizer Says Pivotal Phase III Study Underscores Efficacy Of Zavicefta,2017-04-24 05:47:00-04:00,PFE,neutral
1001464.0,"Pfizer Reports Positive CHMP Opinion for BESPONSA for Treatment of Relapsed, Refractory Acute Lymphoblastic Leukemia",2017-04-21 15:11:00-04:00,PFE,positive
1001465.0,EMA Recommends Approval Of Pfizer's Besponsa For Acute Lymphoblastic Leukemia,2017-04-21 13:28:00-04:00,PFE,positive
1001466.0,What Would A $5.8 Billion NIH Cut Look Like? Devastation,2017-04-20 13:38:00-04:00,PFE,negative
1001467.0,The Lucky Beneficiaries Of Tax Day,2017-04-20 08:23:00-04:00,PFE,positive
1001468.0,Hearing Pfizer Has Said It Received Grand Jury Subpoena Related to DoJ's Antitrust Probe of IV Saline Solution,2017-04-19 10:46:00-04:00,PFE,positive
1001469.0,8-K from ICU Medical Shows Co. Received Grand Jury Subpoena Related to Investigation by DoJ's Antitrust Unit for Pfizer/Hospira Infusion Systems Deal,2017-04-18 16:48:00-04:00,PFE,positive
1001470.0,"HitGen, Pfizer Enter Research Collaboration, License Agreement to Build, Screen Novel DNA-Encoded Libraries",2017-04-18 03:56:00-04:00,PFE,positive
1001471.0,Healthcare Sector Earnings: Making A Comeback In Q1 2017?,2017-04-12 11:46:00-04:00,PFE,neutral
1001472.0,Cardiovascular Players Could Be Eyeing Esperion,2017-04-10 11:53:00-04:00,PFE,neutral
1001473.0,FDA Warns Of Dangerous Hidden Ingredient In 5 OTC Male Sexual Enhancement Supplements,2017-04-07 12:25:00-04:00,PFE,negative
1001474.0,There Is Value To Be Had With The Right Healthcare ETFs,2017-04-05 08:32:00-04:00,PFE,positive
1001475.0,"Benzinga Premarket Prep Host Dennis Dick Tweets: Notable opening imbalances: $PFE -243K, $MRK -93K, $BABA +115K, $KO +104K, $T +111K, $CAT -55K, $IBM -42K",2017-04-03 09:24:00-04:00,PFE,negative
1001476.0,Pfizer Subsidiary Meridian Medical Tech Has Expanded A Voluntary Recall Of Select Lots Of Mylan's EpiPen,2017-03-31 17:13:00-04:00,PFE,neutral
1001477.0,"Pfizer Announces FDA sNDA Approval, Expanded Indication For IBRANCE",2017-03-31 14:04:00-04:00,PFE,positive
1001478.0,Pfizer Shares Volatile Over Last Few Mins as Traders Circulating FDA.gov Page Showing FDA Granted Regular Approval to IBRANCE for Treatment of HR Positive,2017-03-31 13:16:00-04:00,PFE,positive
1001479.0,"If Gender Confirmation Becomes A Legal Human Right, Which Corporations Could Benefit?",2017-03-28 13:05:00-04:00,PFE,positive
1001480.0,Regeneron's Dupixent Passes The FDA Muster; Baird Sees Strong Launch,2017-03-28 12:41:00-04:00,PFE,positive
1001481.0,"Tesaro Gets Approval For Zejula, Expect U.S. Launch Late April",2017-03-28 10:26:00-04:00,PFE,positive
1001482.0,Anatomy Of A Decision Series Highlights Skills Necessary To Climb To The Top Of The Corporate Ladder,2017-03-27 14:16:00-04:00,PFE,positive
1001483.0,Pfizer Receives Positive CHMP Opinion For TRUMENBA From European Medicines Agency,2017-03-24 10:18:00-04:00,PFE,positive
1001484.0,Pfizer Reports EU Medicines Recommends Approval Of Trumenba Drug For Prophylaxis Against Invasive Meningococcal Disease,2017-03-24 08:06:00-04:00,PFE,positive
1001485.0,Adam Feuerstein Tweets: $PFE Merck KgAa — FDA approves avelumab for merkel cell carcinoma. Brand name: Bavencio.,2017-03-23 14:23:00-04:00,PFE,positive
1001486.0,Pfizer Shares Unaffected Following Report Advent Has Pulled bid for Co.'s Brazil Generic Drugs Venture,2017-03-22 15:42:00-04:00,PFE,positive
1001487.0,"PreMarket Prep Recap, March 21: We Haven't Seen A 2% Correction Since The Election",2017-03-21 09:46:00-04:00,PFE,neutral
1001488.0,"Anatomy Of A Decision, Part 1: The C-Suite",2017-03-20 16:12:00-04:00,PFE,neutral
1001489.0,"Benzinga's Premarket Prep Host Dennis Dick Tweets: Notable opening imbalances: $BAC -984K, $JPM -86K, $PFE +115K, $BABA +54K, $GE -88K, $KO +72K, $NKE +64K",2017-03-20 09:27:00-04:00,PFE,negative
1001490.0,"Cronos Group Execs Talk About Cannabis Co., Recent 'Bought Deal' And Expansion Plans",2017-03-18 18:28:00-04:00,PFE,neutral
1001491.0,"Bank Of America, Coach, Pfizer: Fast Money Picks For March 17",2017-03-17 06:53:00-04:00,PFE,neutral
1001492.0,That Was Fast: Healthcare ETF Races To New Highs,2017-03-16 08:09:00-04:00,PFE,neutral
1001493.0,Pfizer Announces Approval By China FDA of XELJANZ for Treatment of Adult Patients With Moderately to Severely Active RA,2017-03-16 04:03:00-04:00,PFE,positive
1001494.0,"Barclays Global Healthcare Conference Continues Today; Presenters Include HCA Holdings, Valeant, Incyte, Celgene, Cotiviti, Aetna, Anthem, Seattle Genetics, Teva Pharma, Pfizer, & Bristol-Myers",2017-03-15 08:25:00-04:00,PFE,neutral
1001495.0,"PreMarket Prep Host Dennis Dick Tweets: Notable opening imbalances: $CAT -197K, $GE -156K, $BABA -46K, $CL -44K, $PFE -92K, $XOM -30K, $CVX -26K",2017-03-14 09:24:00-04:00,PFE,negative
1001496.0,How The Ultra-Wealthy Are Helping Advance Health And Life Sciences,2017-03-10 15:58:00-05:00,PFE,positive
1001497.0,"Servier, Pfizer, Cellectis Announce FDA Clearance of IND Application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia",2017-03-09 04:19:00-05:00,PFE,neutral
1001498.0,"Cowen Annual Healthcare Conference Continues Today; Presenters Include Regulus, Eli Lilly, Oculus, DexCom, Illumina, Allergan, Kite Pharma, Pfizer, and bluebird bio",2017-03-07 08:59:00-05:00,PFE,neutral
1001499.0,"Benzinga Premarket Prep Host Dennis Dick Tweets: Notable opening imbalances: $XRX +467K, $BAC -353K, $PFE -133K, $CRM -129K, $PEP -89K, $JNJ -72K, $PG -50K",2017-03-06 09:18:00-05:00,PFE,negative
1001500.0,"Merck, Pfizer Report U.S. FDA and EMA Filing Acceptances of 3 Marketing Applications for Ertugliflozin-Containing Medicines For Adult Type 2 Diabetes Patients",2017-03-06 08:02:00-05:00,PFE,positive
1001501.0,PR Confirms Earlier Reports That Spark Therapeutics and Pfizer SPK-9001 Granted Access To PRIME Program By EMA,2017-03-01 16:20:00-05:00,PFE,positive
1001502.0,Short Sellers Pile On Pfizer After Buyout Rumors,2017-03-01 06:54:00-05:00,PFE,neutral
1001503.0,Pfizer Receives FDA Warning For Drugs Contaminated With Cardboard At Kansas Facility,2017-02-28 17:22:00-05:00,PFE,negative
1001504.0,"EMD Serono, A Unit Of Merck KGaA and Pfizer Announces FDA Approval Of Biologics License Application for Avelumab For Priority Review",2017-02-28 07:04:00-05:00,PFE,positive
1001505.0,Carl Icahn's Track Record In Big Pharma,2017-02-24 09:40:00-05:00,PFE,neutral
1001506.0,Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer?,2017-02-21 16:48:00-05:00,PFE,neutral
1001507.0,"Boeing, Pfizer And Others Band Together To Ask Congress For More Taxes",2017-02-21 13:28:00-05:00,PFE,neutral
1001508.0,"Pfizer Announces FDA Acceptance Of Regulatory Submission For Inotuzumab Ozogamicin, Sees PDUFA Date In August 2017",2017-02-21 08:04:00-05:00,PFE,positive
1001509.0,Momenta Pharmaceuticals Announces FDA Warning Letter to Contracted Glatopa Fill/Finish Manufacturer,2017-02-17 18:02:00-05:00,PFE,negative
1001510.0,Border Tax Polarizes U.S Companies As Exporters Take Side With Trump Team,2017-02-16 09:17:00-05:00,PFE,neutral
1001511.0,UPDATE: Pfizer XELJANZ 5mg Monotherapy Did Not Meet Primary Endpoint of Non-Inferiority vs. Humira; While XELJANZ plus MTX Met Primary Endpoint vs. Humira,2017-02-16 08:09:00-05:00,PFE,neutral
1001512.0,Pfizer Reports Top-Line Results from Oral Strategy Trial of XELJANZ vs Humira,2017-02-16 08:00:00-05:00,PFE,neutral
1001513.0,Deutsche Bank Casts Doubt On Pfizer's Rumored Takeover Approach To Bristol-Myers,2017-02-15 14:26:00-05:00,PFE,negative
1001514.0,Deutsche Bank on Bristol-Myers Unconfirmed Takeover Chatter Tuesday: 'we would be surprised to see PFE make a move on BMY at this stage',2017-02-15 09:18:00-05:00,PFE,positive
1001515.0,"13F from Tepper's Appaloosa Shows New Stakes in Mylan, Pfizer, Teva",2017-02-14 16:19:00-05:00,PFE,neutral
1001516.0,Pfizer Inc Reports 16.4% Stake In Icu Medical as of Feb 3 in 13D,2017-02-13 16:22:00-05:00,PFE,neutral
1001517.0,How China Lifting Its One-Child Policy Played Into Reckitt Benckiser's $90/Share Offer For Mead Johnson,2017-02-05 17:41:00-05:00,PFE,positive
1001518.0,Mylan Tests Resistance After Pfizer Takeover Rumor,2017-02-03 11:40:00-05:00,PFE,neutral
1001519.0,Pfizer Begins $5 Billion Accelerated Share Repurchase,2017-02-03 08:10:00-05:00,PFE,positive
1001520.0,Hearing Pfizer Has Hired JP Morgan to Consider $2B Portfolio Sale,2017-02-02 12:24:00-05:00,PFE,positive
1001521.0,"FedEx, Freeport-McMoran, Pfizer: Fast Money Picks For February 1",2017-02-01 06:54:00-05:00,PFE,neutral
1001522.0,Pfizer Flat After Q4 Miss,2017-01-31 12:05:00-05:00,PFE,negative
1001523.0,Q4 2016 Real-Time Call Brief,2017-01-31 11:43:00-05:00,PFE,neutral
1001524.0,"President Trump Doubles Down On Healthcare Criticism, Says Drug Prices Are 'Astronomical'",2017-01-31 10:57:00-05:00,PFE,negative
1001525.0,Pfizer CEO States They Are Not Changing Philosophy On Drug Pricing Or When Co. Takes Increases,2017-01-31 10:45:00-05:00,PFE,neutral
1001526.0,"Fed Meeting Starts Today, But Focus Remains On Key Earnings Data",2017-01-31 10:20:00-05:00,PFE,neutral
1001527.0,"The Market In 5 Minutes: Under Armour's Miss, Apple's Q1 Primer",2017-01-31 09:04:00-05:00,PFE,negative
1001528.0,"Healthcare Q4: Eli Lilly Beats, Pfizer Misses",2017-01-31 08:57:00-05:00,PFE,negative
1001529.0,A Peek Into The Markets: U.S. Stock Futures Down; Apple Earnings In Focus,2017-01-31 07:47:00-05:00,PFE,neutral
1001530.0,"Pfizer Sees FY17 Sales $52B-$54B vs $54.03B Est., Adj. EPS $2.50-$2.60 vs $2.57 Est.",2017-01-31 06:46:00-05:00,PFE,neutral
1001531.0,"Pfizer Reports Q4 Adj. EPS $0.47 vs $0.50 Est., Sales $13.6B vs $13.63B Est.",2017-01-31 06:45:00-05:00,PFE,neutral
1001532.0,15 Stocks You Should Be Watching Today,2017-01-31 05:27:00-05:00,PFE,neutral
1001533.0,"Earnings Scheduled For January 31, 2017",2017-01-31 05:08:00-05:00,PFE,neutral
1001534.0,"A Mixed Bag of Earnings Ahead: Eli Lilly, Pfizer, Exxon Mobil, And Under Armour",2017-01-30 12:26:00-05:00,PFE,neutral
1001535.0,"Mixing It Up: Markets Await Host Of Economic Data, Key Earnings, And Fed Meeting",2017-01-30 10:07:00-05:00,PFE,positive
1001536.0,"Pre-Market Prep Host Dennis Dick Tweets: Notable opening imbalances: $BABA -105K, $C -115K, $BAC -139K, $MS -92K, $BA -109K, $GE -170K, $PFE +111K, $BMY +69K",2017-01-30 09:19:00-05:00,PFE,negative
1001537.0,"The Market In 5 Minutes: Walgreens-Rite Aid, Personal Income And Trump's Executive Order",2017-01-30 09:03:00-05:00,PFE,neutral
1001538.0,Can Merck And Pfizer Beat Low Expectations?,2017-01-30 07:16:00-05:00,PFE,negative
1001539.0,"A Mutual Fund For Special Occasions: A Conversation With Value Fund Manager Tobias Carlisle, Part 1",2017-01-27 08:22:00-05:00,PFE,positive
1001540.0,UPDATE: Pfizer Says Positive CHMP Opinion on XELJANZ Will Be Sent to EC For Final Decision,2017-01-27 07:01:00-05:00,PFE,positive
1001541.0,Pfizer Reports Received CHMP Opinion in Europe for XELJANZ for Treatment of Moderate to Severe Active RA,2017-01-27 07:01:00-05:00,PFE,neutral
1001542.0,Pfizer Reports Positive Top-Line Results from Phase 2 Study of Investigational Clostridium difficile Vaccine for the Prevention of C. difficile Infection,2017-01-26 08:00:00-05:00,PFE,positive
1001543.0,Watch These 7 Huge Put Purchases In Tuesday Trade,2017-01-24 04:31:00-05:00,PFE,positive
1001544.0,Benzinga's Option Alert Recap From January 23,2017-01-23 17:12:00-05:00,PFE,positive
1001545.0,"Option Alert: Pfizer Sept. $32 Puts at the Bid: Volume of 3,000 at $2.39 vs Open Interest of 654",2017-01-23 10:58:00-05:00,PFE,positive
1001546.0,"Hearing Gilead, Pfizer CEOs Currently Meeting At Davos, Traders Speculating M&A Talks",2017-01-18 11:46:00-05:00,PFE,neutral
1001547.0,Orphan Drugs Among 2015's Top 10 Best-Selling Medications,2017-01-18 10:40:00-05:00,PFE,positive
1001548.0,"Incyte PDUFA Date Pushed Back, JMP Discusses Impact",2017-01-17 08:13:00-05:00,PFE,neutral
1001549.0,All The Markets Trump Moved During His Speech Today,2017-01-11 15:51:00-05:00,PFE,neutral
1001550.0,Trump: Drug Industry Is 'Getting Away With Murder',2017-01-11 12:15:00-05:00,PFE,negative
1001551.0,"Watching Weakness In Amgen,Biogen, Gilead, Mylan, Pfizer And Other Biotechs After Pres. Elect Trump Negative Statement On Drug Pricing",2017-01-11 11:25:00-05:00,PFE,negative
1001552.0,The Fentanyl Abuse Epidemic,2017-01-10 07:02:00-05:00,PFE,negative
1001553.0,The Year's Biggest Healthcare Conference Commences This Week; Here's What You Need To Know,2017-01-09 06:33:00-05:00,PFE,neutral
1001554.0,Spark Gets A Check From Pfizer And A Downgrade From Vetr,2017-01-05 16:39:00-05:00,PFE,positive
1001555.0,ICU Medical Announces Terms To Acquire Hospira Infusion Systems From Pfizer Have Changed; Purchase Price Maximum Lowered From $1B To $900M,2017-01-05 16:13:00-05:00,PFE,negative
1001556.0,"ICU Medical, Inc. Provides Update on Hospira Infusion Systems Transaction, Says U.S. and Other Required Antitrust Clearances for Transaction Received, Deal To Close Feb. 2017",2017-01-05 16:06:00-05:00,PFE,neutral
1001557.0,"The Market In 5 Minutes: Jobless Claims Fall Again, Retailers Struggle",2017-01-05 09:13:00-05:00,PFE,negative
1001558.0,AbCellera Reports Multi-Target Research Collaboration with Pfizer,2017-01-05 09:02:00-05:00,PFE,neutral
1001559.0,Pfizer Reports Positive Top-Line Results from the Comparative REFLECTIONS B538-02 Study for PF-06410293,2017-01-05 08:31:00-05:00,PFE,positive
1001560.0,Wall Street's M&A Chatter From January 4,2017-01-05 06:51:00-05:00,PFE,neutral
1001561.0,Spark Therapeutics Reports $15 Million Milestone Payment from Pfizer for Progress in Hemophilia B Gene Therapy Program,2017-01-04 07:32:00-05:00,PFE,positive
1001562.0,Barron's Best Income Ideas For 2017,2017-01-02 17:26:00-05:00,PFE,positive
1001563.0,"Standpoint Defends Opko Health, Thinks Bad News Will Reverse Within 3 Months",2016-12-30 12:45:00-05:00,PFE,negative
1001564.0,Opko Health's Phase 3 Data Sends Stock Plunging,2016-12-30 10:12:00-05:00,PFE,neutral
1001565.0,"Pre-Market Prep Host Dennis Dick Tweets: Some huge sell imbalances this morning: $PG -151K, $VZ -242K, $XOM -183K, $WMT -127K, $CVX -117K, $GE -471K, $CAT -95K, $PFE -373K",2016-12-30 09:01:00-05:00,PFE,negative
1001566.0,"OPKO Announces Commencement Of Data Analysis In Phase 3 Study Of hGH-CTP, No Statistical Difference On Primary Endpoint Between hGH-CTP And Placebo",2016-12-30 08:26:00-05:00,PFE,negative
1001567.0,Expensive Breakups In 2016 Surpass GDPs Of Dozens Of Developing Nations,2016-12-28 15:00:00-05:00,PFE,neutral
1001568.0,6 Worst Biotech Stocks Of 2016,2016-12-23 11:50:00-05:00,PFE,negative
1001569.0,"Meet The New Dogs: 2017's Dogs Of The Dow Include Coca-Cola, Boeing",2016-12-22 09:55:00-05:00,PFE,neutral
1001570.0,Breaking Down The Crowded Novel Ovarian Cancer Treatment Space,2016-12-21 09:19:00-05:00,PFE,negative
1001571.0,Phizer Supplemental NDA for IBRANCE Accepted by FDA,2016-12-21 08:01:00-05:00,PFE,positive
1001572.0,7 Companies That Could Be Acquired In 2017,2016-12-20 10:00:00-05:00,PFE,neutral
1001573.0,Jefferies' 2017 Global Pharma Outlook,2016-12-19 10:56:00-05:00,PFE,neutral
1001574.0,Portola Pharmaceuticals Enters into $50 Million Loan Agreement with Bristol-Myers Squibb and Pfizer for Continued Development of AndexXa,2016-12-19 08:00:00-05:00,PFE,positive
1001575.0,Pfizer Receives Approval in the European Union for Nimenrix in Infants Over 6 Months,2016-12-19 07:11:00-05:00,PFE,positive
1001576.0,Pfizer Reports FDA Approves Removal Of Boxed Warning Regarding Serious Neuropsychiatric Events From CHANTIX Labeling,2016-12-16 14:10:00-05:00,PFE,neutral
1001577.0,EMA Recommends Approval Of Pfizer's Lifmior For Treatment of Rheumatoid Arthritis,2016-12-16 07:33:00-05:00,PFE,positive
1001578.0,Watch These 5 Huge Put Purchases In Thursday Trade,2016-12-15 04:25:00-05:00,PFE,positive
1001579.0,"UPDATE: Catalyst Biosciences Says Wyeth Has Granted Co. Exclusive License to Co.'s Proprietary Rights Applying to Factor CB 813a, CB 813d to Research, Develop, Manufacture, Commercialize Products",2016-12-14 16:37:00-05:00,PFE,positive
1001580.0,8-K from Catalyst Biosciences Shows Co. Entered Deal with Pfizer's Wyeth Related to Collaboration on Development of Novel Human Factor VIIa Products,2016-12-14 16:36:00-05:00,PFE,positive
1001581.0,"Pfizer, Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTANDI, Did Not Meet Primary Endpoint In PFS",2016-12-14 16:17:00-05:00,PFE,neutral
1001582.0,FDA Reports Approval of Pfizer's Eucrisa for Eczema,2016-12-14 13:08:00-05:00,PFE,positive
1001583.0,Option Alert: PFE Feb $32 Put; 4000 @Bid @$0.86; Ref=$32.86,2016-12-14 11:59:00-05:00,PFE,positive
1001584.0,Pfizer Reports Research & License Collaboration With Ab Initio To Discover GPCR Activating Antibodies,2016-12-13 13:05:00-05:00,PFE,neutral
1001585.0,Technical Alert: Pfizer Pushes Higher For Second Day In A Row,2016-12-12 13:23:00-05:00,PFE,positive
1001586.0,Pfizer Raises Qtr. Dividend from $0.30 to $0.32/Share,2016-12-12 11:54:00-05:00,PFE,neutral
1001587.0,"European Crohn's, Colitis Organisation Issues New Statement Support a Switch to Biosimilar from Reference Product in Inflammatory Bowel Disease",2016-12-09 10:18:00-05:00,PFE,positive
1001588.0,What If Trump Keeps Badmouthing Drug Pricing?,2016-12-07 13:38:00-05:00,PFE,neutral
1001589.0,"Pfizer, J&J, Other Big Pharma Names Dip Lower Just After the Open",2016-12-07 09:34:00-05:00,PFE,negative
1001590.0,"Citi Global Healthcare Conf. Takes Place Today; Presenters Include Pfizer, Aerie Pharmaceuticals, Bristol-Myers, Alexion, Illumina, & Envision Healthcare",2016-12-07 08:38:00-05:00,PFE,neutral
1001591.0,Pfizer Fined $106 Million For Anti-Epilepsy Drug,2016-12-07 07:56:00-05:00,PFE,neutral
1001592.0,CMA Fines Pfizer £84.2M for Drug Price Hike to NHS for Anti-epilepsy Drug,2016-12-07 04:54:00-05:00,PFE,neutral
1001593.0,8 Of The Biggest Biotech Announcements Out Of The 2016 ASH Meeting,2016-12-06 16:09:00-05:00,PFE,neutral
1001594.0,Pressure Biosciences CEO On Biological Samples: It's All About How You Break Open A Cell,2016-12-05 15:55:00-05:00,PFE,negative
1001595.0,Allergan's Strength Lies In Its New Products And Robust Pipeline,2016-12-05 12:04:00-05:00,PFE,positive
1001596.0,The Medicines Company Is A Major Cardiovascular Player In The Making,2016-12-05 11:42:00-05:00,PFE,neutral
1001597.0,"Pfizer, Avillion Reports Phase 3 BFORE Study Of BOSULIF  Met Its Primary Endpoint",2016-12-05 08:01:00-05:00,PFE,neutral
1001598.0,"Spark Therapeutics, Pfizer Present Updated Preliminary Data from Hemophilia B Phase 1/2 Trial Suggesting Consistent and Sustained Levels of Factor IX Activity at ASH 2016",2016-12-03 14:50:00-05:00,PFE,positive
1001599.0,Pfizer Announces New Phase 2 Results Show Investigational Compound Glasdegib Improved Overall Survival in AML and High-Risk MDS at ASH 2016,2016-12-03 14:38:00-05:00,PFE,positive
1001600.0,Benzinga's Top Initiations,2016-12-02 09:24:00-05:00,PFE,positive
1001601.0,"The Market In 5 Minutes: Payrolls, Smith & Wesson Earnings And Starbucks' CEO Change",2016-12-02 09:03:00-05:00,PFE,neutral
1001602.0,Guggenheim Initiates Coverage On Pfizer at Neutral,2016-12-02 07:18:00-05:00,PFE,neutral
1001603.0,"Pre-Market Prep Host Dennis Dick Tweets: Notable opening imbalances: $BAC +615K, $C +114K, $JPM +120K, $PFE +101K, $GE -143K, $PG -55K, $TWTR +35K",2016-12-01 09:22:00-05:00,PFE,negative
1001604.0,Pfizer's LYRICA Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint,2016-12-01 08:03:00-05:00,PFE,neutral
1001605.0,"IBM, Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery",2016-12-01 08:00:00-05:00,PFE,neutral
1001606.0,Pfizer Announces It Met Primary Endpoint For the Pivotal Comparative REFLECTIONS B3271002 Study for PF-05280014,2016-11-30 08:30:00-05:00,PFE,neutral
1001607.0,"Barclays Downgrades 5 Biopharma Stocks, Upgrades Pfizer And Alexion",2016-11-29 10:39:00-05:00,PFE,neutral
1001608.0,Benzinga's Top Upgrades,2016-11-29 08:49:00-05:00,PFE,positive
1001609.0,FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review,2016-11-29 08:18:00-05:00,PFE,positive
1001610.0,Barclays Upgrades Pfizer to Overweight,2016-11-29 05:56:00-05:00,PFE,negative
1001611.0,Can You Guess This Chart?,2016-11-23 07:36:00-05:00,PFE,neutral
1001612.0,Stop The Presses: Xanax Sales Tend To Pick Up During The Holiday Season,2016-11-22 14:25:00-05:00,PFE,positive
1001613.0,"QuintilesIMS Forms New Collaboration with Bristol-Myers Squibb, Lilly, Merck KGaA, Darmstadt, Germany, and Pfizer to Generate Real World Insights On Usage of Anti-Cancer Therapies Across Europe",2016-11-22 08:04:00-05:00,PFE,neutral
1001614.0,President-Elect Trump and Your Portfolio,2016-11-21 16:20:00-05:00,PFE,neutral
1001615.0,"Pre-Market Prep Host Dennis Dick Tweets: Notable opening imbalances: $BABA +175K, $TWTR -90K, $BAC -236K, $MS -175K, $SQ -182K, $KR -109K, $PFE +109K",2016-11-17 09:25:00-05:00,PFE,negative
1001616.0,PALOMA-2 Phase 3 Study Published In The New England Journal Of Medicine Demonstrates Clinical Benefit Of Pfizer's IBRANCE,2016-11-16 17:11:00-05:00,PFE,positive
1001617.0,"UPDATE: Pfizer Says OPAL Broaden, OPAL Beyond Met Primary Efficacy Endpoints Showing Statistically Significant Improvement with Tofacitinib 5 mg, 10 mg Twice Daily vs Placebo",2016-11-15 08:03:00-05:00,PFE,positive
1001618.0,Pfizer Reports Results from Phase 3 OPAL Development Program Investigating XELJANZ for Psoriatic Arthritis,2016-11-15 08:02:00-05:00,PFE,neutral
1001619.0,"13F from Paulson & Co. Shows Increased Stake in Loxo Oncology, New Stake in Monster Worldwide, Steris, Talend, Tobira Therapeutics, Reduced Stakes in Pfizer, Puma Biotech, Synergy Pharma, Vanda, Liquidated Stake in Rite Aid",2016-11-14 17:54:00-05:00,PFE,positive
1001620.0,"UPDATE: Pfizer Says CRADA 'assesses OX40 agonist, utomilumab and avelumab immuno-oncology assets alone and in various combinations'",2016-11-14 08:14:00-05:00,PFE,negative
1001621.0,Pfizer Reports Collaboration with National Cancer Institute for Studying of Three Immunotherapy Agents Target Multiple Cancers,2016-11-14 08:14:00-05:00,PFE,negative
1001622.0,Landmark Study Demonstrates Pfizer's Celebrex has Similar Cardiovascular Risk vs Prescription Doses of Ibuprofen and Naproxen,2016-11-13 18:01:00-05:00,PFE,negative
1001623.0,"Barron's Picks And Pans: Trump Stocks, Thermo Fisher, Discover And More",2016-11-13 14:59:00-05:00,PFE,neutral
1001624.0,2 Big Medical Marijuana Stocks Riding High Post-Election,2016-11-10 10:45:00-05:00,PFE,neutral
1001625.0,The Market In 5 Minutes: Retail Earnings Come Into Focus,2016-11-10 09:01:00-05:00,PFE,neutral
1001626.0,Wall Street's M&A Chatter From November 10,2016-11-10 06:29:00-05:00,PFE,neutral
1001627.0,Pfizer Announces IBRANCE Receives EU Approval for Treatment of Women with HR+/HER2- Metastatic Breast Cancer,2016-11-10 04:11:00-05:00,PFE,negative
1001628.0,"Pfizer Considering Sale, Spin-off of Consumer Health Unit, Including Advil, Chapstick Brands -Reuters",2016-11-09 19:27:00-05:00,PFE,neutral
1001629.0,Technical Alert: Pfizer Inc. Sharply Higher,2016-11-09 11:51:00-05:00,PFE,positive
1001630.0,Last Night's Election - A Series Of Fortunate Events For Big Pharma,2016-11-09 11:06:00-05:00,PFE,positive
1001631.0,"Pharma Stocks Up Post Election: Ariad 16%, Infinity Up 13%, Allergan, Progenics, Endo 10%, Pfizer, Regeneron 8%, AbbVie 7%, Mylan, Medicines Co. 6%, Perrigo, Merck 5%, Bristol-Myers, Eli Lilly, Sanofi, Novartis 3.5%",2016-11-09 09:41:00-05:00,PFE,neutral
1001632.0,Biotech Is Getting A Big Boost Following Clinton's Loss,2016-11-09 08:38:00-05:00,PFE,positive
1001633.0,Allergan Shares Spike ~$2 Over Last Few Mins as Hearing Unconfirmed Chatter Related to Pfizer Deal,2016-11-08 11:17:00-05:00,PFE,positive
1001634.0,"Pfizer to Present Additional Research For XELJANZ® (Tofacitinib Citrate) In Rheumatologic Diseases, Including Rheumatoid Arthritis and Psoriatic Arthritis",2016-11-07 06:47:00-05:00,PFE,neutral
1001635.0,"Palatin's Female Arousal Drug Data Impresses, Investors React Positively",2016-11-03 09:06:00-04:00,PFE,positive
1001636.0,Spark Therapeutics and Pfizer Announce Updated Data from Hemophilia B Phase 1/2 Trial Suggesting Sustained Therapeutic Levels of Factor IX Activity,2016-11-03 09:05:00-04:00,PFE,positive
1001637.0,Analysts Prescribe A Downgrade For Pfizer Stock,2016-11-02 12:24:00-04:00,PFE,neutral
1001638.0,Benzinga's Top Downgrades,2016-11-02 09:40:00-04:00,PFE,positive
1001639.0,"The Market In 5 Minutes: Alibaba, Brocade And A Game 6",2016-11-02 09:05:00-04:00,PFE,neutral
1001640.0,"A Peek Into The Markets: U.S. Stock Futures Mostly Lower Ahead of ADP Report, Fed Decision",2016-11-02 08:00:00-04:00,PFE,negative
1001641.0,"Argus Downgrades Pfizer, Inc. Common Stock to Hold",2016-11-02 07:13:00-04:00,PFE,neutral
1001642.0,"Pfizer Reports Prevenar 13 Received Approval for Use in Infants, Children in China",2016-11-02 06:50:00-04:00,PFE,positive
1001643.0,"BMO Capital Downgrades Pfizer, Inc. Common Stock to Market Perform",2016-11-02 06:05:00-04:00,PFE,neutral
1001644.0,Mid-Afternoon Market Update: Dow Falls 150 Points; Pitney Bowes Shares Down On Earnings Miss,2016-11-01 15:06:00-04:00,PFE,positive
1001645.0,18 Biggest Mid-Day Losers For Tuesday,2016-11-01 14:17:00-04:00,PFE,negative
1001646.0,Mid-Day Market Update: InspireMD Jumps Following Positive CGuard Results; Neovasc Shares Drop,2016-11-01 12:11:00-04:00,PFE,positive
1001647.0,Nerves Start To Fray Ahead Of Election As Investors Scramble For Protection,2016-11-01 11:37:00-04:00,PFE,negative
1001648.0,The Election Can't Come Soon Enough For Biotechs,2016-11-01 10:39:00-04:00,PFE,neutral
1001649.0,Mid-Morning Market Update: Markets Edge Lower; Pfizer Profit Misses Views,2016-11-01 10:24:00-04:00,PFE,negative
1001650.0,"The Market In 5 Minutes: Pfizer's Earnings, Gannett Drops Tronc Bid",2016-11-01 09:00:00-04:00,PFE,neutral
1001651.0,A Peek Into The Markets: U.S. Stock Futures Rise Following Strong Chinese Manufacturing Report,2016-11-01 07:57:00-04:00,PFE,positive
1001652.0,Investors Disappointed With Pfizer Q3 Earnings,2016-11-01 07:28:00-04:00,PFE,negative
1001653.0,"Pfizer Sees FY 2016 EPS $2.38 to $2.43 vs $2.46 Est, Revenue $52B to $53B vs $53B Est",2016-11-01 06:46:00-04:00,PFE,neutral
1001654.0,"Pfizer Q3 EPS $0.61 vs $0.62 Est, Revenue $13.05B vs $13.05B Est",2016-11-01 06:45:00-04:00,PFE,neutral
1001655.0,"Pfizer Discontinues Global Development of Bococizumab, Its Investigational PCSK9 Inhibitor",2016-11-01 06:32:00-04:00,PFE,negative
1001656.0,"Earnings Scheduled For November 1, 2016",2016-11-01 04:52:00-04:00,PFE,neutral
1001657.0,"Keep an Eye on These 10 Stocks for November 1, 2016",2016-11-01 04:27:00-04:00,PFE,neutral
1001658.0,Watch These 7 Huge Call Purchases In Tuesday Trade,2016-11-01 01:27:00-04:00,PFE,positive
1001659.0,Option Alert: PFE Dec16 34.0 Calls Sweep: 30300 @  Above Ask!  $0.18: 31k traded vs 7146 OI:  Earnings tmrrw Before Open  $31.66 Ref,2016-10-31 15:28:00-04:00,PFE,positive
1001660.0,October 2016 Sets Record For M&A At $251 Billion,2016-10-31 15:21:00-04:00,PFE,neutral
1001661.0,Technical Alert: Pfizer Falls Under $32,2016-10-31 12:12:00-04:00,PFE,positive
1001662.0,"Trick Or Treat! Will Fed, Earnings, Jobs Report Offer Candy Or A Bag Of Rocks?",2016-10-31 11:41:00-04:00,PFE,positive
1001663.0,"Merck KGaA, Pfizer IEMA Validates the Marketing Authorization Application for Avelumab for Treatment of Metastatic Merkel Cell Carcinoma",2016-10-31 04:06:00-04:00,PFE,positive
1001664.0,"Merck KGAA Said To Be Working With JP Morgan On Sale Of Biosimilar Drug Business; Watch Peers AbbVie, Pfizer, And Novartis",2016-10-28 14:31:00-04:00,PFE,positive
1001665.0,6 Big Pharma Companies Left To Report September Quarterly Figures,2016-10-25 13:45:00-04:00,PFE,neutral
1001666.0,Pfizer's Medivation Receives FDA Approval For Prostate Cancer Drug XTANDI,2016-10-21 15:52:00-04:00,PFE,negative
1001667.0,"Bain, Advent, Torrent Capital Favorites to Buy Pfizer JV in Brazil -Reuters",2016-10-21 10:12:00-04:00,PFE,positive
1001668.0,Medivation XTANDI Drug Has PDUFA Date Of Oct. 22 For Label Update With Earlier-Stage Use Data,2016-10-21 08:36:00-04:00,PFE,neutral
1001669.0,Pfizer Reports CDC Recommends Updated Guidance For Adminstering 2-3 Dose Series TRUMENBA,2016-10-19 18:04:00-04:00,PFE,positive
1001670.0,Johnson & Johnson's Robust Pipeline Supports Its Above-Average Valuation,2016-10-19 12:07:00-04:00,PFE,positive
1001671.0,Pfizer Reports Winning of Grant to Evaluate Vaccine to Protect Newborns Against Group B Streptococcus,2016-10-19 08:01:00-04:00,PFE,positive
1001672.0,Pfizer Announces The U.S. Availability Of Biosimilar INFLECTRA,2016-10-17 16:06:00-04:00,PFE,neutral
1001673.0,Pfizer to Present New Data on XELJANZ for Ulcerative Colitis at UEG Week 2016,2016-10-16 10:33:00-04:00,PFE,neutral
1001674.0,Benzinga's Top Downgrades,2016-10-13 09:20:00-04:00,PFE,positive
1001675.0,"The Market In 5 Minutes: Stumpf Leaves Wells Fargo, More Trump Allegations",2016-10-13 08:48:00-04:00,PFE,positive
1001676.0,"Jefferies Downgrades Pfizer, Inc. to Hold",2016-10-13 06:47:00-04:00,PFE,neutral
1001677.0,Theravance Biopharma's Valuation Has Gotten A Little Carried Away,2016-10-12 13:21:00-04:00,PFE,neutral
1001678.0,"Transgene Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate the Combination of TG4001 with Avelumab in HPV-Positive Head & Neck Cancer in a Phase 1/2 Study",2016-10-11 12:01:00-04:00,PFE,negative
1001679.0,Pfizer Announces First Positive Phase 3 Results in Adjuvant Setting for Renal Cell Carcinoma Show SUTENT Extended Disease Free Survival After Surgical Removal at ESMO 2016,2016-10-10 04:51:00-04:00,PFE,positive
1001680.0,Pfizer Announces Promising New Immunotherapy Combination Data With INLYTA in Advanced RCC,2016-10-09 11:26:00-04:00,PFE,positive
1001681.0,Stocks Hitting 52-Week Highs,2016-10-07 10:20:00-04:00,PFE,neutral
1001682.0,12 Biggest Mid-Day Gainers For Thursday,2016-10-06 12:55:00-04:00,PFE,neutral
1001683.0,Hearing Pfizer Will Sell Its NYC HQ by End of '16,2016-10-06 11:03:00-04:00,PFE,neutral
1001684.0,Benzinga's Volume Movers,2016-10-06 10:37:00-04:00,PFE,neutral
1001685.0,Profit-Taking In ICU Medical Following Deal With Pfizer,2016-10-06 10:16:00-04:00,PFE,neutral
1001686.0,"UPDATE: Pfizer Will Receive ~$400M in Newly-Issued Shares of ICUI, $600M in Cash from ICU Medical",2016-10-06 07:46:00-04:00,PFE,positive
1001687.0,"ICU Medical Reports Will Buy Hospira Infusion Systems Unit from Pfizer for $1B in Cash, Stock",2016-10-06 07:45:00-04:00,PFE,neutral
1001688.0,Argus Slightly Disappointed With Pfizer's Decision Not To Split The Company,2016-10-03 10:37:00-04:00,PFE,negative
1001689.0,"Pre-Market Prep Host Dennis Dick Tweets: Notable opening imbalances: $TWTR +351K, $BABA +59K, $PFE -146K, $GE -288K, $PG -155K, $VZ -53K, $CAT -52K, $XOM -90K, $CVX -56K",2016-10-03 09:23:00-04:00,PFE,negative
1001690.0,iTeos Announces Initiation of Phase 1 Clinical Trial of IDO1 inhibitor being Conducted by Pfizer,2016-09-28 04:28:00-04:00,PFE,negative
1001691.0,Markets In Monotone Mode Despite Post-Debate Rally,2016-09-27 14:12:00-04:00,PFE,neutral
1001692.0,Option Alert: PFE 9/30 33.5 Puts (Wkly) Sweep: 4999 @  ASK  $0.16: 5395 traded vs 331 OI:  Earnings 10/25  $33.79 Ref,2016-09-26 09:36:00-04:00,PFE,positive
1001693.0,"The Market In 5 Minutes: Oil, Debates And Epidiolex",2016-09-26 09:04:00-04:00,PFE,neutral
1001694.0,A Peek Into The Markets: U.S. Stock Futures Signal Lower Start On Wall Street,2016-09-26 07:50:00-04:00,PFE,negative
1001695.0,"Pfizer Decides Against Splitting Innovative And Essential Health, Will Remain One Company",2016-09-26 07:17:00-04:00,PFE,positive
1001696.0,UPDATE: Pfizer Says 2 Divisions Will Remain Separately Managed Within Single Company,2016-09-26 06:48:00-04:00,PFE,neutral
1001697.0,Pfizer Will Not Separate Into Two Publicly Traded Companies,2016-09-26 06:46:00-04:00,PFE,neutral
1001698.0,Pfizer Reports Expiration of HSR Waiting Period for Proposed Deal of Medivation,2016-09-23 08:30:00-04:00,PFE,neutral
1001699.0,The Market In 5 Minutes: No Interest Rate Hike...Yet,2016-09-22 09:04:00-04:00,PFE,positive
1001700.0,Can You Guess This Chart?,2016-09-22 07:31:00-04:00,PFE,neutral
1001701.0,More Pharma Deals In The Pipeline?,2016-09-21 09:56:00-04:00,PFE,neutral
1001702.0,"Citi Research Reevaluates Bristol-Myers, Lowers Price Target",2016-09-20 09:13:00-04:00,PFE,negative
1001703.0,3 Pharma Companies Receive Positive EU Opinions,2016-09-16 10:07:00-04:00,PFE,positive
1001704.0,"OncoImmune Announces Option and License Agreement with Pfizer Inc., Pfizer To Pay $250M Upfront and Potential Milestone Payments",2016-09-15 09:00:00-04:00,PFE,positive
1001705.0,The Market In 5 Minutes: Apple Helps Lead Stocks Higher,2016-09-15 08:58:00-04:00,PFE,positive
1001706.0,FDA Votes In Favor Of Removing Side-Effect Warning On Pfizer's Chantix,2016-09-15 08:57:00-04:00,PFE,positive
1001707.0,"UPDATE: Pfizer, Merck's VERTIS SITA2 Also Achieved 4 Secondary Endpoints",2016-09-15 08:34:00-04:00,PFE,neutral
1001708.0,"Merck, Pfizer Reports Ertugliflozin Met Primary Endpoint of A1C Reduction",2016-09-15 08:32:00-04:00,PFE,neutral
1001709.0,Can You Guess This Chart?,2016-09-15 07:22:00-04:00,PFE,neutral
1001710.0,Five of 19 Panelists on FDA Panel Vote In Favor of Keeping Current Boxed Warning on Pfizer's Chantix,2016-09-14 16:24:00-04:00,PFE,positive
1001711.0,10 of 19 Panelists on FDA Panel Have Voted In Favor of Removing Boxed Warning of Serious Neuropsychatric Side Effects from Pfizer's Chantix,2016-09-14 16:24:00-04:00,PFE,neutral
1001712.0,Four of 19 Panelists on FDA Panel In Favor of Modifying Language of Boxed Warning on Pfizer's Chantix,2016-09-14 16:23:00-04:00,PFE,positive
1001713.0,Circle Pharma Enters into an Agreement with Pfizer to Build Screening Library of Macrocyclic Peptides,2016-09-12 08:00:00-04:00,PFE,positive
1001714.0,"Reads For The Weed-Kend: Marijuana Roadside Testing, Pregnancy And Depression",2016-09-11 17:09:00-04:00,PFE,negative
1001715.0,Another Election Year View On Healthcare ETFs,2016-09-08 11:12:00-04:00,PFE,neutral
1001716.0,Pfizer Names Dr. Ole Isacson Chief Scientific Officer,2016-09-07 08:03:00-04:00,PFE,neutral
1001717.0,Retail Investors Loved Beat Up Stocks In August,2016-09-06 16:05:00-04:00,PFE,positive
1001718.0,Investor Movement Index (IMX) for August 2016,2016-09-06 15:33:00-04:00,PFE,neutral
1001719.0,"Out With The Old, In With The New: State Agencies Seem To Prefer Marijuana Over Opioids",2016-09-06 10:26:00-04:00,PFE,neutral
1001720.0,"Pfizer Gets European Approval For XALKORI, A Cell Lung Cancer Treatment",2016-08-31 08:10:00-04:00,PFE,negative
1001721.0,Pfizer Gets European Approval For XALKORI For Non-Small Cell Lung Cancer,2016-08-31 07:02:00-04:00,PFE,negative
1001722.0,Gemphire Therapeutics' Oral Cholesterol Drug Could Have $2.8 Billion Potential In U.S. Market,2016-08-30 13:23:00-04:00,PFE,neutral
1001723.0,"Janney Initiates Galapagos At Buy, Sees Fair Value Of Shares At $64",2016-08-30 12:16:00-04:00,PFE,positive
1001724.0,"In Wake Of Medivation Deal, Argus Thinks Pfizer's Existing Business Is Underrated",2016-08-29 11:21:00-04:00,PFE,neutral
1001725.0,Novogen Names Gordon Hirsch as Chief Medical Officer,2016-08-29 07:05:00-04:00,PFE,neutral
1001726.0,Here Are All The Big Biotech Mergers In 2016,2016-08-27 18:36:00-04:00,PFE,neutral
1001727.0,Pfizer's $1.5 Billion Antibiotics Buy: Strategic Long-Term Planning Or Pre-Split Prep?,2016-08-24 14:42:00-04:00,PFE,neutral
1001728.0,Risk Arbitrage Trading Strategies,2016-08-24 10:56:00-04:00,PFE,negative
1001729.0,Write A Prescription For More Pharma M&A With This ETF,2016-08-24 10:00:00-04:00,PFE,neutral
1001730.0,The Market In 5 Minutes: Stocks Trading Higher As Earnings Season Quiets Down,2016-08-24 09:07:00-04:00,PFE,neutral
1001731.0,Pfizer to Acquire Small Molecule Anti-Infective Business from AstraZeneca for Up to $1.575B,2016-08-24 04:19:00-04:00,PFE,neutral
1001732.0,Pfizer Has Had A Busy M&A Year...Or Has It?,2016-08-23 08:58:00-04:00,PFE,neutral
1001733.0,"Pfizer, Target, JC Penney: Fast Money Picks For August 23",2016-08-23 06:52:00-04:00,PFE,neutral
1001734.0,"Benzinga's M&A Chatter for Monday August 22, 2016",2016-08-22 18:36:00-04:00,PFE,neutral
1001735.0,Monday's Market Wrap: Stocks Closed Mixed In Quiet Trade,2016-08-22 16:28:00-04:00,PFE,neutral
1001736.0,Mid-Afternoon Market Update: CIFC Rises Following Acquisition News; Marathon Oil Shares Slide,2016-08-22 15:02:00-04:00,PFE,positive
1001737.0,10 Biggest Mid-Day Gainers For Monday,2016-08-22 13:24:00-04:00,PFE,neutral
1001738.0,Mid-Day Market Update: Crude Oil Down 2.8%; Intersil Shares Spike Higher,2016-08-22 12:45:00-04:00,PFE,negative
1001739.0,Benzinga's Volume Movers,2016-08-22 11:22:00-04:00,PFE,neutral
1001740.0,Mid-Morning Market Update: Markets Mostly Lower; Pfizer To Buy Medivation For $14 Billion,2016-08-22 10:22:00-04:00,PFE,negative
1001741.0,Technical Alert: Pfizer Holds Support After Takeover Of Medivation Inc.,2016-08-22 10:22:00-04:00,PFE,positive
1001742.0,The Market In 5 Minutes: Indexes Remain In Tight Range As Rio Olympics Come To An End,2016-08-22 09:03:00-04:00,PFE,neutral
1001743.0,5-Month Timeline: A Look Back At Medivation's Takeover Story,2016-08-22 08:46:00-04:00,PFE,neutral
1001744.0,Goldman Sachs Talks Pfizer's Acquisition Deal Of Medivation,2016-08-22 08:17:00-04:00,PFE,neutral
1001745.0,8 Stocks Moving In Monday's Pre-Market Session,2016-08-22 08:13:00-04:00,PFE,neutral
1001746.0,Pfizer Has Emerged The Victor In The Buyout Battle For Medivation,2016-08-22 08:09:00-04:00,PFE,negative
1001747.0,A Peek Into The Markets: U.S. Stock Futures Down; Crude Oil Drops 2.7%,2016-08-22 07:51:00-04:00,PFE,negative
1001748.0,"Pfizer Buys Medivation For $14 Billion, Accelerating Its Pathway To Be A Leader In Oncology",2016-08-22 07:29:00-04:00,PFE,neutral
1001749.0,Pfizer To Acquire Medivation For $81.50/Share Cash,2016-08-22 06:45:00-04:00,PFE,neutral
1001750.0,"Must Watch Stocks for August 22, 2016",2016-08-22 05:05:00-04:00,PFE,neutral
1001751.0,Medivation +20% Premarket @$81; FT Reported on Sunday Pfizer to Offer ~$80/Share,2016-08-22 04:22:00-04:00,PFE,neutral
1001752.0,Benzinga's Weekend M&A Chatter,2016-08-21 20:59:00-04:00,PFE,neutral
1001753.0,Pfizer to Pay ~$80/Share For Medivation -Reuters,2016-08-21 18:27:00-04:00,PFE,negative
1001754.0,Deutsche Takes A Look At Johnson & Johnson's Patent Woes,2016-08-18 14:53:00-04:00,PFE,negative
1001755.0,Recent Patent Ruling A Positive For Pfizer,2016-08-18 14:26:00-04:00,PFE,positive
1001756.0,"UPDATE: Reuters Says Merck, Sanofi, Pfizer, Gilead, Celgene Have Each Submitted Expressions of Interest for Medivation",2016-08-17 12:55:00-04:00,PFE,positive
1001757.0,The Least Popular Stocks This 13F Season,2016-08-16 12:08:00-04:00,PFE,negative
1001758.0,ViiV Healthcare Launches Phase III Program Evaluating Two-drug Regimen Combining Dolutegravir and Lamivudine for HIV-1 Treatment - PRN,2016-08-16 08:59:00-04:00,PFE,neutral
1001759.0,"13F from Paulson & Co. Shows Reduced AIG, Pfizer, T-Mobile Stakes",2016-08-15 17:27:00-04:00,PFE,neutral
1001760.0,13F from Corvex Shows Liquidated ~17.5M Share Stake in Pfizer,2016-08-15 16:40:00-04:00,PFE,positive
1001761.0,13F from Elliott Shows Liquidated Nearly 4M Share Stake in Pfizer,2016-08-15 16:19:00-04:00,PFE,positive
1001762.0,GlycoMimetics Initiated At Outperform By Cowen And Company,2016-08-15 12:01:00-04:00,PFE,neutral
1001763.0,Jana Partners Dissolves Stake In Pfizer,2016-08-15 09:52:00-04:00,PFE,neutral
1001764.0,"Appaloosa 13F Shows Dissolved Stake In Delta Air Lines, Valeant, Tenet Healthcare, United Rentals, Pfizer, Facebook, Bank Of America",2016-08-12 16:24:00-04:00,PFE,positive
1001765.0,"13F from David Tepper's Appaloosa Shows Liquidated Position in Facebook, Pfizer, United Rentals",2016-08-12 16:15:00-04:00,PFE,positive
1001766.0,Biogen Cancels Out Of Citigroup Conference Following Weeks Of Rumors,2016-08-11 15:02:00-04:00,PFE,negative
1001767.0,"UPDATE: Pfizer, Sanofi, German Bidder Said to be Competing for Medivation",2016-08-11 10:18:00-04:00,PFE,neutral
1001768.0,Canada's Plan To Fight Opioid Addiction Might Hurt Its Weakest Patients,2016-08-08 16:59:00-04:00,PFE,negative
1001769.0,"Biogen Shares Unaffected Amid Dealreporter Report Suggesting Pfizer, J&J Could Also Be Looking at Co.",2016-08-08 11:28:00-04:00,PFE,positive
1001770.0,Pfizer Reports Publication of New Analysis Demonstrating Long-Term Therapy with VYNDAQEL Slowed Progression of Rare Neurodegenerative Disease,2016-08-08 08:11:00-04:00,PFE,neutral
1001771.0,Terms Of The Trade: Dogs Of The Dow Investing Strategy,2016-08-03 14:38:00-04:00,PFE,neutral
1001772.0,Mid-Afternoon Market Update: Crude Oil Down 1.5%; RetailMeNot Shares Gain On Strong Results,2016-08-02 14:31:00-04:00,PFE,positive
1001773.0,"Following Pfizer's Q2 Results, Citi Says Investors Remain Focused On Potential Breakup",2016-08-02 14:26:00-04:00,PFE,positive
1001774.0,Mid-Day Market Update: Dow Drops Over 100 Points; Avon Shares Surge Following Earnings Beat,2016-08-02 12:14:00-04:00,PFE,positive
1001775.0,Hearing Evercore ISI Analyst Suggesting Medicines Co. Overhang May Have Been Removed as Pfizer Exec on Earnings Call Disclosed Co.'s PCSK9 Being Shelved,2016-08-02 11:20:00-04:00,PFE,neutral
1001776.0,"Barclay Reviews Pfizer's Second Quarter, Maintains $34 Target",2016-08-02 10:39:00-04:00,PFE,neutral
1001777.0,Pfizer Says Plans to Decide by End of Year on Potential Company Split,2016-08-02 10:16:00-04:00,PFE,neutral
1001778.0,Mid-Morning Market Update: Markets Open Lower; Pfizer Tops Q2 Views,2016-08-02 09:58:00-04:00,PFE,positive
1001779.0,The Market In 5 Minutes: Futures Trending Lower For Seventh Session In A Row,2016-08-02 09:19:00-04:00,PFE,negative
1001780.0,It's Normal For Pfizer To Trade Down After Beating Estimates,2016-08-02 09:08:00-04:00,PFE,negative
1001781.0,"Pfizer Q2 EPS $0.64 vs $0.62 est, Revenue $13.1B vs $13.0B est",2016-08-02 06:46:00-04:00,PFE,neutral
1001782.0,12 Stocks You Should Be Watching Today,2016-08-02 05:00:00-04:00,PFE,neutral
1001783.0,"Earnings Scheduled For August 2, 2016",2016-08-02 04:03:00-04:00,PFE,neutral
1001784.0,"How Can Pfizer's Drugs, Trials, And Acquisitions Grow Sales?",2016-08-01 10:54:00-04:00,PFE,neutral
1001785.0,"After GDP Surprise, Market Looks Ahead to More Earnings, July Jobs Report",2016-08-01 10:16:00-04:00,PFE,positive
1001786.0,Pfizer Acquires Bamboo Therapeutics For $150M Upfront And Potential Milestones Of $495M,2016-08-01 10:00:00-04:00,PFE,neutral
1001787.0,Pfizer Reports Top-Line Results from Phase 3 Maintenance Trial of Oral XELJANZ in UC,2016-07-28 17:09:00-04:00,PFE,neutral
1001788.0,Pfizer And Western Oncolytics Reach Immuno-Oncology Research Collaboration,2016-07-28 11:02:00-04:00,PFE,neutral
1001789.0,Pfizer Reports Deal with Western Oncolytics for Research Collaboration Related to Investigation of Novel Oncolytic Virus Technology,2016-07-28 10:02:00-04:00,PFE,positive
1001790.0,18 Biggest Mid-Day Gainers For Wednesday,2016-07-27 12:10:00-04:00,PFE,neutral
1001791.0,Option Alert: PFE Aug16 37.0 Puts Sweep: 3255 @  ASK  $0.86: 3255 traded vs 1906 OI:  Earnings 8/2 Before Open  $36.73 Ref,2016-07-27 10:13:00-04:00,PFE,positive
1001792.0,18 Stocks Moving In Wednesday's Pre-Market Session,2016-07-27 08:33:00-04:00,PFE,neutral
1001793.0,BIND Therapeutics Says Pfizer's $40M Bid is 'Highest and Best' in 363 Auction,2016-07-26 17:28:00-04:00,PFE,positive
1001794.0,"Teva, Mylan Said to have Interest in Pfizer's 40% Interest in Brazil JV -Reuters",2016-07-26 09:39:00-04:00,PFE,positive
1001795.0,"Spark Therapeutics, Pfizer Announce Updated Data from First Cohort in Hemophilia B Phase 1/2 Trial Demonstrating Consistent, Sustained Therapeutic Levels of Factor IX Activity",2016-07-25 08:30:00-04:00,PFE,positive
1001796.0,The Market In 5 Minutes: The Dow's Win Streak Comes To An End,2016-07-22 08:55:00-04:00,PFE,positive
1001797.0,"Benzinga's M&A Chatter for Thursday July 21, 2016:",2016-07-21 16:46:00-04:00,PFE,neutral
1001798.0,Medivation Spikes to High of $63.23 on Pfizer Takeover Rumor,2016-07-21 10:55:00-04:00,PFE,neutral
1001799.0,Traders Attributing Spike Higher in Medivation to Unconfirmed Chatter of Rival Bid from Pfizer,2016-07-21 10:48:00-04:00,PFE,negative
1001800.0,"Opioid Addiction: What To Do When A Loved One Is Hooked, According To Science",2016-07-21 08:40:00-04:00,PFE,positive
1001801.0,"Spark Therapeutics, Pfizer Announce Receipt of FDA Breakthrough Therapy Designation for SPK-9001 for the Treatment of Hemophilia B",2016-07-21 07:34:00-04:00,PFE,positive
1001802.0,Here Are The 14 Stocks Morgan Stanley Wants You To Focus On During Q2 Earnings,2016-07-19 08:30:00-04:00,PFE,neutral
1001803.0,Pfizer Reports Received WHO Prequalification for Multi-Dose Vial Presentation of Prevenar 13,2016-07-19 08:04:00-04:00,PFE,neutral
1001804.0,"Pfizer Reports Results from Two Pivotal Phase 3 Studies of Crisaborole Ointment: Achieved Statistically Significance on Primary, Secondary Endpoints",2016-07-13 08:06:00-04:00,PFE,positive
1001805.0,"Allergan, Teva Pharmaceutical Industries Entered into Amendment, Dated July 11, 2016 to Master Purchase Agreement; Amendment Reduced Cash Consideration to Be Paid By $221M;  Actonel; Carafate Added to List of Excluded Products -8K",2016-07-13 06:57:00-04:00,PFE,positive
1001806.0,Watch These 7 Huge Put Purchases In Wednesday Trade,2016-07-13 03:35:00-04:00,PFE,positive
1001807.0,Pfizer Reports Received FDA Approval for Prevnar 13 in Adults 18-49,2016-07-12 16:05:00-04:00,PFE,positive
1001808.0,Option Alert: PFE Jun17 30.0 Puts: 2500 @  ASK  $0.97: 2533 traded vs 928 OI:  Earnings 8/2 Before Open  $36.08 Ref,2016-07-12 11:10:00-04:00,PFE,positive
1001809.0,Pfizer's Phase 3 S-TRAC Trial Of SUTENT Meets Primary Endpoint,2016-07-08 10:34:00-04:00,PFE,neutral
1001810.0,Pfizer Reports Positive Top-Line Results From Phase 3 S-TRAC Trial of SUTENTas Adjuvant Therapy in Patients at High Risk of Recurrent Renal Cell Carcinoma,2016-07-08 08:00:00-04:00,PFE,positive
1001811.0,Medivation Bidders Will Have To Price In Talazoparib; BMO Sees $68-$76 Takeout Price,2016-07-07 15:33:00-04:00,PFE,neutral
1001812.0,Credit Suisse Says Medivation Market Value Is Approaching Its Target,2016-07-07 08:11:00-04:00,PFE,positive
1001813.0,Pfizer And Merck Germany Initiate Phase III Study To Assess Avelumab As First-line Treatment For Ovarian Cancer,2016-07-06 09:03:00-04:00,PFE,negative
1001814.0,"Merck, Pfizer Report Initiation of Phase III Trial to Evaluate Avelumab as First-Line Treatment for Ovarian Cancer",2016-07-06 08:01:00-04:00,PFE,negative
1001815.0,"Hearing Pfizer, Celgene Signed Medivation Confidentiality Deals",2016-07-05 17:45:00-04:00,PFE,neutral
1001816.0,8 Biggest Mid-Day Gainers For Tuesday,2016-07-05 13:13:00-04:00,PFE,neutral
1001817.0,12 Stocks Moving In Tuesday's Pre-Market Session,2016-07-05 08:21:00-04:00,PFE,neutral
1001818.0,Fast Money Traders Share Their Biotech Picks,2016-07-01 08:10:00-04:00,PFE,positive
1001819.0,Guggenheim Introduces Equal-Weight S&P 100 ETF,2016-06-30 15:01:00-04:00,PFE,neutral
1001820.0,Pfizer Announces Two Phase 3 Bococizumab Trials Met Primary Endpoints,2016-06-28 08:34:00-04:00,PFE,neutral
1001821.0,Pfizer ro Invest $350M in Global Biotechnology Center in China,2016-06-28 04:07:00-04:00,PFE,neutral
1001822.0,Could Chili Peppers Be The Answer To Opioid-Reliance For Chronic Pain?,2016-06-27 13:50:00-04:00,PFE,negative
1001823.0,Chinese Expats Revolutionizing China's Homegrown Biopharma Sector,2016-06-27 09:41:00-04:00,PFE,neutral
1001824.0,Pfizer Completes Anacor Acquisition,2016-06-24 13:21:00-04:00,PFE,neutral
1001825.0,The Pros And Cons Of Pfizer Separating GEP,2016-06-20 14:25:00-04:00,PFE,neutral
1001826.0,"Jefferies Maintains Buy on Pfizer, Lowers PT to $40.00",2016-06-20 08:37:00-04:00,PFE,negative
1001827.0,Merck KGAA to Apply for Marketing Authorization for Avelumab Against Merkel Cell Carcinoma in H2 2016,2016-06-20 06:29:00-04:00,PFE,neutral
1001828.0,Jefferies Shares Pharma Stock Catalyst Outlook,2016-06-14 16:33:00-04:00,PFE,positive
1001829.0,5 Pharmaceutical Price Target Raises From Jefferies,2016-06-14 15:13:00-04:00,PFE,neutral
1001830.0,February 27 Earnings Update,2016-06-14 11:28:00-04:00,PFE,neutral
1001831.0,Shire Will License PF-00547659 from Pfizer,2016-06-14 07:02:00-04:00,PFE,neutral
1001832.0,"Has Cancer Research Become Cancerous? Same Cancer Strategy Targeted By 'Too Many Drugmakers,' Say Regulators",2016-06-13 09:37:00-04:00,PFE,negative
1001833.0,"Spark Therapeutics Announces Updated Data from First Cohort in Hemophilia B Phase 1/2 Trial Demonstrating Consistent, Sustained Therapeutic Levels of Factor IX Activity",2016-06-13 07:15:00-04:00,PFE,positive
1001834.0,Pfizer Announces INO-VATE ALL Study Met One Primary Endpoint; Did Not Meet Second,2016-06-12 08:54:00-04:00,PFE,neutral
1001835.0,"Merck, Pfizer Announce Two Pivotal Phase 3 Studies for Ertugliflozin Met Primary Endpoints, Showing Significant A1C Reductions in Patients with Type 2 Diabetes at the American Diabetes Association's 76th Scientific Sessions",2016-06-12 08:29:00-04:00,PFE,positive
1001836.0,A Peek Into The Markets: U.S. Stock Futures Slide Ahead Of Consumer Sentiment Report,2016-06-10 07:54:00-04:00,PFE,neutral
1001837.0,ICON Reveals Service Deal With Pfizer,2016-06-10 07:17:00-04:00,PFE,neutral
1001838.0,"ICON Reports Service Deal with Pfizer, No Terms Disclosed",2016-06-10 06:02:00-04:00,PFE,negative
1001839.0,PAREXEL Announces Master Services Agreement with Pfizer,2016-06-10 04:18:00-04:00,PFE,positive
1001840.0,Takeover Talk A Help To Wide-Moat ETFs,2016-06-09 09:21:00-04:00,PFE,positive
1001841.0,UPDATE: FDA Panels Votes Saying Pfizer Troxyca ER Should Not Be Labeled 'Abuse-Deterrent' by oral Route Of Abuse,2016-06-08 15:32:00-04:00,PFE,negative
1001842.0,Pfizer To Present 23 Abstracts At European League Against Rheumatism Congress,2016-06-08 08:03:00-04:00,PFE,neutral
1001843.0,Pfizer Research Data For Tofacitinib Citrate  Providing Clinicians With Additional Information For The Treatment Of Moderate to Severe RA,2016-06-08 07:02:00-04:00,PFE,negative
1001844.0,Pfizer Reports Results from Second Phase 3 Trial of Oral XELJANZ in Adults with Psoriatic Arthritis: Met Primary Efficacy Endpoints,2016-06-07 07:02:00-04:00,PFE,neutral
1001845.0,4 Key Takeaways From ASCO,2016-06-06 17:32:00-04:00,PFE,neutral
1001846.0,Pfizers Reports 7.1% Stake In Merus,2016-06-06 16:59:00-04:00,PFE,neutral
1001847.0,Pfizer Reports 7.1% Passive Stake in Merus in 13G,2016-06-06 16:59:00-04:00,PFE,positive
1001848.0,"Merck, Pfizer Offers Results from Pivotal Avelumab Study",2016-06-06 09:09:00-04:00,PFE,neutral
1001849.0,"Pfizer Offers Data from Next-Gen ALK/ROS1 Inhibitor Trial, Results Presented at Oral Abstract at ASCO",2016-06-06 08:04:00-04:00,PFE,negative
1001850.0,How Trade Imbalances Affect Stock Prices,2016-06-04 15:06:00-04:00,PFE,neutral
1001851.0,Pfizer Presents Data from Phase 1b Trial Investigating Utomilumab (a 4-1BB agonist) in Combination with a Checkpoint Inhibitor at #ASCO16,2016-06-04 09:40:00-04:00,PFE,negative
1001852.0,"Ouch! Jobs Report Miss Sends Rate Hike Odds Down, Raises Questions",2016-06-03 13:49:00-04:00,PFE,negative
1001853.0,Cantor Fitzgerald Sees 81% Upside In Spark Therapeutics; Initiating with A Buy,2016-06-03 09:18:00-04:00,PFE,positive
1001854.0,BioRap Technologies to Enter Strategic Collaboration With Pfizer Inc. to Research and Develop Novel Immunomodulators,2016-05-31 09:04:00-04:00,PFE,positive
1001855.0,"Anacor Says Citi Reps Conveyed That Company Board Was Not Prepared To Accept May 6th Pfizer Proposal Because Company Received Third Party Offer; Pfizer Then Proposed ""Best And Final"" Offer Of $99.25/Share Cash May 16th",2016-05-26 14:20:00-04:00,PFE,positive
1001856.0,UPDATE: Filing Out Regarding Pfizer Tender Offer,2016-05-26 14:02:00-04:00,PFE,neutral
1001857.0,JPMorgan: Monsanto Shares Could Hit $180 Over The Next 5 Years,2016-05-24 15:32:00-04:00,PFE,positive
1001858.0,Pfizer Updates CHAMPIX To Add New Safety And Efficacy Data In European Union,2016-05-23 08:41:00-04:00,PFE,positive
1001859.0,Pfizer Reports EU Label For CHAMPIX Updated,2016-05-23 07:03:00-04:00,PFE,neutral
1001860.0,Pfizer Gets European Regulator Acceptance For Review Of Marketing For TRUMENBA,2016-05-20 09:03:00-04:00,PFE,positive
1001861.0,Pfizer Announces European Medicines Agency Acceptance For Review Of Marketing Authorization Of Trumenba,2016-05-20 08:01:00-04:00,PFE,positive
1001862.0,JPMorgan's Take On Big Pharma's New ASCO Abstracts,2016-05-19 11:07:00-04:00,PFE,neutral
1001863.0,Pfizer's Hospira Unveils LifeCare PCA 7.0 Infusion System,2016-05-19 11:03:00-04:00,PFE,neutral
1001864.0,Fitch Says Drug Approvals Are Driving Targeted Acquisitions In U.S. Pharma,2016-05-17 17:26:00-04:00,PFE,neutral
1001865.0,Is Avoidance Of Morally Ambiguous Or Offensive Activities Justifiable In Corporate America?,2016-05-17 16:13:00-04:00,PFE,negative
1001866.0,A Look At All Of Pfizer's Acquisitions Over The Past 2 Years,2016-05-17 11:22:00-04:00,PFE,neutral
1001867.0,Bull And Bear Takeaways From Pfizer's $5.2 Billion Deal,2016-05-17 07:26:00-04:00,PFE,neutral
1001868.0,"Benzinga's M&A Chatter for Monday May 16, 2016",2016-05-16 20:09:00-04:00,PFE,neutral
1001869.0,An ETF That Takes Investors To Dividend Growth,2016-05-16 15:53:00-04:00,PFE,positive
1001870.0,Mid-Afternoon Market Update: Dow Jumps 200 Points; Aduro Biotech Shares Drop Following Announcement of Failed Phase 2b ECLIPSE Trial,2016-05-16 14:31:00-04:00,PFE,negative
1001871.0,8 Biggest Mid-Day Market Gainers,2016-05-16 12:32:00-04:00,PFE,neutral
1001872.0,Mid-Day Market Update: Nanosphere Jumps Following Luminex Deal; Breitburn Energy Partners Shares Drop,2016-05-16 12:06:00-04:00,PFE,positive
1001873.0,Benzinga's Volume Movers,2016-05-16 10:40:00-04:00,PFE,neutral
1001874.0,Omega Advisors Liquidates 1.29M Share Position In Pfizer,2016-05-16 10:28:00-04:00,PFE,positive
1001875.0,Mid-Morning Market Update: Markets Open Higehr; Pfizer To Acquire Anacor Pharmaceuticals For $5.2B,2016-05-16 10:08:00-04:00,PFE,neutral
1001876.0,The Market In 5 Minutes: Need A Hand?,2016-05-16 09:48:00-04:00,PFE,positive
1001877.0,10 Stocks Moving In Monday's Pre-Market Session,2016-05-16 08:24:00-04:00,PFE,neutral
1001878.0,"Merger Monday: 6 Deals, Rumors And Bids You Might Have Missed",2016-05-16 08:13:00-04:00,PFE,negative
1001879.0,Pfizer To Buy Anacor For $5.2 Billion,2016-05-16 07:34:00-04:00,PFE,neutral
1001880.0,Pfizer Acquisition of Anacor Valued at $5.2B,2016-05-16 06:47:00-04:00,PFE,positive
1001881.0,Pfizer Announces Acquisition of Anacor for $99.25/Share Cash,2016-05-16 06:46:00-04:00,PFE,neutral
1001882.0,Pfizer Blocks Drugs from Use in Lethal Injections - New York Times,2016-05-13 16:08:00-04:00,PFE,negative
1001883.0,13F Season: A Look Back At Q4 2015,2016-05-13 14:07:00-04:00,PFE,neutral
1001884.0,Pfizer's Stage 3 Results On TRUMENBA Meet All Endpoints,2016-05-13 08:15:00-04:00,PFE,neutral
1001885.0,What To Expect This 13F Season (And Which Hedge Funds To Watch),2016-05-13 06:50:00-04:00,PFE,neutral
1001886.0,Pfizer Presents Results from Two Phase 3 TRUMENBA Studies at the European Society for Paediatric Infectious Diseases Meeting,2016-05-13 06:33:00-04:00,PFE,neutral
1001887.0,"Berenberg Unimpressed With Pfizer, Initiates Coverage At Hold",2016-05-12 17:59:00-04:00,PFE,negative
1001888.0,Is This The Right Time To Do A Huge M&A Deal?,2016-05-12 13:46:00-04:00,PFE,positive
1001889.0,The Market In 5 Minutes: Nothing's Impossible,2016-05-12 09:59:00-04:00,PFE,neutral
1001890.0,Benzinga's Top Initiations,2016-05-12 09:00:00-04:00,PFE,positive
1001891.0,Pfizer Reports 8% Passive Stake in Wave Life Sciences in 13G,2016-05-12 08:58:00-04:00,PFE,positive
1001892.0,Pfizer Reports 8% Stake In Wave Life Sciences 13G Filing,2016-05-12 08:57:00-04:00,PFE,neutral
1001893.0,"Berenberg Initiates Coverage on Pfizer at Hold, Announces $38.00 PT, Expects Co To Deliver Mid-Single Digit Earnings Growth In Intermediate Term",2016-05-12 08:46:00-04:00,PFE,positive
1001894.0,"Jefferies Updates Price Targets In Global Pharma, Sees 'Rich Catalyst Environment' Ahead",2016-05-11 13:05:00-04:00,PFE,positive
1001895.0,The Market In 5 Minutes: Don't Stop Me Now,2016-05-11 09:34:00-04:00,PFE,positive
1001896.0,The Market In 5 Minutes: Better Late Than Never,2016-05-10 10:04:00-04:00,PFE,positive
1001897.0,Report: Medivation Committed To Selling Itself,2016-05-10 08:42:00-04:00,PFE,positive
1001898.0,First Dosing of Pfizer DART Candidate in Phase 1 Study Triggers Milestone Payment to MacroGenics Of $2M,2016-05-10 07:33:00-04:00,PFE,neutral
1001899.0,"Benzinga's M&A Chatter for Monday May 9, 2016",2016-05-09 20:40:00-04:00,PFE,neutral
1001900.0,Dealogic: 2016 Has Already Seen Failed U.S. Deals Worth $378 Billion,2016-05-09 15:51:00-04:00,PFE,negative
1001901.0,Allergan Rallies Ahead Of Q1 Report,2016-05-09 15:50:00-04:00,PFE,neutral
1001902.0,"Medivation Spikes to High of $62.48 on Reuters Report of NDA's With Pfizer, Amgen",2016-05-09 13:05:00-04:00,PFE,neutral
1001903.0,"Benzinga's M&A Chatter for Thursday May 5, 2016",2016-05-05 20:02:00-04:00,PFE,neutral
1001904.0,"Synergy Pharma Seen 'Weighing' Options, Sell-Side Forecasts Upside Regardless Of M&A Rumors",2016-05-05 12:29:00-04:00,PFE,neutral
1001905.0,A Pfizer Split Is 'Clearly' On The Table,2016-05-05 10:59:00-04:00,PFE,neutral
1001906.0,"WAVE Life Sciences Enters Partnership with Pfizer to Develop Genetically Targeted Therapies for the Treatment of Metabolic Diseases, Pfizer To Pay $40M Upfront With $30 As Equity Inv. In Wave At $16/Share; Potential For $871M Through Milestones",2016-05-05 07:44:00-04:00,PFE,negative
1001907.0,12 Stocks Moving In Wednesday's Pre-Market Session,2016-05-04 08:32:00-04:00,PFE,neutral
1001908.0,Pfizer Q1'16 Earnings Conference Call: Full Transcript,2016-05-03 19:08:00-04:00,PFE,neutral
1001909.0,"Benzinga's M&A Chatter for Tuesday May 3, 2016",2016-05-03 18:52:00-04:00,PFE,neutral
1001910.0,Pfizer has Approached Medivation Regarding Potential Acquisition -Reuters,2016-05-03 18:01:00-04:00,PFE,neutral
1001911.0,Hearing Pfizer Has Approached Medivation,2016-05-03 18:01:00-04:00,PFE,neutral
1001912.0,Pfizer Rallies Off Q1 Report,2016-05-03 15:07:00-04:00,PFE,neutral
1001913.0,Mid-Afternoon Market Update: On Deck Capital Drops Following Earnings Miss; Symmetry Surgical Shares Spike Higher,2016-05-03 14:31:00-04:00,PFE,positive
1001914.0,The Next Sector Rotation Will Be To Biotechs,2016-05-03 12:17:00-04:00,PFE,neutral
1001915.0,Mid-Day Market Update: Dow Falls 1%; Cognex Shares Gain Following Earnings Beat,2016-05-03 12:08:00-04:00,PFE,positive
1001916.0,"From Pfizer Q1 Earnings Conference Call: If Co. Decides to Split Up Co. This Year, Could Sell or Spin Off Its Established Products Unit by End of Next Year",2016-05-03 10:51:00-04:00,PFE,neutral
1001917.0,Mid-Morning Market Update: Markets Open Lower; Pfizer Beats Q1 Expectations,2016-05-03 09:55:00-04:00,PFE,negative
1001918.0,The Market In 5 Minutes: Do Or Die,2016-05-03 09:44:00-04:00,PFE,negative
1001919.0,12 Stocks Moving In Tuesday's Pre-Market Session,2016-05-03 08:25:00-04:00,PFE,neutral
1001920.0,"Pfizer Delivers Strong Q1 Numbers Helped By Hospira Acquisition, Boosts Guidance",2016-05-03 07:26:00-04:00,PFE,positive
1001921.0,"Pfizer Raises FY 2016 Guidance; Sees EPS $2.38 to $2.48 vs $2.29 est, Revenue $51.0B to $53.0B vs $51.2B est",2016-05-03 06:48:00-04:00,PFE,neutral
1001922.0,"Pfizer Q1 EPS $0.67 vs $0.55 est, Revenue $13.0B vs $12.0B est",2016-05-03 06:47:00-04:00,PFE,neutral
1001923.0,"Keep an Eye on These 12 Stocks for May 3, 2016",2016-05-03 04:38:00-04:00,PFE,neutral
1001924.0,"Earnings Scheduled For May 3, 2016",2016-05-03 04:02:00-04:00,PFE,neutral
1001925.0,GeoInvesting Says Anavex Life Sciences' Stock Has A Book Value Of Just $0.36,2016-05-02 12:25:00-04:00,PFE,positive
1001926.0,Earnings: Drug Makers Merck And Pfizer Report Q1 Results,2016-05-02 10:58:00-04:00,PFE,neutral
1001927.0,"The Market In 5 Minutes: May, She Will Stay",2016-05-02 09:49:00-04:00,PFE,neutral
1001928.0,Benzinga's Weekend M&A Chatter,2016-05-01 20:36:00-04:00,PFE,neutral
1001929.0,Merck And Pfizer Earnings: Will They Beat Expectations Again?,2016-05-01 11:25:00-04:00,PFE,neutral
1001930.0,$45 Billion Thursday For M&A Shows There Are Still Plenty Of Buyers Out There,2016-04-29 16:14:00-04:00,PFE,neutral
1001931.0,Pfizer Spokesperson Declines Comment Following Bloomberg Report Co. is One of Several Cos. Working with Advisors for Possible Medivation Bid,2016-04-29 13:42:00-04:00,PFE,neutral
1001932.0,"Hearing Medivation Seeking Bids of At Least $65/Share, AstraZeneca, Pfizer Mentioned as Weigh Bids",2016-04-29 12:32:00-04:00,PFE,neutral
1001933.0,"Pfizer Shares Also Spiked Slightly Higher with Medivation, Novartis Moves",2016-04-29 12:31:00-04:00,PFE,positive
1001934.0,"Hearing DoJ Has Said Wyeth, Pfizer Have Agreed to Pay $784.6M to Resolve Suit Which Alleges Underpayment of Drug Rebates",2016-04-27 10:37:00-04:00,PFE,positive
1001935.0,Pfizer Reports SPIRE-2 CV Outcome Study for Bococizumab Full Enrolled,2016-04-26 08:31:00-04:00,PFE,neutral
1001936.0,Pharma Names Under Pressure Amid Perrigo Warning,2016-04-25 13:53:00-04:00,PFE,negative
1001937.0,The Largest M&A Spreads On The Market,2016-04-25 13:11:00-04:00,PFE,neutral
1001938.0,Pfizer Partners With Rexall On OneStopMeds Service,2016-04-20 10:04:00-04:00,PFE,neutral
1001939.0,"Notable Imbalances: Coca-Cola, Oil Stocks Under Pressure",2016-04-20 09:56:00-04:00,PFE,negative
1001940.0,Teva Strength Attributed By Traders To Comments Making Rounds Regarding Possible Pfizer Interest,2016-04-19 11:41:00-04:00,PFE,positive
1001941.0,Pfizer Reveals Positive Results Of Phase 3 PALOMA-2 Clinical Trial Of IBRANCE,2016-04-19 10:14:00-04:00,PFE,positive
1001942.0,Pfizer Reports Phase 3 PALOMA-2 Trial Of IBRANCE Met Primary Endpoint For PFS,2016-04-19 08:09:00-04:00,PFE,neutral
1001943.0,Cramer Gives His Opinion On Starwood And Time Warner Cable,2016-04-19 06:27:00-04:00,PFE,neutral
1001944.0,Benzinga's Top Initiations,2016-04-18 09:47:00-04:00,PFE,positive
1001945.0,"The Market In 5 Minutes: Brazil, Doha, And Earnings Season",2016-04-18 09:44:00-04:00,PFE,neutral
1001946.0,Goldman Reinstates Coverage On Pfizer And Allergan Following Failed Merger,2016-04-18 08:06:00-04:00,PFE,negative
1001947.0,"Goldman Sachs Reinstates Neutral on Pfizer, Announces $35.00 PT",2016-04-18 07:05:00-04:00,PFE,neutral
1001948.0,"Barron's Picks And Pans: Ford, Intel, Sealed Air And More",2016-04-17 18:47:00-04:00,PFE,neutral
1001949.0,"Lachapelle: If Bayer Expands In Animal Healthcare, Zoetis Is Obvious Choice",2016-04-15 13:05:00-04:00,PFE,positive
1001950.0,Favus Gives 10 Reasons To Sell Allergan,2016-04-13 11:06:00-04:00,PFE,neutral
1001951.0,"Notable Imbalances Before Wednesday's Open: Investors Bullish On Financials, Selling Gold Stocks",2016-04-13 09:21:00-04:00,PFE,neutral
1001952.0,"U.S. Appeals Court Revives Shareholder Lawsuit vs Pfizer Regarding Alleged Misrepresentations Concerning Celebrex, Bextra Safety -Reuters",2016-04-12 10:39:00-04:00,PFE,positive
1001953.0,"Benzinga's M&A Chatter for Monday April 11, 2016",2016-04-11 20:38:00-04:00,PFE,neutral
1001954.0,The 10 Least Likely M&A Deals To Go Through,2016-04-11 10:06:00-04:00,PFE,neutral
1001955.0,"Friday's After-Hours Movers: Energy, Pharmaceuticals Active",2016-04-08 16:41:00-04:00,PFE,positive
1001956.0,How One Analyst Is Playing The Biotech Rebound This Week,2016-04-07 15:45:00-04:00,PFE,positive
1001957.0,"Street Struggles for Direction, Looking for Catalyst As Earnings Approach",2016-04-07 14:04:00-04:00,PFE,negative
1001958.0,IBM Teams Up With Pfizer To Move Towards Parkinson's Cure,2016-04-07 13:47:00-04:00,PFE,neutral
1001959.0,White House Says Treasury Department Working on More Steps to Counter Tax Avoidance -Reuters,2016-04-07 13:25:00-04:00,PFE,negative
1001960.0,"The Market In 5 Minutes: Thursday, April 7, 2016",2016-04-07 10:36:00-04:00,PFE,neutral
1001961.0,"Pfizer's Valuation Is Attractive, And JPMorgan Wouldn't Be Surprised To See A Breakup",2016-04-07 09:52:00-04:00,PFE,positive
1001962.0,Pfizer & IBM Report Collaboration To Experiment With Treatment Decision and Clinical Trial Design In Parkinson's,2016-04-07 08:32:00-04:00,PFE,neutral
1001963.0,"Morgan Stanley Assumes Pfizer at Equal-weight, Announces $35.00 PT",2016-04-07 08:25:00-04:00,PFE,neutral
1001964.0,"JP Morgan Assumes Pfizer at Overweight, Announces $38.00 PT",2016-04-07 07:27:00-04:00,PFE,neutral
1001965.0,"Pfizer, Allergan: Fast Money Picks For April 7",2016-04-07 06:40:00-04:00,PFE,neutral
1001966.0,"JP Morgan Assumes Pfizer at Overweight, Announces $38.00 PT, Says Co Is 'well-positioned as a defensive business with healthy fundamentals'",2016-04-07 04:32:00-04:00,PFE,positive
1001967.0,"Benzinga's M&A Chatter for Wednesday April 6, 2016",2016-04-06 20:22:00-04:00,PFE,neutral
1001968.0,"After-Hours Recap: Bed Bath & Beyond, Apollo, Valeant, eBay & More",2016-04-06 18:36:00-04:00,PFE,neutral
1001969.0,6 Investment Banks Lost More Than $200 Million From Pfizer-Allergan Deal Collapse,2016-04-06 15:51:00-04:00,PFE,negative
1001970.0,New Tax Inversions Rules: Threats To Healthcare ETFs?,2016-04-06 15:33:00-04:00,PFE,negative
1001971.0,"PPH May Be Home To Hedge Fund Hotels, But This ETF Can Endure",2016-04-06 14:26:00-04:00,PFE,neutral
1001972.0,SocGen Picks New Favorites In Big Pharma,2016-04-06 13:44:00-04:00,PFE,positive
1001973.0,Mylan Is 'Comfortable Moving Forward' With Acquisition Of Sweden-Based Meda,2016-04-06 13:23:00-04:00,PFE,positive
1001974.0,Barron's: Allergan And Pfizer Still Buys Even After Deal Fell Through,2016-04-06 13:18:00-04:00,PFE,neutral
1001975.0,Pfizer Gets European Nod For Prevenar 13,2016-04-06 13:14:00-04:00,PFE,neutral
1001976.0,Investors Applaud Ending Of Pfizer-Allergan Deal,2016-04-06 12:25:00-04:00,PFE,positive
1001977.0,Is Allergan Worth Over $300 Without Pfizer?,2016-04-06 11:57:00-04:00,PFE,positive
1001978.0,Societe Generale Initiates Coverage on Pfizer at Hold,2016-04-06 11:47:00-04:00,PFE,neutral
1001979.0,What Will Fed Minutes Mean To Markets?,2016-04-06 11:39:00-04:00,PFE,neutral
1001980.0,Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13,2016-04-06 11:01:00-04:00,PFE,positive
1001981.0,Pfizer Receives FDA Approval For Cheaper Version Of Johnson & Johnson's Top Drug Remicade,2016-04-06 10:45:00-04:00,PFE,positive
1001982.0,"The Market In 5 Minutes: Wednesday, April 6, 2016",2016-04-06 10:33:00-04:00,PFE,neutral
1001983.0,Benzinga's Volume Movers,2016-04-06 10:16:00-04:00,PFE,neutral
1001984.0,10 Stocks Moving In Wednesday's Pre-Market Session,2016-04-06 08:19:00-04:00,PFE,neutral
1001985.0,Pfizer Announces Merger Termination With Allergan; Will Pay $150 Million Breakup Fee,2016-04-06 07:09:00-04:00,PFE,negative
1001986.0,Allergan Release Says Company Still Has Strong Future Following Pfizer Merger Termination,2016-04-06 06:50:00-04:00,PFE,positive
1001987.0,Pfizer to Pay Allergan $150M Breakup Fee,2016-04-06 06:46:00-04:00,PFE,negative
1001988.0,Pfizer Announces Termination of Merger with Allergan,2016-04-06 06:45:00-04:00,PFE,neutral
1001989.0,"Stocks To Watch For April 6, 2016",2016-04-06 04:29:00-04:00,PFE,neutral
1001990.0,"Benzinga's M&A Chatter for Tuesday April 5, 2016",2016-04-05 20:22:00-04:00,PFE,neutral
1001991.0,"If Pfizer Saves Allergan Deal, These Two Things Should Be Changed",2016-04-05 16:13:00-04:00,PFE,neutral
1001992.0,Report: Pfizer May Abandon Allergan Deal,2016-04-05 15:11:00-04:00,PFE,negative
1001993.0,Obama: Tax Inversions Are 'Wasteful',2016-04-05 13:50:00-04:00,PFE,neutral
1001994.0,"Hearing Pfizer is Leaning Towards Abandoning, Not Altering, Deal with Allergan",2016-04-05 13:39:00-04:00,PFE,negative
1001995.0,Pfizer Rallies Off Allergan News,2016-04-05 12:56:00-04:00,PFE,neutral
1001996.0,Evidence Pfizer Could Revisit GlaxoSmithKline Or AstraZeneca Deals If Allergan Falls Through,2016-04-05 12:30:00-04:00,PFE,neutral
1001997.0,Allergan Now Trades Cheaper Than Its Standalone Value,2016-04-05 11:07:00-04:00,PFE,positive
1001998.0,Hearing Pres Obama Will Make Statement on Tax Inversions at 12:15 p.m. EDT,2016-04-05 11:06:00-04:00,PFE,neutral
1001999.0,"The Market In 5 Minutes: Tuesday, April 5, 2016",2016-04-05 10:38:00-04:00,PFE,neutral
1002000.0,"Leerink: Treasury Notice Lowers Pfizer-Allergan Deal Chances, Ownership Test Changes A 'Surprise'",2016-04-05 08:49:00-04:00,PFE,positive
1002001.0,"Merck KGaA, Pfizer Report First Patient Treated in Phase 3 Combo Study With Avelumab and INLYTA",2016-04-05 08:02:00-04:00,PFE,neutral
1002002.0,"Pfizer, Allergan, Disney, Tesla: Fast Money Picks For April 5",2016-04-05 07:02:00-04:00,PFE,neutral
1002003.0,"Pfizer Reports Top-Line Results From Phase 3 Tofacitinib Trial, Met Primary Endpoints Of Superior Treatment To Placebo",2016-04-05 07:01:00-04:00,PFE,positive
1002004.0,"Pfizer Says Conducting Review of Treasury Action, Won't Speculate on Potential Impact -Reuters",2016-04-04 19:01:00-04:00,PFE,positive
1002005.0,Betting On The Pfizer-Allergan Merger? You Now Have A 35% Arbitrage Opportunity After New Treasury Fears,2016-04-04 18:38:00-04:00,PFE,positive
1002006.0,David Faber @davidfaber Tweet: 3 year look back provision on new inversion regs from Treasury is aimed at killing $PFE $AGN deal and may well succeed in doing just that.,2016-04-04 18:08:00-04:00,PFE,positive
1002007.0,"PFE Trading Higher After Hours, Traders Attribute As Sympathy Move To AGN Selloff Following US Trsy. Tax Inversion Limitations",2016-04-04 17:25:00-04:00,PFE,positive
1002008.0,"Allergan Shares Down From $277 To Low Of $228 After Hours On Tax Inversion Limitations By US Treasury, Now Trading At $235/Share",2016-04-04 17:25:00-04:00,PFE,positive
1002009.0,"The Stocks That Moved The S&P, Dow And Nasdaq Today",2016-04-04 16:52:00-04:00,PFE,neutral
1002010.0,Make A House Call With A Familiar Healthcare ETF,2016-04-04 08:28:00-04:00,PFE,neutral
1002011.0,Cramer Gives His Opinion On Fitbit And Allergan,2016-04-03 16:48:00-04:00,PFE,neutral
1002012.0,"The Stocks That Moved The S&P, Dow And Nasdaq Today",2016-04-01 16:43:00-04:00,PFE,neutral
1002013.0,Pfizer Offers Topline Results from Second Phase 3 Lipid-Lowering Study Evaluating Bococizumab,2016-04-01 08:00:00-04:00,PFE,neutral
1002014.0,Pfizer Releases Statement Stating A False PR was Linked To A Fake Web Site Anonymously Earlier Today and Was Erroneously Attributed To Pfizer,2016-03-31 16:30:00-04:00,PFE,negative
1002015.0,"Pfizer, Allergan Announce Received Added Info from FTC Related to Deal, Continue to Expect Deal to Close in 2H'16",2016-03-30 12:42:00-04:00,PFE,neutral
1002016.0,"The Stocks That Moved The S&P, Dow And Nasdaq Today",2016-03-28 17:38:00-04:00,PFE,neutral
1002017.0,"Biopharma Names LLY, PFE, MRK, And More Popping Higher Following Reports China FDA To Investigate Improper Vaccine Trading",2016-03-28 11:29:00-04:00,PFE,neutral
1002018.0,Pfizer Reports EMA Acceptance for Review of MAA for XELJANZ for Treatment of Moderate to Severe Rheumatoid Arthritis,2016-03-23 16:17:00-04:00,PFE,positive
1002019.0,Why Is The Allergan-Pfizer Spread Near All-Time Highs?,2016-03-21 10:25:00-04:00,PFE,neutral
1002020.0,"UPDATE: Pfizer Expects 3 Phase-3 Stidies, LT Extension Trial Will FOrm Potential Submission Package To Regulatory Authorities For UC Indication",2016-03-18 11:04:00-04:00,PFE,neutral
1002021.0,Pfizer Announces Oral Tofacitinib Meets Primary/Key Secondary Endpoints In 2 Pivotal Phase 3 Ulcerative Colitis Trials,2016-03-18 11:02:00-04:00,PFE,neutral
1002022.0,Pfizer Says CEO Total Comp For 2015 At $18M Vs Prior Year $23.3M; CFO Total Comp In 2015 $6.7M Vs Prior $8.5M,2016-03-15 16:40:00-04:00,PFE,neutral
1002023.0,"The Stocks That Moved The S&P, Dow And Nasdaq Today",2016-03-14 16:29:00-04:00,PFE,neutral
1002024.0,AstraZeneca Looks to Link Executive Compensation to $45B Revenue Target -Bloomberg,2016-03-13 17:17:00-04:00,PFE,neutral
1002025.0,"The Stocks That Moved The S&P, Dow And Nasdaq Today",2016-03-11 16:19:00-05:00,PFE,neutral
1002026.0,Pfizer Shares Quiet Following Co. Release XALKOR Has Been Approved by the FDA for Treatment of Patients with ROS1-Positive Metastatic Non-Small Cell Lung Cancer,2016-03-11 13:18:00-05:00,PFE,negative
1002027.0,XALKORI Approved by U.S. FDA for the Treatment of Patients with ROS1-Positive Metastatic Non-Small Cell Lung Cancer,2016-03-11 13:10:00-05:00,PFE,negative
1002028.0,FDA Approves Generic Version of Viagra,2016-03-09 17:48:00-05:00,PFE,positive
1002029.0,Pfizer Reports Commencement of $5B Accelerated Buyback Plan,2016-03-09 06:47:00-05:00,PFE,neutral
1002030.0,UPDATE: Pfizer Says Phase 3 Study Showed Prophylaxis with BeneFIX Significantly Reduced Annualized Bleeding Rate Compared to On-Demand Therapy,2016-03-08 17:01:00-05:00,PFE,neutral
1002031.0,Pfizer Reports Publication of Study Results for BeneFIX Coagulation Factor IX Once-Weekly Prophylaxis for Hemophilia B,2016-03-08 17:00:00-05:00,PFE,neutral
1002032.0,"UBS Maintains Buy On Pfizer & PT $36, Says Allergan Deal Makes Strategic Sense And Believes Consensus Fails To Give Sufficient Credit To Allergan Pipeline",2016-03-08 06:51:00-05:00,PFE,negative
1002033.0,"Jefferies Maintains Buy On Pfizer, Lowers PT From $45 To $42",2016-03-08 06:00:00-05:00,PFE,negative
1002034.0,The Other Sector ETF Player,2016-03-07 14:26:00-05:00,PFE,neutral
1002035.0,Allergan Files Form S-4 for Offering of Securities Related to Merger With Pfizer,2016-03-07 06:25:00-05:00,PFE,positive
1002036.0,"UPDATE: Merck, Pfizer, and Verastem Combination Trial Of Avelumab and VS-6063 Expected To Begin In 2nd Half 2016",2016-03-03 07:16:00-05:00,PFE,neutral
1002037.0,"Merck KGaA, Darmstadt, Germany, Pfizer and Verastem Report Combination Trial of Avelumab and VS-6063 in Ovarian Cancer",2016-03-03 07:10:00-05:00,PFE,negative
1002038.0,Stocks To Watch During Cowen's 36th Annual Healthcare Conference,2016-03-01 13:21:00-05:00,PFE,neutral
1002039.0,Bernie Sanders  ‏@SenSanders Tweet: Enough is enough. Pfizer and other pharmaceutical companies can no longer be allowed to rip off American patients.,2016-02-25 14:12:00-05:00,PFE,negative
1002040.0,Pfizer ReportsFDA Approval of XELJANZ Extended-Release Tablets Treatment for Rheumatoid Arthritis,2016-02-24 11:16:00-05:00,PFE,positive
1002041.0,"Viiv Healthcare Phase II Study, Says Comparable Viral Suppression Rates Btwn Injectable Regiment & 3 Drug Oral Regimen",2016-02-23 14:57:00-05:00,PFE,neutral
1002042.0,"Allergan Gains 1.50% Following Q4 Beat, Company Updates On M&A Activity",2016-02-22 08:51:00-05:00,PFE,positive
1002043.0,Slump Could Be Healthcare ETF Buying Opportunity,2016-02-22 07:44:00-05:00,PFE,positive
1002044.0,"The Stocks That Moved The S&P, Dow And Nasdaq Today",2016-02-17 16:32:00-05:00,PFE,neutral
1002045.0,Everything You Might Have Missed This 13F Season: Part 2,2016-02-17 15:58:00-05:00,PFE,negative
1002046.0,Paulson & Co Reports New Stake In Pfizer,2016-02-16 17:09:00-05:00,PFE,neutral
1002047.0,10 M&A Deals The Market Thinks Might Not Happen,2016-02-16 14:53:00-05:00,PFE,neutral
1002048.0,"13F from Cooperman's Omega Shows Reduced Stakes in Anadarko, Facebook, Motorola Solutions, Pfizer, Time Warner",2016-02-16 09:49:00-05:00,PFE,positive
1002049.0,13F from JANA Shows New ~9.17M Share Stake in Pfizer,2016-02-16 08:20:00-05:00,PFE,positive
1002050.0,"Pfizer Reaches Agreement to Resolve Medicaid Protonix Claims, Wyeth to Make ~785M Payment",2016-02-16 06:48:00-05:00,PFE,positive
1002052.0,Schroer: Biotech Will Turn Around,2016-02-13 22:12:00-05:00,PFE,neutral
1002053.0,"13F from Appaloosa Shows New Stakes in Southwestern Energy, Kinder Morgan, Pfizer",2016-02-12 16:34:00-05:00,PFE,positive
1002054.0,The Generic Drug Battle,2016-02-10 09:13:00-05:00,PFE,negative
1002055.0,BoA Adds Pfizer To US 1 List; It 'Won't Keep You Up At Night',2016-02-09 09:52:00-05:00,PFE,neutral
1002056.0,Most Of Credit Suisse's Top Investment Ideas For 2016...In One Place,2016-02-08 15:56:00-05:00,PFE,positive
1002057.0,"Schoenebaum: Biotech P/Es Show 'Buying Signal' With Caveat; Amgen, Biogen, Celgene & Gilead Have Catalysts",2016-02-08 15:27:00-05:00,PFE,neutral
1002058.0,How To Invest In An Aging World With The 'Live Long & Prosper' ETF,2016-02-08 10:53:00-05:00,PFE,neutral
1002059.0,RBC Analyst Says 'Buy The Spread' On Allergan-Pfizer Deal,2016-02-08 09:12:00-05:00,PFE,neutral
1002060.0,Pharmaceuticals Turn To Politics To Protect Prices,2016-02-08 08:17:00-05:00,PFE,positive
1002061.0,"RBC Capital Positive On AGN, Would Use Co To Be Long On PFE/AGN Spread, Expects Deal To Close In H2 2016, Maintains Outperform And $354 PT",2016-02-08 07:57:00-05:00,PFE,positive
1002062.0,A Checkup On A Big Healthcare ETF,2016-02-05 13:19:00-05:00,PFE,neutral
1002063.0,How To Build A Defensive Portfolio,2016-02-04 15:13:00-05:00,PFE,neutral
1002064.0,25 Companies That Could Still Buy Back Mountains Of Stock,2016-02-04 12:39:00-05:00,PFE,neutral
1002065.0,Is Big Pharma Hinting At A SMID-Cap Biotech Rally?,2016-02-03 13:16:00-05:00,PFE,neutral
1002066.0,Joe McCann: Here's How To Play Biotech Market In Earnings Season,2016-02-03 11:48:00-05:00,PFE,positive
1002067.0,Earnings Recap For February 2,2016-02-02 16:45:00-05:00,PFE,neutral
1002068.0,Pfizer Holds Steady After Q4 Report,2016-02-02 13:42:00-05:00,PFE,neutral
1002069.0,From Conf Call: Pfizer CEO Feels Planned Tax-Inversion Merger With Allergan Is Fully Within U.S. Law,2016-02-02 10:47:00-05:00,PFE,neutral
1002070.0,"Hearing Intercept Pharma hires JPM to Handle Interest from Pfizer, Gilead, BristolMyers -Daily Mail",2016-02-02 09:43:00-05:00,PFE,positive
1002071.0,"Pfizer Reports Better-Than-Expected Q4, Shares Dip Lower",2016-02-02 07:23:00-05:00,PFE,neutral
1002072.0,Pfizer Sees FY Rennue $49B to $51B vs $52.5B est,2016-02-02 06:49:00-05:00,PFE,neutral
1002073.0,Pfizer Sees FY EPS $2.20 to $2.30 vs $2.36 est,2016-02-02 06:48:00-05:00,PFE,neutral
1002074.0,"Pfizer Q4 EPS $0.53 vs $0.52 est, Revenue $14.05B vs $13.56B est",2016-02-02 06:46:00-05:00,PFE,neutral
1002075.0,Must Watch Stocks for Today,2016-02-02 04:23:00-05:00,PFE,neutral
1002076.0,"Earnings Scheduled For February 2, 2016",2016-02-02 04:01:00-05:00,PFE,neutral
1002077.0,"Earnings: Pharma Tends to Top Street Estimate—Can PFE, MRK Repeat?",2016-02-01 10:38:00-05:00,PFE,positive
1002078.0,"Stock Marquee is Crowded in Week Ahead: Oil, Earnings, Labor Data",2016-02-01 10:28:00-05:00,PFE,neutral
1002079.0,UPDATE: Portola Pharma Licensing Deals for Andexanet Alfa in Japan Valued at Up to $120M,2016-02-01 07:04:00-05:00,PFE,positive
1002080.0,Bristol-Myers and Pfizer Announce Collaboration with Portoloa Pharma,2016-02-01 06:56:00-05:00,PFE,neutral
1002081.0,Mixed Earnings Expectations For Merck And Pfizer,2016-01-31 19:21:00-05:00,PFE,neutral
1002082.0,Large Johnson & Johnson Shareholder Just Revealed 8 Major Concerns,2016-01-28 15:27:00-05:00,PFE,neutral
1002083.0,"JNJ Kicks Off Health Care Earnings—What About Deals, Buybacks?",2016-01-25 11:43:00-05:00,PFE,positive
1002084.0,US Big Pharma: What To Watch For In Q4 Results,2016-01-25 11:16:00-05:00,PFE,neutral
1002085.0,The FDA Just Crushed Sarepta Therapeutics' Hopes Of Releasing A Muscular Dystrophy Drug,2016-01-21 11:23:00-05:00,PFE,neutral
1002086.0,"Philogen Announces Pfizer Exercised Options Granted Under Deal Established in Dec. '14 for Potential Development, Commercialization of Multiple ADCs",2016-01-21 09:06:00-05:00,PFE,positive
1002087.0,Write A Prescription For This Healthcare ETF,2016-01-15 08:24:00-05:00,PFE,neutral
1002088.0,"Pfizer Announces Acquisition Of Top Chinese Healthcare Brand, Considering Sale Of Hospira Pump Unit",2016-01-14 10:10:00-05:00,PFE,positive
1002089.0,Pfizer Considers Sale of Hospira Pump Unit -Bloomberg,2016-01-14 04:33:00-05:00,PFE,neutral
1002090.0,Pfizer Acquires Treerly Healthfrom Sirio Pharma; Terms Not Disclosed,2016-01-14 04:28:00-05:00,PFE,neutral
